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Abstract
This thesis deals with the development of a living biointerface between syn-
thetic substrates and living cells to engineer cell-material interactions for tissue
engineering purposes. This living biointerface is made of Lactococcus lactis, a
non-pathogenic lactic bacteria widely used as starter in the dairy industry and,
recently, in the expression of heterologous proteins in applications such as oral
vaccine delivery or membrane-bound expression of proteins.
L. lactis has been engineered to display the III7−10 fragment of the human
fibronectin, fused to GFP as reporter protein. Fibronectin is a ubiquitous protein
present in the extracellular matrix, a complex mesh of structural and adhesive
proteins which serve as mechanical support and development niche for cells
of a wide variety of tissues. This fragment contains two important sequences,
RGD and PHSRN. RGD is an adhesive sequence that interacts with a wide range
of integrins, membrane-bound receptors that play a role in cellular processes
such as adhesion, migration, proliferation and differentiation. On the other
hand, PHSRN binds synergistically with RGD to some integrins such as α5β1
and others, increasing the specificity of this interaction.
Genetically engineered L. lactis has been thoroughly characterized to test its
capabilities as a living interface. This strain was engineered to express the FN
III7−10 -GFP fragment covalently linked to the cell wall and biological activity
and expression levels of this fragment were assessed with techniques such as
Western blot, ELISA and immunofluorescence. Moreover, this strain still holds
the ability to develop biofilms, communities of sessile, attached bacteria to
abiotic surfaces which helps greatly in the generation of a stable monolayer of
bacteria between synthetic substrates and mammalian cells.
Mammalian cell behaviour in response to the expressed fibronectin fragment
on L. lactis membrane was also assessed. Several cell lines were tested, such as
Fn−/Fn− and NIH3T3 fibroblasts, C2C12 myoblasts and human bone-marrow
derived mesenchymal cells. This living biointerface was found to trigger cell
adhesion and FAK phosphorylation, a marker for intracellular integrin-mediated
i
signalling in all of the tested cell lines. It also triggered myoblast-to-myotube
differentiation on C2C12 cells. In hMSCs, the cell-wall exposed fibronectin
fragment was found to enhance the phosphorylation of ERK1/2, a kinase
involved in the MAPK pathway, which is deeply involved in a multitude of
cellular processes related to differentiation, proliferation and migration.
Nevertheless, this thesis is a proof of concept that this novel system can be
further exploited to express almost any desired protein or small molecule to
help in the development of new tissues from progenitor cells. These molecules
can be either secreted in the medium or displayed in the membrane, and can
also be constitutively expressed or in-demand, due to the great flexibility of L.
lactis and the wide variety of expression systems available.
This interface based on living bacteria establishes a new paradigm in surface
functionalization for biomedical engineering applications.
ii
Resumen
Esta tesis aborda el desarrollo de una biointerfase viviente entre materiales
sintéticos y células vivas con el objetivo de dirigir la interacción célula-material
en aplicaciones de ingeniería tisular. Esta biointerfase está formada por Lactococ-
cus lactis, una bacteria láctica no patógena, ampliamente usada en la industria
láctea como inóculo y recientemente, en la expresión heteróloga de proteínas
para su uso como vacunas de administración oral o su expresión en membrana.
L. lactis ha sido modificada genéticamente para expresar el fragmento III7−10
de la fibronectina humana unida a GFP como reporter. La fibronectina es una
proteína presente de forma ubicua en la matriz extracelular, una compleja red
de proteínas adhesivas y estructurales cuyo propósito es servir como soporte
estructural y como nicho de desarrollo para diversos tejidos. Este fragmento
contiene dos secuencias importantes, RGD y PHSRN. RGD es una secuencia
adhesiva de unión que interacciona con una amplia variedad de integrinas,
receptores de membrana que juegan muchos e importantes papeles en diferentes
procesos celulares como adhesión, proliferación, migración o diferenciación.
Por otra parte, PHSRN se une a las integrinas de forma sinérgica con RGD
facilitando aún más estos procesos y aumentando la especificidad de esta
interacción.
Esta cepa modificada de L. lactis ha sido caracterizada para estudiar su
idoneidad como interfaz funcional viviente. Se ha demostrado que L. lactis
es capaz de expresar el fragmento FN III7−10–GFP covalentemente anclado a
la pared celular bacteriana, habiéndose caracterizado también su actividad
biológica con técnicas como Western blot, ELISA e inmunofluorescencia. Esta
cepa mantiene la capacidad de desarrollo de biofilms presente en la gran
mayoría de microorganismos. Los biofilms son comunidades de bacterias sésiles
adheridas a un sustrato que pueden ser usadas como interfase física entre
células de mamífero y sustratos abióticos.
También se ha estudiado la respuesta celular a la fibronectina expuesta en la
membrana de L. lactis. Se estudiaron varias líneas celulares, como fibroblastos
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Fn−/Fn− y NIH3T3, mioblastos C2C12 y células mesenquimales humanas de-
rivadas de médula ósea. Esta interfase viviente fue capaz de provocar respuesta
celular en forma de adhesión en todas las líneas estudiadas, además de inducir
diferenciación de mioblastos a miotubos en C2C12 y de provocar la fosforilación
de FAK, un marcador de señalización celular mediada por integrinas.
En células mesenquimales humanas se demostró la capacidad del fragmento
de fibronectina expuesto para fosforilar ERK1/2, una kinasa perteneciente a la
ruta de señalización MAPK, ruta que forma parte de muchos procesos celulares
importantes como diferenciación, proliferación y migración.
Pese a todo, esta tesis es sólo una prueba de concepto de un sistema que
puede ser utilizado para expresar casi cualquier proteína o molécula pequeña
deseada, que puede ser muy útil en el desarrollo de nuevos tejidos a partir de
sus células progenitoras. Estas moléculas pueden ser secretadas en el medio o
ancladas en la pared celular, de forma constitutiva o bajo demanda, debido a
la flexibilidad y amplia variedad de sistemas de expresión disponibles para L.
lactis.
Esta biointerfaz basada en bacterias vivas establece un nuevo paradigma en




Aquesta tesi aborda el desenvolupament d’una interfase viva entre materials
sintètics i cèl·lules vives amb l’objectiu de dirigir la interacció cèl·lula-material,
per al seu ús en aplicacions d’enginyeria tissular. Aquesta interfase està com-
posta de Lactococcus lactis, un bacteri làctic, no patogènic i àmpliament utilitzat
en l’industria làctica com a inòcul, i, recentment, en l’expressió heteròloga
de proteïnes per al seu ús com vacunes d’administració oral o per a la seva
expressió en membrana.
L. lactis ha sigut genèticament modificada per a expressar el fragment III7−10
de la fibronectina humana, unida a GFP com a reporter. La fibronectina és una
proteïna present de forma ubiqua en la matriu extracel·lular, una complexa
xarxa de proteïnes adhesives i estructurals que serveixen de suport estructural
i nínxol de desenvolupament per a diversos teixits. Aquest fragment conté
dos seqüències importants, RGD i PHSRN. RGD és una seqüència adhesiva
d’unió a integrines, receptors de membrana que juguen molts i molt importants
papers en diferents processos cel·lulars, com adhesió, proliferació, migració o
diferenciació. Per altra banda, PHSRN s’uneix a les integrines de forma sinèrgica
amb RGD facilitant encara més aquests processos i augmentant l’especificitat
d’aquesta interacció.
Aquest cep de L. lactis ha estat àmpliament caracteritzat per estudiar les
seves característiques com a interfase funcional vivent. S’ha demostrat que
L. lactis és capaç d’expressar el fragment FNIII7−10-GFP covalentment ancorat
a la paret cel·lular bacteriana, havent-se caracteritzat també la seva activitat
biològica amb tècniques com Western blot, ELISA i immunofluorescència. A més,
aquest cep manté la capacitat de desenvolupament de biofilms, comunitats de
bacteris sèssils adherits a un substrat que poden ser utilitzades com a interfase
física entre cèl·lules de mamífer i substrats abiòtics.
També s’ha estudiat la resposta cel·lular a la fibronectina expressada en la
paret cel·lular de L. lactis. El estudi es va fer utilitzant diverses línies cel·lulars,
com fibroblasts Fn−/Fn− i NIH3T3, mioblasts C2C12 i cèl·lules mesenquimals
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humanes derivades de medul·la òssia. Aquesta interfase vivent va ser capaç de
provocar resposta cel·lular en forma d’adhesió a totes les línies estudiades, a
més d’induir diferenciació de mioblasts a miotubs en C2C12 i de provocar la
fosforilació de FAK, un marcador de senyalització cel·lular mediat per integrines,
en les línies assajades. En cèl·lules mesenquimals humanes es va demostrar
la capacitat del fragment de fibronectina exposat per a fosforilar ERK1/2,
una kinasa pertanyent a la ruta de senyalització MAPK, ruta que forma part
d’important processos cel·lulars com diferenciació, proliferació i migració.
Malgrat tot, aquesta tesi només és una prova de concepte d’un sistema
que pot ser utilitzat per expressar quasi qualsevol proteïna o molècula petita
desitjada, que pot ser molt útil en el desenvolupament de nous teixits a partir
de les seves cèl·lules progenitores. Aquestes molècules poden ser secretades en
el medi o ancorades a la paret cel·lular, de manera constitutiva o baix demanda,
a causa de la flexibilitat i àmplia varietat de sistemes d’expressió disponibles
per a L. lactis
Aquesta biointerfase basada en bacteris vius estableix un nou paradigma
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1.1 Biomaterials and tissue engineering
Tissue engineering is defined as an interdisciplinary field that applies the prin-
ciples of engineering and life sciences toward the development of biological substi-
tutes that restore, maintain, or improve tissue function or a whole organ [1]. The
loss or failure of an organ or tissue is one of the most frequent and devastating
healthcare problems, and has tried to be solved using different approaches,
such as transplants, autologous grafts, prostheses and tissue regeneration. [1]
Nowadays, the main purpose of tissue engineering is the repair of damaged
organs and the recreation of new ones. Tissue engineering makes use of different
approaches to regenerate or create a new tissue. A first approach involves the
isolation of cells from the patient, followed by an in vitro expansion and their
culture on suitable biomaterials with the ability to direct cellular behaviour
and function, followed by their posterior implantation on the damaged site
(autologous implant).
Other approach consists in the in situ liberation of growth factors and other
proteins or compounds with the ability to direct cell fate. This approach relies
on the regenerative ability of the already existent cells, by directing its behaviour.
A third approach involves the use of polymeric scaffolds, trying to recreate and
mimic the characteristics of the extracellular matrix, followed by cell seeding
within the scaffold.
These approaches are complementary and require a deep understanding
of the dynamics and composition of the extracellular matrix, the interaction
between cells and their surroundings and the intracellular processes triggered
by the cell-microenvironment bidirectional communication.
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2 CHAPTER 1. INTRODUCTION
Therefore, tissue engineering requires the use of biomaterials, which are
characterized by its ability to coexist with living tissues inside the human body,
without causing any rejection reaction or harm. [2]
Different inorganic materials have been used as biomaterials, such as metals,
glass or synthetic polymers. Depending on their purpose, properties like bio-
degradability can be useful. For example, implanted patches to assist in the
growth of new tissue which will eventually degrade leaving the mature tis-
sue, or non-biodegradable materials with specific physical properties and good
biocompatibility, such as titanium parts used in hip replacement. [3]
However, almost all of the tissue engineering approaches require a cell
source. Stem cells, with suitable differentiation capabilities, are routinely used
in research as of today, and several appropriate sources have been identified,
such as bone marrow and adipose tissue. Induced pluripotent stem cells [4]
(iPS) are widely used. These cells show differentiation capabilities similar to
embryonic stem cells, without its ethical and legal issues. The use of iPS derived
from the same patient for its use in autoimplants and alloimplants can overcome
the problems derived from immune rejection. [5–7]
iPS pluripotency is a promising way to regenerate absent or damaged tissue
if the adequate microenvironmental conditions are properly fulfilled. Besides
iPS, other multipotent cell lineages are being used, such as stromal mesenchymal
stem cells, which hold great promise in present and near-future applications
for tissue engineering.
Nevertheless, growth and differentiation of stem cell lineages is unavoidable
without the establishment of an adequate microenvironment where these cells
can grow and differentiate in response to the biochemical, mechanical and
other required stimulus in the development of a new tissue.
1.2 The need for dynamic interfaces
A deep understanding of cell behaviour on synthetic surfaces is of paramount
interest to engineer microenvironments with the ability to direct cell adhesion,
proliferation and differentiation. Surfaces of synthetic materials have been
functionalized with a broad range of proteins, peptides and growth factors,
including fibronectin (FN), laminin, vitronectin, synthetic peptides and others,
by means of physical and chemical strategies. [8–10]
Tissue engineering is a wide knowledge area whose objective is to repair
the structure and function of damaged tissues and organs through a multidiscip-
linary approach, by engineering advanced material-based systems. [1]
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To the date, the most used approach has consisted in the use of passive
coatings such as protein or growth factors, to assist cells in the interaction with
synthetic substrates. [8, 9]
Cells interact with surfaces via integrins [11], a family of transmembrane
receptors which serve as a link between the extracellular environment and
the cytoskeleton. Integrins initiate several intracellular signaling pathways
acting also as mechanical transducers, controlling cell motility, cytoskeleton
reorganization amongst other complex cellular processes. [11–13]
However, the development of a mature tissue requires the display of a
sequence of biochemical signals to the growing tissue in a highly controlled
manner. Passive coatings cannot provide these dynamic stimuli, although
significant efforts have focused on engineering materials that recapitulate ECM
characteristics. Some examples of these coatings include cell adhesive motifs
or protease degradable cross-links. Photoactivable RGD adhesive peptides
have been used to investigate the effect of density and time point of ligand
presentation on cell adhesion, proliferation and differentiation. [14].
Similarly, enzyme-responsive surfaces have been tested. These surfaces
display cell adhesive RGD sequences on-demand, by presenting inactive RGD-
containing precursors that carry cleavable steric blocking groups, which can be
later exposed to the cells by means of an enzymatic hydrolysis. [15]
Consequently, the development of a cell-material interface able to present
different biochemical stimuli on demand, that is, a functional dynamic interface
between stem cells and synthetic materials, has not been established yet.
Our working hypothesis is that non-pathogenic bacteria can play this role,
since they are able to colonize a broad range of synthetic materials, from
synthetic polymers to glass or metals and thus can establish an interfacial layer
between these materials and the mammalian cells. This interfacial layer is
functionally equivalent to surfaces coated with extracellular matrix components
such as fibronectin, collagen and others, with the added advantage of the
on-demand expression of almost any desired biochemical cue.
These bacteria can be genetically modified easily, allowing a constitutive or
on-demand expression of any needed protein or growth factor, which will aid in
the development of a new tissue. The aim of this work is to further investigate
this hypothesis and show the feasibility of dynamic biointerfaces based on living
organisms.
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1.3 Interfaces based on living bacteria as a novel concept
In this thesis we hypothesize that genetically modified, non-pathogenic bacteria
can play the role of a living biointerface between mammalian cells and synthetic
biomaterials.
Interfaces based on living bacteria have some advantages over classic bio-
materials, which interact with living cells only in a limited way, or show no
interaction at all [16]. Therefore, an intermediate protein layer is required to
display active biochemical signals to the cells that are in contact with. These
protein layers are, in most cases, a passive coating that can only provide a static
stimulus, not sufficient to create a dynamic microenvironment, which is needed
for the successful development of a mature tissue. To resolve these issues, we
propose a living biointerface as a feasible solution to address these issues.
The proposed biointerface is composed by a monolayer of Lactococcus lactis
subsp. cremoris MG1363 that express the III7−10 fragment of human fibronectin
in its surface. L. lactis is a gram-positive, non-pathogenic, lactic bacteria which,
since its genome has been fully sequenced, has been object of an intense research
in recent years [17, 18]. Several constitutive and inducible protein expression
systems are readily available. [19–24]
Moreover, this strain has become a broadly used host for heterologous
protein expression [25–30]. The heterologously expressed III7−10 fragment in
its cell wall contains the adhesive RGD peptide, located on the III10 repeat,
and the synergy PHSRN motif, located on the III9 repeat. Both sequences
interact synergistically with the α5β1 integrin, involved in the cellular adhesion
process and in the later migration, proliferation and differentiation and plays
an important role in the tissue development process. [11]
The III7−10 fragment has been shown to induce cell response when coated
on synthetic substrates [31]. The initial purpose of this work is the membrane-
bound expression of this fragment and the assessment of the biological beha-
viour of a mammalian cell population cultured on top of this biointerface.
1.4 Bacterial adhesion
Since bacteria-based biointerfaces will be assessed throughout this work, it
is important to have a good understanding of its interaction with synthetic
surfaces.
Microbial adhesion is the first step in the development of a biofilm. Al-
though biofilms can be detrimental to human life and industrial processes, due
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to its ability to colonize implants and its role in conditions such as periodontitis,
caries [32] and other diseases, amongst the enhanced corrosion rates of metallic
surfaces [33], they also play beneficial roles in the nature, such as degrada-
tion of environmental hazardous chemicals in soil [34, 35], in bioreactors for
wastewater treatment [36] or off-gas treatment [37], in agricultural uses of
root nodule bacteria in the rhizosphere [38], in the degradation of biopolymers
such as cellulose [39], and in bioflocculants used for the separation of coal
particles [40].
Bacterial cells have a size range from 0.5 to 2 µm, similar to colloids,
consequently interaction between charged bacterial cells and surfaces can be
described using the DLVO (Derjaguin–Landau–Verwey–Overbeek) theory [41],
originally developed to describe the interaction between colloidal particles and
surfaces.
The interaction between a particle and a surface can be expressed as the
sum of the Van der Waals and Coulomb forces. Van der Waals are attractive,
very short-ranged forces whose intensity decreases exponentially with distance,
being negligible at long distances, while Coulomb or electrostatic forces can be
either attractive or repulsive, with a longer interaction range [42]. Van der Waals
forces become dominant below 5 nanometres, hence particles that approach
to a surface at a short enough distance can attach irreversibly. This approach
can be via Brownian motion or due to cell motility. Usually, natural surfaces
are negatively charged [41], and that is the case for most bacteria. Surfaces
in contact with an aqueous environment exhibit a net negative charge. To
compensate this charge, a cationic counterion layer is formed in the immediate
vicinity of the charged surface, either on the material or bacterial surface.
This counter-ion layer acts as an “electrostatic shield", resulting in an ionic
double layer and a net repulsive force at medium distances (Figure 1.1). This
electrostatic repulsion is highly dependent on the ionic strength of the medium.
Therefore, three different scenarios can be described.
At low ionic strengths, when a charged bacterium approaches the surface,
appears a repulsive energy barrier that cells cannot overcome by Brownian
motion or motile forces. As ionic strength increases, the electric double layer
becomes shielded by the ions present in the medium and this repulsive elec-
trostatic interaction lessens. At intermediate ionic strengths, there is still an
energy maximum, but also a shallow secondary energy minimum outside the
of the energy barrier (Figure 1.2, center). At very high ionic strengths, the
electrostatic energy barrier almost disappears, and theoretically, a charged
particle would be able to approach to a surface and attach irreversibly.
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Figure 1.1 Bacteria and surfaces are, typically, negatively charged. This negative
charge is counterbalanced by cations, creating a double layer that results in a net
electrostatic repulsion between cells and surfaces.
Figure 1.2 Free Gibbs energy (G) in three different ionic strength scenarios.
From left to right, high ionic strength, where charged colloids become shielded
and the maximum fades. In the middle, a shallow minimum appear and charged
particles can approach to a distance close to the surface. In the low ionic strength
scenario, charged particles are not shielded and the repulsive electrostatic force
increases as the particle approaches to the charged surface.
In light of the above, only the intermediate ionic strength medium scenario
will be taken in account, as it is the most frequent scenario for bacterial and
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cell culture medium (Figure 1.2).
The distance from the surface to the secondary minimum is usually located
within several nanometres, depending on the ionic strength. A charged particle
will be able to approach to this minimum and attach reversibly. This is the first
step of bacterial adhesion. If we were bearing in mind only colloidal particles,
this adhesion would be considered reversible, because strong enough shear
forces would detach the particle from the surface.
Nevertheless, in a bacterial adhesion scenario, there is a chance that some
adhered bacteria will use nanofibres, such as pili and fimbriae, with the ability
to pierce the energy barrier and irreversibly attach the cell to the surface (Figure
1.3).
Figure 1.3 Two-step model of bacterial adhesion. In the first step, the cell
approaches to the secondary minimum, attaching reversibly to the surface. In
the second step, nanostructures such as pili and fimbriae are used by the cell to
overcome the electrostatic potential barrier leading to an irreversible attachment.
A correlation between decreased bacterial adhesion and decreased ionic
strength has been found, which is consistent with the DLVO theory [41]. How-
ever, DLVO theory is not enough to properly describe the interaction between
charged cells and surfaces. Van Oss developed the extended DLVO (XDLVO)
theory [43, 44], also known as the thermodynamic approach, based on the
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surface free energy, defined as
∆Gadh = γSB − γSL − γLB
Where ∆Gadh is the free interaction energy, γSB, γSL and γLB the surface-
bacteria, surface-liquid and bacteria-liquid interfacial free energies, respectively.
Negative ∆Gadh values will favour the interaction.
The DLVO model describes a two-step adhesion process. Since in the first
adhesion step there is not direct contact between the substrate and the bacterial
surface due to the energy barrier depicted in the Figure 1.3, the minimum dis-
tance among bacteria and surface is always in the range of several nanometres.
The first reversible interaction is instantaneous while the second phase is time-
dependent. The thermodynamic approach only takes into account interfacial
energies, thus the formation of a new cell-surface interaction is at the expense
of the surface-liquid and bacteria-liquid interfaces, in contrast with the DLVO
theory where the interaction energy is distance-dependent.
This approach helps with the explanation of a common observation, that is,
hydrophobic cell surfaces have a preference on hydrophobic materials and vice
versa.
Hydrophobicity is an important factor that affects bacterial self-agglutina-
tion and adhesion [45–51]. The hydrophobic interaction is only a consequence
of the water hydrogen-bonding forces surrounding the hydrophobic moieties
[52], and can be viewed as a form of a more general electron-donor and accepter
or Lewis acid-base interaction. [53] The surface tension γ, according to Van
Oss, involves the Lifshitz-Van der Waals component and the Lewis acid-base
component, γLW and γAB respectively.
The Lifshitz-Van der Waals component comprises the London dispersion,
the Keesom dipole-dipole and the Debye dipole-induced dipole forces. Hydro-
phobic/hydrophilic and osmotic interactions are also included in the extended
DLVO theory [54, 55], but the osmotic interaction is negligibly small in bacterial
adhesion and is not taken into account. [56]
In view of these considerations, free energy can be rewritten as
∆Gadh =∆GvdW +∆Gdl +∆GAB
where ∆Gadh denotes Van der Waals, ∆Gdl electric double layer and ∆GAB
Lewis acid-base interactions. Lewis acid-base interactions includes an attractive
component when hydrophobic and repulsive when hydrophilic. This acid-base
interaction is much higher than the Van der Waals attractive component, but
is only operative at very short distances, with the benefit that there is not a
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repulsive barrier in the vicinities of the surface. This is an advantage over the
DLVO theory, but this acid-base interaction is very short ranged, 5 nanometres
at most.
The energy barrier height can be calculated from the ζ-potential, which can
be determined using the Smoluchowsky equation [57] from the electrophoretic
mobility of cells. A problem of this approach is the fact that electrophoretic
mobility approaches a non-zero value at high ionic strengths [58, 59], in dis-
crepancy with the value proposed in the DLVO theory. Therefore, ζ-potential
is not appropriate for measuring the surface potential of bacterial cells. The
Smoluchowsky equation is only valid for rigid particles, but bacteria can be con-
sidered as soft particles covered with a polymer layer where ions and water can
freely diffuse within. Ohshima proposed a model to determine the ζ-potential
with more accuracy, and Morisaki [58, 59] proposed the following formula to

























Where εR is the relative permittivity of the medium, ε0 is the permittivity
of the vacuum, η the viscosity of the medium, Ψ the surface potential of the
particles, ΨDON the Donnan potential of the polymer layer, κm the Debye-Hückel
parameter of the polymer layer, z the valence of the charged groups in the
polymers, e the electron charge, N the density of the charged groups and λ the
softness parameter. Bacterial cells can be described as particles coated with a
soft polymer layer.
When applying the Ohshima model to bacterial cells, surface potential
of bacterial cells is much smaller than the ζ-potential calculated with the
Smoluchowsky equation, and the energy barrier disappears when the ionic
strength of the medium reaches a sufficiently high value. Only at very low ionic
strength conditions, this energy potential is high enough to prevent bacterial
cells adhering to a surface.
Once an initial attachment has been achieved, bacterial cells start the bio-
synthesis of adhesive structures, such as pili, fimbriae and lipopolysaccharides.
In Lactococcus lactis, there are three major cell-wall anchored proteins or CWAP
responsible of its adhesion behaviour: CluA, PrtP and NisA [60, 61]. CluA
[62, 63] is a chromosomally-encoded sex factor. Both PrtP [64–66], a ser-
ine proteinase, and NisA, a proteinase, are plasmid-encoded proteins. In the
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plasmid-cured strain L. lactis MG1363, the only relevant adhesin is CluA, a 136
kDa cell-wall bound protein which plays a major role in defining its hydrophobic
properties. It is involved in horizontal gene transfer by conjugation, and seems
to be an important protein in bacterial clumping and aggregation, facilitating
the cell-cell adhesion in the early phases of biofilm development.
Biofilms are defined as a microbially derived sessile community characterized
by cells that are irreversibly attached to a substratum or interface or to each other
and are embedded in a matrix of extracellular polymeric substances that they have
produced, and exhibit an altered phenotype with respect to growth rate and gene
transcription. [67] Biofilms can be developed on almost any abiotic or biologic
surface, giving the adequate conditions. The formation and development of a
biofilm is a survival strategy of the microbial cells and can be described as a
four-step process.
Figure 1.4 Biofilm development stages. In the early phase, some cells attach
reversibly to the surface. As cell population growths, in the log phase, few of the
reversibly attached cells adhere and, via the expression of adhesins and clumping
proteins, more cells are recruited. In the stationary phase the biofilm is firmly
established on the surface. The dispersal phase comprises the detachment and
dispersal of the cells adhered within the biofilm, detachment that is caused by the
depletion of the nutrients in the medium or by changes in the physiological state
of these sessile cells.
In the first step, some of the free-floating bacteria, motile or not, approach
the surface and, using the mechanisms described before, reversibly attach to it.
Bacterial adhesion is a stochastic process, and only few of the initially attached
cells will attach irreversibly. [68]
The second step [69] of this process takes place when adhesins such as
CluA and secreted exopolysaccharides, although in very low amount in L. lactis,
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promotes the aggregation and attachment of more cells. This step usually takes
place in the exponential growth phase, assuming that biofilm formation starts
when the culture is still in the early latent phase, with very low bacterial density
in the medium. In this phase, some of the attached cells detach and reattach in
the vicinities.
As the optical density of culture increases, attached bacteria proliferate,
getting to a maximum when the culture reaches the stationary phase, which
can be considered the third phase in biofilm development [70]. In this phase,
the cell division/death ratio approaches to one. Depending on the strain, a
biofilm can be described as a monolayer —that is the case of L. lactis— or
a multi stratified structure, mushroom-like, where cells located next to the
surface display different physiological characteristics when compared to the
ones in close contact with the medium. This behaviour can be attributed to
the repression of genes involved in the biosynthesis of exopolysaccharides and
adhesins, whose expression levels are still high in the planktonic cells.
The fourth and final stage of the biofilm development is the release and
breakdown of the adhered sessile cells. Through quorum-sensing, attached cells
start to express enzymes specialised in exopolysaccharide hydrolysis, resulting
in cell detachment. These cells, although not adhered to a surface, are still
viable and can colonize other surfaces in the vicinities (Figure 1.4). [71]
1.5 Genetic engineering and synthetic biology
Genetic engineering is a knowledge field that deals with the direct manipulation
at a molecular level of an organism genome, by means of biotechnological and
molecular biology techniques. This manipulation involves insertion, deletion or
modification of the existing genetic material. This modification at the molecular
level makes use of enzymes, such as restriction endonucleases, exonucleases,
polymerases, ligases and others. As a result, a genetically modified organism,
either unicellular or pluricellular is obtained. IUPAC defines genetic engineering
as the process of inserting new genetic information into existing cells to modify a
specific organism for the purpose of changing its characteristics. [72]
Several types of genetic manipulations are possible: insertion of a foreign
gene from one species into another, altering a specific gene (mutagenesis), activ-
ating, silencing or changing the expression levels of one or multiple genes using
multiple techniques, e.g. RNA interference [73, 74], antisense oligonucleotides
[74] and riboswitches and ribozymes [75], catalytic RNA molecules with the
ability to cut RNA strands at precise positions. Genetic engineering involves
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the use of recombinant nucleic acid techniques, either DNA or RNA, to create
new genetic sequences into living organisms, transient or permanently, via the
direct modification of the genome or using vectors.
The process of modifying the genetic material of an organism can be arbit-
rarily divided in several steps (Figure 1.5). The first one is the selection of the
organism that will be modified, the host organism. Genetic manipulations can
be carried on bacteria, yeast, fungus, mammalian cells and viruses.
One of the most important hosts used for genetic manipulations is Escherichia
coli, a gram-negative bacteria. This strain has been extensively used in plasmid
engineering and heterologous protein expression, but as of today, there are
commercially available tools for genetic modification and engineering in gram-
positive strains, especially in the lactic acid bacteria clade.
Figure 1.5 General workflow for genetic engineering.
This work deals with the genetic modification of Lactococcus lactis, a gram-
positive strain with industrial interest. It is also important to select the most
adequate vector for our purposes. A genetic vector is a piece of circular DNA,
for example plasmids, cosmids, bacterial artificial chromosomes or others that
carry the desired genetic sequence. Lactococcus lactis is a strain with a wide
variety of commercially available plasmids, with either inducible or constitutive
promoters, several selectable genetic marker genes and multiple cloning sites
(MCS) or polylinkers, where a group of restriction sequences are conveniently
found and ready to use. The use of inducible or constitutive promoters depends
much on the intended application; e.g., proteins toxic to the host organism
cannot be constitutively expressed [76, 77] and must be expressed under the
control of a inducible promoter. Constitutive promoters are in an “always-
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on” state, while inducible promoters require an external stimulus to initiate
the transcription and induce the expression of the protein. Expression on
inducible promoters can be triggered with chemical compounds, environmental
conditions such as pH or temperature, or even light or low-frequency sound
waves. Some inducible promoters show an on/off behaviour, while in others
the expression can be controlled in a stimulus-dependent fashion. [21, 22,
78–80]
The next step in a classic genetic engineering workflow is the preparation of
the DNA sequence to be cloned. This sequence can be obtained from multiple
sources, either living or dead organisms, and amplified with the help of the poly-
merase chain reaction (PCR) to obtain adequate amounts of genetic material. If
the source is RNA, a previous step with reverse transcriptase is required. Reverse
transcriptase is an enzyme that synthesizes complementary DNA strands, or
cDNA, from RNA templates. PCR is a very versatile technique and can be used
to add specific restriction sequences at the 5′ or 3′ ends of sequences, helping
further cloning steps. PCR can also be used to introduce single-nucleotide
mutations, insertions or deletions, by using appropriate primers.
The result of a PCR reaction is a mixture of proteins (the polymerase) and
nucleic acids such as the amplicon, the template, primers, dNTPs and other by-
products. Depending on the application, the amplified DNA should be subjected
to a purification step. This amplicon, which should have a unique and specified
length, can be separated with electrophoretic separative techniques and isolated
and purified from the electrophoretic gel, generally made of agarose. Restriction
endonucleases can be used to cleave in the newly introduced restriction sites
and make it compatible for ligation reactions.
Those restriction enzymes can be used to cleave and linearize the destination
vector. Usually, the multiple cloning site of the destination vector contains
different short-length sequences that can be cleaved with appropriate restriction
endonucleases, which are very useful to generate blunt or sticky ends where
a foreign sequence can be ligated. A well-designed cloning planning will end
with a digested vector with two different sticky ends and the amplified DNA
with the same, compatible cohesive ends.
In the next step, vector and amplified DNA are joined using ligases, enzymes
that covalently join two different DNA sequences by creating a phosphodiester
bond in the sugar backbone of the DNA molecule, resulting in a double stranded
DNA molecule with the desired sequence inserted at the exact point needed.
Besides the classic workflow that makes use of restriction endonucleases
to cleave, linearize vectors and generate compatible ends, newer approaches
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does not need restriction sites at all, such as TOPO® [81], Gateway® [82],
overlap extension PCR [83, 84] or Gibson assembly [85] techniques. These
techniques make use of PCR to generate fragments with overlapping sequences
that can be partially digested with an exonuclease, repaired and joined again
by a polymerase and a ligase.
When the recombinant DNA molecule is ready to be inserted in the host
organism, a bunch of techniques are available to help in this task. In bacterial
cells, electroporation or heat-shock transformation are widely used techniques.
In gram-positive cells, electroporation is the technique of choice, because
of the cell-wall structure. This transformation method consists, first, in the
generation of competent cells with different methods (culture in glycine-rich
medium, to obtain cells with a weakened cell wall) followed by the introduction
of heterologous DNA inside the cell through the application of a very short,
high voltage pulse to the cells in presence of the heterologous DNA.
This electric pulse makes the bacterial membrane permeable through the
formation of temporary pores which last few nanoseconds but allow the entry
of foreign DNA into the cell.
In the heat-shock transformation, cells are kept at 0 °C in presence of cal-
cium chloride and mixed with the plasmid, which attaches to the cell wall. A
quick temperature increase from 0 to 42 °C modifies the fluidity of the lipid
bilayer, giving as a result the formation of temporary pores which allow the
penetration of the plasmid molecules attached to the cell wall into the cyto-
plasmic medium through membrane invagination. Decreasing the temperature
again to 0 °C returns the membrane fluidity to its original value, closing the
pores and trapping the DNA inside the cell.
Other transformation techniques are also available, for exaple the gene gun
or biolistic technique [86, 87], mainly used in plant biotechnology, where DNA-
coated, dense tungsten microparticles are fired through intact cells, entering the
cytoplasm and achieving the desired genetic transformation. For mammalian
cells, lipofection [88, 89] is another technique which involves the generation of
liposomes, usually cationic, containing the heterologous DNA to be inserted in
the cells. Due to the similar structure of the cell membrane and the liposome,
and favoured by their opposite charge, DNA-loaded liposomes fuse to the cell
membrane, releasing the DNA inside the cell cytoplasm.
After a successful transformation, a screening step is necessary to select
the transformed cells. In E. coli, the white-blue colony is the method of choice.
Vectors used to transform E. coli cells usually contain the β-galactosidase gene,
whose function is to metabolise β-galactosides into simpler monosaccharides.
1.5. GENETIC ENGINEERING AND SYNTHETIC BIOLOGY 15
Figure 1.6 Cloning DNA fragments. a) Source DNA is fragmented through the
use of restriction enzymes and b) joined to carrier molecules or vector to produce
recombinant DNA molecules. c) Recombinant DNA molecules are introduced into
a host cell and d) grown to propagate the clones.
Cells cultured on agar plates containing X-gal (5-bromo-4-chloro-3-indolyl-β-
D-galactopyranoside), an indoxyl glycoside, form white colonies when the
β-galactoside gene has been disrupted, that is to say, a heterologous sequence
has been successfully cloned into the plasmid, or blue if the integrity of the gene
is complete. Other selection mechanisms are based on antibiotic resistance.
In bacteria, virtually all of the engineered vectors contain one or more
antibiotic resistance genes, so when a cell has been successfully transformed,
it will be able to grow in medium supplemented with the proper antibiotic.
This technique is not only used on bacteria. Vectors used for mammalian cell
transformation usually contain a geneticin-resistance gene, an aminoglycoside
antibiotic. Geneticin is very toxic to both prokaryotic and eukaryotic cells,
since its mechanism of action involves the inhibition of the polypeptide chain
assembly, leading to cell death. Thereby, correctly transformed cells will display
geneticin resistance.
Positive clones can also be detected by the expression of reporter proteins
such as the green fluorescent protein or GFP [90], a fluorescent protein originally
isolated from the Aequorea victoria jellyfish. This protein displays fluorescence
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at room temperature without the need of external factors. Other commonly
used reporter proteins are the urogen III methyltransferase (UMT), or luxCDABE
[91], a system that comprises a five-gene cassette whose expression proteins
are able to generate and sustain a bioluminescent reaction without the need of
adding any external substrates.
The result of these manipulations is a genetically modified cell that carries
foreign genes, has an altered nucleotide sequence or modified expression levels
of the protein or gene of interest.
Genetic engineering is directly related to synthetic biology (hereinafter
referred to as SB), an emerging knowledge field aimed at the design and
engineering of biologically based parts, novel devices and systems as well as
the redesign of existing, natural biological systems, using engineering design
principles. [92]
While genetic engineering deals with the modification of existing biological
systems, using a sort of copy-paste or de novo synthesis of genes and proteins,
SB holds the potential to entirely develop new genes and, in the long-term,
new organisms tailored to any desired application. The key engineering design
principles that synthetic biologists attempt to incorporate into their experiments
are modularization and standardization of biological parts, such as the BioBrick
approach [93, 94], which is analogous to modularization and standardization
of electronic parts such as inverters, switches, counters, and amplifiers. By
doing so, biological parts may become reusable, and can be readily assembled
to build large and complex biological systems.
Synthetic biology had emerged from genetic engineering. As of today,
researchers are not limited by the naturally occurring DNA sequences that can
be isolated from existing organisms. There are tools available for designing
new DNA sequences, by applying engineering principles [93, 94]. Entire genes
can be synthesized from scratch, and may incorporate some desirable genetic
features with great flexibility. The complexity of new biological systems is
boosted by the capacity of building, apart from genes, large DNA molecules
such as plasmids, pathways and whole genomes. Furthermore, computational
modelling tools are being used by researchers to make better predictions of
the properties of a biological system prior to physical construction. Synthetic
biology can be seen as a “quantum leap" in genetic engineering. [95]
The foundations of genetic engineering established in the later decades,
allowing researchers to manipulate living organisms at a molecular level, have
evolved into an entirely new, highly multidisciplinary discipline, where biologists
and engineers work together to design from scratch, predict properties of and
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build new biological systems, either using existent biological components or
designing new ones. This work focus in the use of genetic engineering to develop
a modified version of L. lactis, by using classic GE techniques, like restriction,
amplification and transformation, making use of new synthetic biology tools. A
commonly used example are the genetically engineered plasmids. These small
circular DNA sequences are as old as life, but when SB burst in, new plasmids,
tailored to specifically designed applications were produced. Example given,
the two plasmids used in this work are real examples of the application of
synthetic biology to solve an actual problem.
Taking pT1NX as an example, we can see that different sequences from
diverse species, with specific functionality, have been joined in order to create
a useful tool for heterologous protein expression in Lactococcus. This plasmid
contains the P1 putative lactococcal promoter, an isolated genetic sequence
where the RNA polymerase I attaches and starts the DNA to RNA transcription.
This genetic sequence can be cloned and re-used in other applications. Other
features of pT1NX are the presence of an erythromycin resistance gene isolated
from Enterococcus faecalis, a gene that gives antibiotic resistance to the bacteria.
The most interesting region of this plasmid is the coding sequence, formed by
Usp45sp, a multiple cloning site and the spaX gene. Usp45sp is a secretion
peptide originally found in Usp45, a strictly secreted protein found in L. lactis
with no known biological activity; this is not an obstacle to use it as a small
functional part. In between, the polylinker, a nucleotide sequence comprised of
several small (5-8 nucleotides) sequences cleavable with the proper restriction
endonucleases. Polylinkers are not found in the nature, and can be considered
artificial constructs with a specific purpose.
Finally, the spaX gene translates into the S. aureus protein A, a cell-wall
anchored protein used in a wide variety of plasmids to efficiently promote the
membrane localization of any desired protein. pT1NX takes advantage of genes
found in other species, with defined functions, to achieve the goal to promote
the membrane localisation of any desired protein, so this is a small but clear
example of synthetic biology applied to a specific problem.
Nevertheless, the scope of synthetic biology goes beyond the re-use of
already existing parts “produced” by evolution [96]. In the long-term, once a
substantially knowledge of how nature works is achieved, biologists and engin-
eers, in collaboration with bioinformatics, mathematicians and physics, will be
able to create proteins and genes, from scratch, with the desired functionality.
Until the present day, SB had achieved some remarkable advances, for example
new promoters with either high or low potency, inducible and combinatorial
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promoters [97] or synthetic oscillators. [98]
These oscillators share a defining characteristic: the ability to express a
protein in a periodic fashion without the need of any external stimulus. They are
based on repression-activation transcription factors and can be used to replicate
the circadian cycle found in many organisms. Other remarkable achievements
of synthetic biologists are the creation of logic gates [99]— XOR, OR, AND, NOT,
and the development of a DNA-based memory, equivalent to computer memory,
that is permanently integrated in the DNA sequence and lasts hundreds of
generations (DNA replications).
The modified, fibronectin-expressing bacterial biofilm presented in this work
can be considered as proof of concept where a living system composed of a
clonal population of genetically modified bacteria has been modified to play a
role replacing and enhancing another system such as the protein coatings used
in cell culture and tissue engineering, allowing its use as a dynamic interface
where mammalian cells are able to attach, grow, differentiate and migrate in
response to the stimulus provided by the bacterial population. This modified
bacteria is playing a completely different role of its intended industrial use as
dairy starter.
This system can take advantage of recent developments in synthetic biology,
such as the feedback loop constructs [100], which can be used for the develop-
ment of a self-regulating interface that can provide a way to establish a two-way
communication between the biofilm and the mammalian cells. In mesenchymal
stem cells, metabolic and signalling pathways become activated as the differen-
tiation progresses and can be used as triggers for the expression of biochemical
cues in the underlying biointerface, helping cells in its differentiation process.
Moreover, this interface does not need to be strictly composed of living
organisms. Some authors [101] have successfully developed micro-scale cell-
free expression systems where, using the minimal required machinery, proteins
can be biosynthesized and promoted to its optimal location, either exposed in a
surface or secreted in the medium. The combination of feedback loop constructs
with cell-free artificial expression systems enclosed in biomimetic membranes
[102, 103], with tightly regulated protein expression, enables the development
of tailored systems without the disadvantages of genetically modified organisms.
For example, the presence of undesirable proteins and unwanted metabolic
products such as L-lactic acid or ethanol can be avoided, and the uncontrolled
bacterial proliferation or biofilm formation, establishment and breakup cycle,
that could limit the long-term stability of these cultures can be surpassed.
In the long term, a fully synthetic and tightly regulated biointerface could
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be developed, based entire or partially on reusable components. In this biointer-
face, a constant two-way communication among the mammalian cells and the
underlying protein production machinery would exist, allowing the precisely
timed expression of the required signalling needed for the development of new
tissues from its progenitor cells.
1.6 Cell adhesion
The extracellular matrix
The extracellular matrix (ECM) is a heterogeneous and dynamic mesh of fibrillar
and non-fibrillar components that serve as support and provides an active
microenvironment that supports cell adhesion, differentiation, migration and
proliferation. It regulates a wide variety of cell functions by activating multiple
signalling pathways at adhesion sites. ECM acts as a reservoir for growth factor
and fluids and can be assembled into elaborated structures participating in
basement membranes and providing a scaffold for tissue organization.
The main components of the ECM are structural proteins such as collagens
and elastin, which provide strength and flexibility for the matrix, constituted by
proteoglycans, protein-polysaccharide complexes where the structural proteins
are inserted, and glycoproteins such as fibronectin and laminin, which provide
adhesion cues to the cells.
ECM components are produced in situ by resident cells and secreted as non-
functional protein units, which are assembled into functional supramolecular
structures in a highly regulated manner. [104–107]
It also plays an important role in processes like growth, wound healing and
fibrosis. Defects in assembly stops embryogenesis, deranged assembly promotes
scarring, tumorigenesis and fibrotic disease, while delayed assembly provokes
birth defects, skeletal malformations and chronic wounds. [108]
The most representative ECM proteins include proteoglycans, carbohydrate
polymers that are usually attached to other proteins to form proteoglycans.
Those proteins have a net negative charge that attracts cations such as Na+,
which attracts water molecules via osmosis keeping the ECM cells hydrated. It
also helps to trap growth factors within this matrix. The most representative
proteoglycans are heparan sulphate, chondroitin sulphate and keratin sulphate.
Hyaluronic acid is a special non-proteoglycan polysaccharide which retains
large amounts of water, making the ECM turgent and increasing its resistance
to the compressive forces usually found in tissues such as load-bearing joints.
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[109]
The fibrous protein family is composed by collagens and elastin. Collagens
are the most abundant proteins of the human body [110, 111], giving structural
support to resident cells. On the other hand, elastin gives elasticity to tissues, a
useful characteristic found in blood vessels, lungs or skin.
Fibronectin, fibrinogen, laminin and vitronectin are a family of proteins in
charge of the cell-ECM interaction. Fibrinogen is a large (328 kDa), complex and
fibrous glycoprotein present in human plasma, composed of six polypeptides
organized into a trinodular structure [112]. It plays an essential role in many
biological functions including wound healing, haemostasis, inflammation and
angiogenesis. Laminins are large (900 kDa) multidomain proteins consisting on
trimeric molecules of α, β and γ chains [113] and are the main components of
basement membranes, providing interaction sites for many other constituents
including cell surface receptors. Vitronectin is an adhesive glycoprotein found in
the blood and different tissues. It is a medium-sized protein (75 kDa) involved
in several physiological and pathological processes and regulates proteolysis
initiated by plasminogen activation. [114]
Within the large variety of proteins that compose the ECM, this work is
focused in fibronectin, a large (220 kDa), fibrous and complex glycoprotein
that exists in dimeric form. It is synthesized by adherent cells that assemble it
into a fibrillar network in an integrin-binding dependent mechanism [115]. It
is also the first assembled protein in the incipient formation of a mature ECM.
A FN matrix is formed by fibrils that form linear, interconnected networks; in
the early stages of the ECM formation only thin fibrils are found (5 nm), and as
the ECM matures and more proteins are recruited, fibronectin fibrils become
thicker (25 nm), as a result of the clustering of thinner fibrils.
Cell adhesion
Cell attachment to ECM or surface-grafted proteins takes place via integrins, a
large family of α/β heterodimers which recognize specific sequences of ECM
proteins such as the arginine-glycine-aspartic acid tripeptide (RGD), present in
several proteins such as fibronectin and vitronectin, providing a trans-membrane
link between the ECM and actin cytoskeleton. [12]
Although integrins are constitutively expressed, most of them are present
in the cell surface in an inactive state, in which there is neither ligand binding
nor signaling. Integrins can be activated by ligand binding or by intracellular
signaling, due to effects in its cytoplasmic domains, leading to conformational
changes which expose epitopes for specific activation antibodies. The most com-
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Figure 1.7 The extracellular matrix is composed by a complex mixture of struc-
tural and adhesive proteins such as fibronectin and vitronectin. Interaction
between cells and the ECM takes place via integrins, membrane-bound receptors
that trigger several signalling pathways and influences cell behaviour. [116]
mon integrin type found in in vitro adhesions are α5β1, the classical fibronectin
receptor, and αVβ3, the vitronectin receptor.
Integrins play a dual role when activated through ligand binding: mediating
cell attachment and triggering several intracellular signaling pathways, which
can in turn influence growth, migration, differentiation or proliferation. [117]
When bound to its substrate, integrins cluster and develop focal adhe-
sions, discrete supramolecular complexes that contain important structural
proteins and signaling molecules, anchoring physically the cell to the sub-
strate. Anchored cells develop a spread morphology showing a developed
actin cytoskeleton, providing mechanical stability and transmitting forces to
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the intracellular regions. [118, 119]
Adhesions with the ECM act as binding bridges which link the extracellular
matrix to the actin cytoskeleton. Four well-defined varieties of adhesion struc-
tures have been defined: focal adhesions, fibrillar adhesions, focal complexes
(dot contacts) and podosomes.
Focal adhesions (FA) are small, flat and elongated structures that are several
square microns in size and often located near the cell periphery [120–123] that
mediate strong adhesion to the substrate linking bundles of actin microfilaments
through a plaque formed by many different proteins such as vinculin, paxillin,
talin and tyrosine phosphorylated proteins. Focal adhesion development is
enhanced by the Rho-A GTPase and driven by actomyosin contractility. It is
believed that focal adhesion act as mechanosensors, allowing cells to sense
physical properties of the substrate such as stiffness and convert them into
specific biological signals. [124]
As said, a small group of structural proteins, namely vinculin, paxillin, talin,
α-actinin, tensin and filamin can assume the role of integrin-actin linkers [121–
129]. Vinculin is a universal adaptor protein, due to its ability to interact with
many plaque proteins, acidic phospholipids, membranes and actin.
Focal adhesions not only play the role of mechanical anchors between the
ECM and the actin cytoskeleton. After integrin clustering, several signaling
molecules such as the focal adhesion kinase (FAK) and the integrin-linked
kinase (ILK) [130] are recruited by adapter proteins, becoming activated and
triggering several intracellular signaling pathways. FAK triggers the major-
ity of those signaling pathways [131–134] and has emerged as an important
mechanotransducer, translating extracellular mechanical inputs into intracellu-
lar biochemical signals. It is a key signaling protein contributing to control cell
motility, invasive phenotype, survival, cell cycle progression, proliferation and
development. [135–139]
FAK is also overexpressed in a variety of human cancers and can promote
invasive behaviour of tumor cells. Phosphorylation of Tyr-397 determines
the activation of FAK. This activation takes place through the interaction of
integrin-associated proteins and the FAT and FERM domains of FAK [140–142].
Once activated, phosphorylated Y-397 binds the SH2 domain of Src, recruiting
and activating more Src molecules [143, 144]. The formation of the FAK-Src
complex is the most critical event in the FAK-associated signaling. Y-397 site
bound to Src phosphorylates other FAK residues, namely Y-576, Y-577 and Y-861,
important for maximal FAK autophosphorylation activity [145]. Once activated
and bound to Src, the signaling pathway activates other downstream pathways
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responsible for different cellular events, such as differentiation, migration and
proliferation (see section 5.1).
Fibronectin structure and functions
Fibronectin is a single-gene encoded protein, with an mRNA size of 8 kb. It
can be spliced in up to 20 monomeric isoforms in human and 12 in mice
[146], which may result in an even larger variety of FN isoforms if the possible
combinations between monomers to form FN dimers is considered. The most
common splicing mechanism generates two major different forms of FN – plasma
or soluble FN (pFN) and cellular FN (cFN). pFN is produced by hepatocytes and
secreted into the blood, where it remains in a soluble state until the activation
of hematopoietic cells’ integrins by a platelet-mediated mechanism allows pFN
to bind and assemble into fibrils, required for thrombus growth and stability
[147, 148]. cFN is secreted by cells as a dimer in a compact globular structure
and then is assembled into insoluble, fibrillar form in a cell-dependent process.
FN is a multidomain protein. It contains domains to interact with other ECM
proteins, such as glycosaminoglycans (GAGs), integrins, other FN molecules
and pathogens (bacteria) [149]. FN subunit sizes ranges from 230 to 270 kDa,
depending on the alternative splicing of the mRNA, and forms dimers through
two disulfide bonds at the C-terminus of the protein. Its structure is composed
by three types of repeating modules, I, II and III. Both type I and II contain
intramolecular disulfide bonds to stabilize the folded structure, while type III
lacks these disulfide bonds. Type I and II modules are structured in beta-sheets
enclosing a hydrophobic core that contains highly conserved aromatic amino
acids. [108, 149]
Extra type III repeats (A and B) are produced by alternative splicing and
included in cFN molecules, but are not present in pFN; it seems that the al-
ternative exons are unnecessary for matrix assembly, but its lack might affect
matrix levels. [108, 151]
cFN subunits have a variable V region present, but only in one subunit of
the pFN dimer. Results concerning this region suggest that this is essential for
FN dimer secretion [152] and that it provides the binding site for α4β1 integrin.
[153]
FN matrix assembly is a cell-dependent process mediated by the binding of
FN dimers to integrin receptors, although exist other mechanisms for FN-FN
assembly in absence of cells such as the addition of reducing [154, 155] or
oxidizing [156] agents to the protein solution; the use of denaturing [157–
159], cationic [160, 161] or anionic [162, 163] compounds; the use of peptidic
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Figure 1.8 Molecular structure of the fibronectin, which consists in three differ-
ent modules (type I, blue; type II, brown, and type III, green). B, A and variable
region V (ochre) are alternatively spliced. The dimer is joined through a disulphide
bond in the C-terminal region. Integrin binding sites are indicated, as well as
other binding domains for FN and other proteins. [150]
fibronectin fragments [164–166]; also, the use of mechanical tension [167,
168], shear forces [169–175] or surface-initiated assembly. [176–180]
The essential domains for FN assembly include, first, FN dimerization,
which depends on the covalent association of the subunits mediated by a pair
of disulfide bonds at the C-terminus of the FN molecule. Second, the 70-
kDa fragment extending from I1 to I9, including the N-terminal assembly and
the collagen-gelatin binding domains. Within the 70-kDa fragment, the 40-
kDa collagen-gelatin binding modules does not appear to play a direct role
in the assembly. This 70-kDa fragment binds to cells in monolayer culture
environments and blocks FN matrix assembly when added in excess. [181]
It seems that the binding activity resides only in the type I1−5 N-terminal por-
tion of the molecule, the so-called N-terminal assembly domain. FN molecules
binds to each other via non-covalent interactions. [182]
Finally, the Arg-Gly-Asp (RGD) sequence located in III10 and the PHSRN
synergy sequence located in the III9 modules are required for interaction with
the α5β1 integrin, which is required for the cell-mediated FN assembly [183].
Although both sites are required, synergy site does not seems to be essential
since matrix levels are drastically reduced but not ablated with FN lacking
this sequence [184]. RGD not only binds to α5β1, but to several additional
integrins, including all the αV subfamily, α8β1, α9β1 and the platelet-specific
integrin αIIbβ3. Interestingly, in absence of α5β1 integrin expression in cells
or ablation of α5 integrin gene in mice, FN can still be assembled by the other
integrins, most notably the αV subfamily [185, 186]. However, the αV -class
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produced fibrils are shorter and thicker than the α5-produced. [150]
Summarising, the N-terminal assembly domain I1−5 is essential for FN
fibrillogenesis, although other FN binding domains are implicated in matrix
assembly: III1−2 and III12−14 can bind FN; additionally III1 can bind to III7 and
III2−3 can also interact with III12−14 [149]. All of these domains can promote FN
fibrillogenesis due to their FN binding properties, but they can also participate
in intramolecular interactions which keep soluble FN in a compact form. [187]
Interaction between FN and integrins induces integrin clustering, which
groups together cytoplasmic molecules such as Src kinase, focal adhesion kinase
(FAK), paxillin and others, promoting the formation of focal adhesion com-
plexes. These complexes activate the polymerization of the actin cytoskeleton
and kinase cascades-mediated intracellular signaling pathways [12]. Receptor
clustering by dimeric FN helps to organize FN into short fibrils.
FN fibril formation is enhanced by the contractility of the cytoskeleton [188,
189]. This contractility induces a progressive extension of the FN molecule
and the exposure of binding sites that mediate lateral interactions between FN
molecules.
There is also an intrinsic protein-disulfide isomerase activity in the C-
terminal module I12 that may introduce intermolecular disulfide bonds within
fibrils [190]. Initial thin fibrils grow in length and thickness as the matrix
matures and the FN fibrils are converted in an insoluble form [108]. Proper
integration of extracellular signals with active intracellular pathways plays
a crucial role in the initiation, progression and regulation of the FN matrix
assembly.
The III7−10 fragment
III7−10 comprises from 7 to 10 type III modules. These modules are the largest
and the most common of the FN molecule. Depending on the splicing variant,
a subunit of a fibronectin molecule can have up to 15-17 contiguous type III
modules. They also occur often in pairs.
Structures of individual type III modules reveal a conserved beta-sandwich
structure with one sheet containing three parallel strands and the other four
strands, hiding a hydrophobic environment inside. The 10th type III repeat
contains the Arg-Gly-Asp (RGD) sequence, an integrin-binding sequence [191,
192]. RGD sequences are not only found in fibronectin, but also in fibrinogen
[193, 194], vitronectin [195] and Von Willebrand factor [193] mediate a wide
variety of cell adhesion events [192]. That has led to the investigation of
RGD peptides and its analogs as potential therapeutic agents. Apart from the
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Figure 1.9 Major steps in fibronectin fibril assembly. A) cFN fibronectin binds
to α5β1 integrin (gold) via its cell binding domain. The exact organization of
FN seems to depend on intramolecular interactions between III2−3 and III12−14,
amongst other FN binding sites (red). B) FN binds to other receptors which
induces actin cytoskeleton reorganization and activates intracellular signalling
complexes (silver circles). Cell contractility aids in FN conformational changes
thus exposing sequestered FN binding domains in the extended module. C) Fibrils
are formed through FN-FN interactions. Alignment of FN molecules within fibrils
may vary depending on which domain interact, such as I1−5 binding to III1−2
versus III12−14 [151]. When in solution, FN does not form fibrils and keeps a glob-
ular conformation even at extremely high concentrations, due to intramolecular
interactions between modules III2−3 and III12−14. [187]
prominent RGD sequence, 9th type III repetition contains the PHSRN synergy
region.
The RGD loop (Figure 1.13) is found near N-terminus of III10 [196, 197].
Interactions with near regions or domains might be able to stabilize the RGD
loop, leading to protein conformations or providing a specific context that
allows recognition by specific integrins.
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Figure 1.10 FN III7−10 fragment structure. At the right of the molecule, the
III10 domain with the RGD loop marked in red. To the left, III9 with the PHSRN
synergy site colored in green and the III8 and III7 domains showing a slightly
twisted conformation. PDB file id. 1FNF
This fragment features four contiguous modules in an extended array of
approximately 140 Å long. Domains 7 and 8 have a tilt angle of 52°, 8 and 9 of
48° and 9 and 10 of only 12°. That confers a spiral-like shape to this fragment.
Individual type III modules are very similar to each other, both inside the
III7−10 and compared to other fibronectin type III modules. Each module consist
of two beta sheets, one with four strands (denoted as G, F, C and C′) and the
other with three strands (A, B and E), arranged as a beta sandwich (Figure
1.11). The main differences between type III modules are mainly found in the
loop regions.
Since individual type III modules share a highly conserved framework
structure, [196, 198–200], many properties of the type III repeated arrays are
found in the interdomain relationships. The III7-III8 and III8-III9 reveals no
rules relating the orientations between adjacent domains, but the interface
between III9 and III10 has some distinctive features, such as relative rotation
and tilt angle, smaller than other known inter-type III interfaces, as stated
previously (12 compared to 48 and 52 tilt angle degrees).
This difference is due to Ser-1417, a polar aminoacid; interfaces between
domains III7-III8 and III8-III9 have a hydrophobic aminoacid that is completely
buried in the interdomain. Except in III1 and III10, residues homologous to the
Ser-1417 are hydrophobic. This conformational change leads to place the RGD
loop on the 10th and the PHSRN on the 9th type III domains in the same side
of the molecule, although they are separated by around 40 Å. Nevertheless, in
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Figure 1.11 Structure of the 10th type III fibronectin module, showing a beta
sandwich geometry with the RGD integrin-binding sequence loop protruding from
the core of the molecule. Adapted from PDB file id. 1FNF
practice, an integrin can span this distance and interact simultaneously with the
RGD and the PHSRN peptides (Figure 1.12). This simultaneous interaction adds
specificity by providing an exposed array of residues that are hardly mimicked
by other pairs of type III modules.
This fragment is predicted to show some structural rigidity, since can easily
crystallize under the adequate conditions (i.e. for crystallographic structure
determination). The III9−10 interdomain is probably the most flexible of the
whole fragment, but this flexibility is limited to facilitate the simultaneous
RGD-PHSRN recognition by at least two different integrins [201, 202] (Figure
1.12). The fact that α5β1 and αVβ3 share this ability to interact with the III9−10
modules favours this hypothesis.
RGD loop structure
The RGD loop located on the 10th type III domain protrudes approximately
10 Å from the core of the beta sheet and is not in close contact with any other
part of the molecule (Figure 1.13). This is a satisfactory explanation on why
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Figure 1.12 Hypothesized interaction model for the FN III7−10–GFP fragment
and an integrin. The PHSRN and the RGD motifs are separated by approximately
40 Å, which not prevents a direct interaction with the integrin, wide enough to span
this distance. GFP, although fused to the III10 fragment, does not seem to interfere
with the FN-integrin interaction, a hypothesis supported by our experimental
results. PDB file id. 1FNF (FNIII7−10), 2Y0G (GFP) and 1JV2 (integrin).
small RGD-containing peptides can block interactions between FN and cells.
RGD seems to be a low energy conformer of a, in principle, flexible loop, [203]
showing the characteristics of a slightly deformed type II′ beta hairpin turn.
[204]
These II’ turns require a central glycine to allow this conformation with
canonical values of φ = 60°and ψ = –120°. A further proof of this hypothesis
is that other RGD sequences which acquires an II′ beta turn, either tenascin or
an artificial protein made from a CRGDSC sequence inserted into lysozyme are
able to interact with at least three different integrins. Tenascin’s RGD interacts
with αIIbβ3 while fibronectin RGD interacts with α5β1, αIIbβ3 and αVβ3.
Moreover, cyclic RGD peptides show a highly antiadhesive behaviour sug-
gesting that this particular loop structure represents a general integrin-binding
conformation. In the particular case of the fibronectin III10 RGD, two residues
flanking both sides of the adhesive sequence are able to extend the hairpin 7 Å
more over the molecule core, an extension that has not been seen in any of the
other FN type III domains and appears to be an adaptation to project the RGD
for optimal interaction with integrins.
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Figure 1.13 RGD loop structure of the 10th type III fibronectin domain. Arginine
(red), glycine (green) and aspartic acid (blue) residues are shown as sticks inside
its solvent-accessible isosurface. These three residues form the II′ beta hairpin
loop, which extends approximately 10 Å from the core of the III10 module. That
distance can be extended up to 17 Å, depending on the molecule conformation.
1.7 L. lactis, why and how
Amongst the huge amount of non-pathogenic bacterial species, L. lactis has
been chosen for several reasons. It features a very low production of exopoly-
saccharides [61, 205] (EPS), a mandatory condition for making the membrane-
anchored proteins accessible to cells.
In some lactic acid bacteria (LAB) strains, including the Lactococcus genus,
most of the carbon obtained from glucose and other available carbon sources is
metabolized to L-lactic acid through the glycolytic pathway, although researchers
are developing effort in metabolic engineering to obtain EPS overexpression
in LAB [205]. Here, this low EPS production [61] is needed to guarantee the
accessibility of the expressed FNIII7−10 fragments on the bacterial membrane.
L. lactis, among other LAB, are Generally Regarded as Safe (GRAS) [61]
microorganisms. This classification is due to its natural presence in milk and
dairy products and its contribution to a healthy mucosal microflora. [206]
Lactococcus lactis is a very well-studied strain. Its genome has been fully
sequenced [18, 207] and has been widely used for recombinant therapeutic
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proteins production, therapeutic drug delivery and vaccine production. [27, 29,
30, 208]
Another important characteristic of this strain is its ability to spontaneously
develop biofilms [64, 209, 210]. Despite its low EPS production, L. lactis adheres
to and colonizes a broad range of surfaces such as synthetic polymers, glass,
metals and live tissues. These biofilms remain stable for weeks and support cell
adhesion, growth and differentiation [211], as will be further discussed.
Figure 1.14 pT1NX vector map, showing the P1 lactococcal promoter, NgoMIV
and BamHI restriction sites, usp45 secretion signal, spaX protein A anchor and
the ermAM erythromycin resistance gene.
pT1NX has been the chosen expression vector in this work. Originally
engineered by Dr. L. Steidler, pT1NX features the P1 lactococcal promoter [212,
213], the usp45 secretion peptide [214], the Staphylococcus aureus protein
A anchor [212] and an erythromycin resistance gene. mRNA traduction is
controlled by the T7g10 ribosome binding site and the T7g10 terminator from
phage T7 [215]. The replicon comes from an Enterococcus faecalis plasmid
pAMβ1 origin, including repD and repE. With a size of 5706 bp, it has been
successfully used as a membrane-anchored protein expression vector in L. lactis
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and other LAB. [61, 215, 216]
Protein A (SpA) is a 42 kDa cell-wall anchored protein expressed by Staphyl-
ococcus aureus [212]; the anchoring mechanism includes a 35-residue sorting
signal located at the C-terminal end of the protein A is required. SpA contains
the LPETG motif followed by a C-terminal hydrophobic domain and tail com-
posed of mainly positively charged residues. A signal peptidase cleaves the
amino-terminal end of SpA, followed by the translocation of the protein.
The positively charged residues of the C-terminal end of SpA prevents its
full secretion. Once in place, the proteolytic activity of a sortase [217–219], a
prokaryotic enzyme that modifies surface proteins by recognizing and cleaving
a C-terminal sorting signal, recognizes the LPETG motif, cleaving between the
threonine and glycine residues and leaving the C-terminal end anchored to the
lipid bilayer. Then, threonine is covalently linked to the free amino groups of
the peptidoglycan cross bridge via an amide bond, before the final crosslinking
is completed.
Although this anchoring mechanism is extremely efficient, some of the
molecules are found in the extracellular medium, mainly due to the physiological
turnover and release of peptidoglycan fragments with linked surface proteins.
A model of this anchoring mechanism is depicted in the Figure 1.15. [220]
Figure 1.15 Anchoring mechanism of the LPETG motif onto the peptidoglycan
layer. A signal peptidase cleaves near the N-termini of the protein, which is
translocated to the outer part of the cell wall. Then, a sortase cleaves the poly-
peptide chain between the threonine and glycine and anchors the threonine to
the tetrapeptide motif that crosslinks the peptidoglycan layer
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The Usp45sp signal peptide [214] is part of Usp45 (unknown secreted
protein 45), a strictly secreted protein by mesophilic Lactococcus genus (L. lactis
subsp. cremoris and L. lactis subsp. lactis) with no known biological activity,
neither proteolytic nor anti-bacterial. This secretion peptide comprises the first
27 residues of the N-terminal region. Secretion is, in principle, not limited by
the protein size, since proteins up to 160 kDa have been successfully expressed
in L. lactis, but seems to be more conformation dependent. [61]
Due to these characteristics, L. lactis is currently one of the preferred
vehicles for oral delivery of heterologous proteins, either secreted or membrane-
anchored, with a wide range of expressed proteins, from bacterial and eukaryotic
antigens to interleukins, virulence factors, bacteriocins and enzymes. [19, 215,
221, 222]
1.8 L. lactis phylogeny, metabolism and physiology
Phylogeny
Lactic acid bacteria can be classified attending to restriction fragment length
polymorfism (RFLP) or 16s rRNA sequence, obtained by reverse transcriptase
or direct PCR techniques (Figure 1.16). [223]
Eubacteria are subdivided into gram-negative and gram-positive phyla.
Within the gram-positive (2 of a total of 12), a main classification criterion is
the G+C content (molar percentage of guanine plus cytosine in the genomic
DNA), where a break point can be established at 53-55 %. High G+C content or
Actinomycetes comprises the genera Bifidobacterium, Arthrobacter, Micrococcus,
Propionibacterium, Microbacterium, Corynebacterium, Actinomyces, and Strepto-
myces. (Stackebrandt and Teuber 1988; Woese 1987). Lactic acid bacteria are
included in the low-G+C content or Clostridium subdivision, along with aerobes
such as Bacillus, Staphylococcus and Listeria and anaerobes such as Clostridium,
Peptococcus and Ruminococcus. L. lactis, based on this criterion, is classified
within the gram-positive, low G+C content eubacterium.
LAB is considered a supercluster (Figure 1.16)[224–232], located between
facultative aerobic species (staphylococci, bacilli) and strictly anaerobic species
(clostridia), although some LAB species can use oxygen if available.
Lactococcus lactis is a strain pertaining to the lactic acid bacteria (LAB herein-
after) clade, which comprises a group of roughly 20 genera, namely Aerococcus,
Carnobacterium, Enterococcus, Oenococcus, Streptococcus, Tetragenococcus, Vago-
coccus, Weisella, Lactobacillus, Pediococcus, Leuconostoc and Lactococcus.
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Figure 1.16 Phylogenetic tree of the lactic acid bacteria (LAB) clade [206]
It is important to note the impossibility to give an unequivocal definition of
lactic bacteria [233]. A typical LAB could be defined as a gram-positive, non-
spore-forming, catalase-negative —although a pseudocatalase activity, mediated
by hohmene, can be found in some LAB [234]—, anaerobic but aerotolerant,
devoid of cytochromes, acid-tolerant, requiring complex growth media and
strictly fermentative, being the lactic acid the major end product of the sugar
fermentation.
It can be further subdivided into high and low G+C (molar percentage of
guanine and cytosine in the genomic DNA) content, where L. lactis is part of the
low G+C content group. The absence of a true catalase, cytochromes and the
impossibility to synthesize heme groups unless added in the growth medium
is the actual physiological background of some of the defined characteristics,
especially its fermentative metabolism, as heme group and hence cytochromes
are required for the electron transport chain system [235–242]. Therefore,
absence of cytochromes is a reliable indicator of the presence of lactic acid
bacteria. [233]
Attending to its metabolism, LAB can be split in two groups. Homoferment-
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ative strains such as L. lactis metabolize glucose almost quantitatively into lactic
acid. Heterofermentative strains metabolize glucose into several compounds
such as lactic acid, ethanol, carbon dioxide or acetic acid.
Other LAB classification attends its shape: rods and coccis. Lactobacillus
and Carnobacterium are rod-shaped while all the other genera are coccis, except
Weisella that includes both cocci and rods (Figure 1.17). [226]
Figure 1.17 Lactic acid bacteria classification attending to its morphology and
arrangement. L. lactis, formerly known as Streptococcus lactis, grows in a chain-like
arrangement.
Lactococcus genus comprises three strains: L. lactis subsp. cremoris, L. lactis
subsp. lactis and L. lactis subsp. hordniae. L. lactis subsp. cremoris can be
distinguished from subsp. lactis by its inability to grow at 40 °C (the optimal
growh temperature of L. lactis subsp. cremoris is 30 °C), in 4 % NaCl and to
hydrolyze arginine and ferment ribose. There are also differences in DNA-DNA
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homology and in the 16S rRNA sequences.
Metabolism
The whole LAB clade shows a high carbohydrate fermentation rate coupled
to substrate-level phosphorylation activity for ATP synthesis. A membrane-
bound H+–ATPase creates a proton-motive force that drives the transport of
ions and metabolites into the cell. Both permease and sugar phosphotransferase
systems (PTS) makes use of this proton-motive force. There are two major
ways of carbohydrate and related compounds metabolism. L. lactis, as a strict
homofermentative strain, metabolizes glucose using the glycolytic (or Embden-
Meyerhof-Parnas) pathway, also known as homolactic fermentation.
Glucose, usually found in excess in the culture medium in laboratory condi-
tions, is transformed into almost exclusively L-(+)-lactic acid, through the form-
ation of fructose-1,6-diphosphate, which is converted into dihydroxyacetone-
phosphate and glyceraldehyde-3-phosphate (GAP) by a FDP aldolase. Both
dihydroxyacetone-P, which is transformed to glyceraldehyde-3P, and glyceralde-
hyde3P is eventually converted to pyruvate.
In laboratory conditions, where there is restricted oxygen access and glucose
excess, pyruvate is reduced to lactic acid by a NAD+-dependent lactate dehyd-
rogenase, oxidizing NADH into NAD+ produced during the earlier glycolytic
steps. Usually, the only metabolic product is lactic acid, except in some cases
where the complex products found in the medium can lead to the formation of
acetic acid and other metabolic products [243] (Figure 1.18).
L. lactis can also metabolize sugars like mannose, fructose and galactose. In
the case of mannose or fructose, a permease transport system brings the sugar
into the cytoplasm, while in the case of the galactose a sugar-phosphotransferase
system (PTS) converts galactose into galactose-6-P, entering the glycolytic path-
way at the glyceraldehyde-3-P (GAP) level (Figure 1.18, left). In species lacking
the PTS system, galactose follows the Leloir pathway (Figure 1.18, right),
entering the glycolytic pathway at the glucose-6-P level.
Besides monosaccharide fermentation, L. lactis features a PTS for disac-
charides. In this case, a phosphohydrolase splits the disaccharide into a free
and a phosphorylated monosaccharide. Lactose is readily metabolized by L.
lactis by using a lactose-specific PTS [244, 245]. Lactose enters the cell as
lactose phosphate, which is cleaved into glucose and galactose-6-phosphate by
a phospho-β-D-galactosidase (P-β-gal). Glucose is then phosphorylated into
glucose-6-phosphate and enters the glycolytic pathway. Galactose-6-phosphate
is metabolized via the tagatose-6-phosphate pathway (Figure 1.19). Both
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Figure 1.18 Glycolytic pathway of Lactococcus lactis, yielding L-(+)-lactate as
final product.
lactose PTS and P-β-gal are inducible and repressed by glucose.
L. lactis can also metabolize pentoses, although these compounds are meta-
bolized by the ending part of the 6-phosphogluconate/phosphoketolase pathway,
which L. lactis lacks. In theory, only heterofermentative strains would be able
to metabolize pentoses, but in practice all LAB strains, including L. lactis, are
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Figure 1.19 Galactose metabolism in lactic acid bacteria. Left, tagatose-6-
phosphate pathway; right, Leloir pathway.
pentose-positive, with the exception of group I lactobacilli.
Lactic acid configuration
The configuration of the lactic acid is strain-dependent. Some strains produce
exclusively L-lactic acid, some only D-lactic acid and some others a racemic
mixture of both D and L-lactic acid, either equimolar or with different ratios
[206]. This configuration depends on the presence of specific NAD+-dependent
lactate dehydrogenases (n-LDH) and their respective activities. L. lactis and
L. casei have an allosteric L-nLDH dehydrogenase, activated by fructose-1,6-
diphosphate, that converts the glucose exclusively to L-lactate.
Chapter 2
Objectives
The aim of this work is to assess the use of living, bacteria-based biointerfaces
between synthetic substrates and mammalian cells, seeking to develop a new
engineered interface with the ability to direct cell fate in a dynamic manner.
To play this role as a living interface, these bacteria must be genetically
engineered to display active cues, specifically the III7−10 fragment of the human
fibronectin.
FN III7−10 enables the direct interaction between the genetically engineered
bacteria and mammalian cells through integrins, membrane-bound receptors
that interact with the extracellular environment and act as a link between
extracellular events and the regulation of a wide variety of cellular processes,
such as adhesion, proliferation, migration and differentiation, all of them
involved in the development of new tissues.
The concrete objectives of this work are:
1. Identify an appropriate strain that will play the role of the living biointer-
face. Ideally, this strain should be able to coexist with the mammalian
cells and be a suitable candidate for genetic modification. Moreover, this
living biointerface will remain viable, strongly attached to the supporting
substrate and ready for the expression of dynamic biochemical signals.
2. To genetically modify the bacteria to express the desired protein, FN
III7−10 fused to GFP as a reporter protein.
3. To characterize the properties of the genetically engineered strain, to
evaluate its localisation in the membrane and assess its biological activity.
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4. Develop immobilisation methods to ensure that a proper physical bac-
terial layer between synthetic materials and cells can be produced, and
characterize this interface.
5. To investigate and characterize the cellular response of mammalian cells
cultured onto the living biointerface.




In this chapter, a general description of each protocol is described, going in
depth in the pertinent materials and methods section of the following chapters.
3.1 Cloning protocols
Endonuclease restriction
Endonuclease restriction reactions were carried out according to the manufac-
turers protocol. A typical reaction mix contained 1 µL of the restriction enzyme,
1 µg of DNA, 2 µL of 10× reaction buffer and nuclease-free sterile ultrapure
water to complete 20 µL. The reaction was carried out for 1h at 37 °C in a
thermostatic block.
Ligation
Purified DNA from the digestion step of both insert and plasmid were mixed in
a 5:1 molar ratio, with a typical mass of 50 ng of insert and 30 ng of plasmid.
Then, 2 µL of 10× T4 ligase buffer, 1 µL of T4 DNA ligase and nuclease-free
water were added to complete 20 µL. The reaction was gently mixed by pipetting
up and down one time. The reaction was completed in 15 minutes at room
temperature. Reaction products were purified using the Illustra GFX DNA and
gel band purification kit (GE Healthcare).
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E. coli transformation
A 50 µL aliquot of E. coli NEB5α high-efficiency competent cells (New England
Biolabs) stored at –80 °C was kept on ice for 10 minutes for thaw the cells.
Then, 5 µL with a maximum of 100 ng of plasmid DNA of the purified reaction
mixture from the ligation reaction was added to the competent cells and gently
mixed by inversion, while avoiding vortexing.
This mix was left 30 minutes on ice, heated at 42 °C for 30 seconds and
placed on ice for 5 minutes, followed by the addition of 950 mL of SOC medium
(New England Biolabs). The tube was kept in a shaking incubator for one hour
at 37 °C. 100 µL of the resulting culture was spread in several Luria-Bertani agar
plates supplemented with 50 µg/mL kanamycin and left overnight at 37 °C
to screen the positive clones, based on the incorporation of the kanamycin
resistance gene in the pGFP–C2 plasmid.
E. coli culture
Escherichia coli is a gram-negative aerobic strain which grows in Luria-Bertani
medium [246] (LB), composed of 10 g/L tryptone, 5 g/L yeast extract and
10 g/L NaCl. This medium is then sterilised at 121 °C for 30 minutes. Its
optimal growth temperature is 37 °C with shaking, in aerobic conditions (open
container). LB–agar plates were prepared by adding 1.5 % w/v agar, sterilised
at 121 °C for 20 minutes and poured into Petri dishes. Freshly prepared LB–agar
plates can be stored at 4 °C for several weeks in closed containers.
Polymerase chain reaction (PCR)
PCR reactions were carried on an Eppendorf Personal Thermal Cycler (Eppen-
dorf, Germany), using AmpliTAQ Gold polymerase (Applied Biosystems). The
same PCR program was used for each amplicon:
1. 1st denaturation step: 10 minutes at 95 °C
2. 35 amplification steps:
Denaturation, 40 seconds at 95 °C
Annealing, 45 seconds at 56 °C
Extension, 1:45 minutes at 72 °C
3. Final extension step, 72 °C for 10 minutes.
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Preparation of L. lactis electrocompetent cells
2 mL of an overnight L. lactis culture was inoculated into 200 mL of M17
medium with 1 % glycine and grown at 30 °C. When the culture reached an
optical density (OD) of 0.6-0.8, measured at 660 nm, cells were harvested by
centrifugation at 4000 g for 5 minutes at 4 °C, and thoroughly washed in an
sterile ice-cold solution of sucrose 0.5 M and glycerol 10 % v/v.
Then, cells were resuspended in the same solution, aliquoted in volumes of
50 µL and frozen at –80 °C. These cells keep their electrocompetent capabilities
for up to three months.
L. lactis electrotransformation
Electrotransformation of L. lactis cells was performed using a BTX electroporator
(Harvard Apparatus). The electrotransformation protocol involved a prior
desalting and purification of the DNA with the Illustra GFX DNA and gel band
purification kit (GE Healthcare). Frozen electrocompetent cells were thawed
on ice for 10 minutes. 5 µL of the purified plasmid DNA was gently mixed with
competent cells with the pipette and transferred to a sterile electroporation
cuvette with 1 mm gap between electrodes. A 2.5 kV pulse with a typical time
constant of 4.5 was applied, followed by the addition of 5 mL of recuperation
medium containing M17, sucrose 0.5 M, MgCl2 20 mM and CaCl2 2 mM. Cells
were allowed to recover for 2 h at 30 °C.
Cells were then harvested at 3000 g for 5 min. The resulting pellet was
resuspended in 500 µL of the same medium, seeded on M17-agar plates sup-
plemented with 0.5% w/v glucose and 10 µg/mL erythromycin and incubated
at 30 °C for 24–48 h to select positive (erythromycin resistant) clones.
Plasmid isolation from L. lactis
Plasmid extraction was carried over using a combination of a standard protocol
[247] and the GenElute five-minute plasmid miniprep kit (Sigma). Stationary
phase cultures grown overnight at 30 °C in sterile M17 medium supplemented
with 0.5 % v/v glucose and 10 µg/mL erythromycin (hereinafter GM17-E)
were harvested by centrifugation at 3000 g for 10 minutes. The pellet was
resuspended in 25 % sucrose containing 30 mg/mL lysozyme and 1 mg/mL
RNase, to a final volume of 200 µL, and incubated at 37 °C for 15 minutes.
Lysozyme helps in the hydrolysis of the peptidoglycan cell wall, while the
resulting protoplasts become lysed by the osmotic shock induced by sucrose at
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high concentrations. Then, 400 µL of 3 % SDS in 0.2 N NaOH solution were
added, mixing by inversion, to solubilize the lipid bilayer and the DNA.
After a 7-minute incubation at room temperature, 300 µL of ice-cold 3 M
sodium acetate solution (pH 4.8) was added, vortexing the resulting solution.
This solution was then centrifuged at 18000 g for 15 minutes at 4 °C. The super-
natant was recovered, further purifying the plasmidic DNA with the GenElute
five-minute miniprep kit from Sigma.
DNA purification from PCR or enzymatic reactions
Purification of PCR or enzymatic restriction products were carried on using the
Illustra GFX DNA and gel band purification kit (GE Healthcare).
Briefly, 500 µL of capture buffer were added to up to 100 µL of reaction
sample (containing PCR or enzymatic products) and spun to collect the liquid
at the bottom of the tube. This mix was transferred to a silica column and
centrifuged at 16000 g for 30 seconds, discarding the eluted liquid.
Then, 500 µL of the washing buffer was loaded onto the column and
centrifuged at 16000 g for 30 seconds, discarding the eluted liquid.
Finally, 40 µL of the eluted buffer was loaded onto the column, followed by
a 1 minute incubation at room temperature and centrifuged at 16000 g for 1
min.
DNA purification from gel bands
DNA gel bands from agarose gel electrophoresis were purified using the Illustra
GFX DNA and gel band purification kit (GE Healthcare).
Bands containing the desired DNA from the gel electrophoresis were care-
fully cut with a scalpel under UV transiluminator visualization and transferred
to a reaction microtube. Then, 10 µL of capture buffer per 10 mg of gel were
added and incubated at 60 °C in a thermostatic block for 15-30 minutes, until
agarose was completely dissolved.
The microtube was subjected to a short spin to collect the liquid at the bottom
of the tube and the resulting liquid was transferred to a silica column included
in the kit, followed by a 1 minute incubation step at room temperature. The
column was centrifuged at 16000 g for 30 seconds, discarding the flow-through.
Then, 500 µL of washing buffer was added followed by a 30 s centrifugation at
16000 g.
Finally, 40 µL of elution buffer was carefully loaded onto the silica column,
incubated for 1 minute and centrifuged at 16,000 g for 1 minute, to recover
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the purified DNA. Purified DNA was stored at –20 °C or immediately used.
Cell lysis and plasmid purification
Plasmidic DNA was extracted and purified according to the manufacturer’s
protocol. Briefly, 500 µL of column preparation solution were centrifuged at
maximum speed for 15 seconds, discarding the flow-through.
Then, the lysed bacterial solution, up to 780 µL, was centrifuged again
at maximum speed for 20 seconds, discarding the flow-through. The column
was twice washed using 700 and 200 µL of washing buffer, also discarding the
flow-through.
Finally, elution solution was used to recover the plasmid DNA, by centrifu-
gation at maximum speed a 1.5 mL microtube. This purified DNA was later
used for cloning or transformation.
3.2 Bacterial culture
L. lactis strain was cultured in GM17-E medium to ensure the positive selection
of the pT1NX plasmid, which carries an erythromycin resistance gene. The
composition of the M17 medium is [248]:
• Tryptone (5 g/L)
• Soya peptone (5 g/L)
• “Lab-lemco” powder (5 g/L)
• Yeast extract (2.5 g/L)
• Ascorbic acid (0.5 g/L)
• Magnesium sulphate (250 mg/L)
• Di-sodium glycerophosphate (19 g/L)
The reconstituted medium has a pH of 6.9 ± 0.2 measured at 25 °C. This
medium is commercially sold as a highly hygroscopic, dehydrated powder that
was reconstitued at 37.25 g/L in ultrapure or distilled water and sterilized at
121 °C for 20 minutes. Once cooled down, it was supplemented with 0.5 % v/v
sterile glucose and 10 µg /mL erythromycin, to avoid glucose caramelisation
or erythromycin degradation during the sterilization process.
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L. lactis grows optimally at 30 °C in anaerobic conditions as a standing
culture. When cultures reaches the stationary phase, bacteria slowly settles
forming a pellet in the bottom of the container. We observed that L. lactis-FN
produces compact pellets whilst the L. lactis-empty strain produces a turbid
medium with a smaller pellet. Brightfield microscopic imaging of the stationary
phase cultures shows that L. lactis-FN grows in chains of 5 to 15 cells in contrast
to L. lactis-empty, which grows in short chains of 4-5 cells at most.
3.3 L. lactis biofilm production
The protocol to establish a biofilm on a material surface has been adapted from
elsewhere [209, 249]. A frozen glycerinate of L. lactis-FN kept at –80 °C was
used to streak a fresh GM17-E 1 % agar plate. The plate was kept at 30 °C for
18-24 h until 1-2 mm colonies grew up. Then, a single colony was inoculated in
10 mL of fresh GM17-E medium and grown until the optical density, measured
at 600 nm, reached a value between 0.3 and 0.5. Then, the bacterial culture
was poured into a multiwell plate, sealed with adhesive tape or parafilm and
kept in the incubator at 30 °C for at least 18-24 h.
Once the stationary point was reached, the culture was removed, washing
the wells with sterile ultrapure water to remove the non-attached (planktonic)
bacteria. After three gentle washes, a monolayer of adhered bacteria remained
attached on the material surface. The same protocol was used for L.lactis-empty
and L. lactis-FN.
3.4 Mammalian cell culture
Several mammalian cell lines have been used in this work, human and murine.
The first assays were done with murine fibronectin null (Fn−/Fn−) fibroblasts.
The rationale for using these cells was to ensure that cell behavior was only
affected by the fibronectin displayed in the L. lactis membrane, since fibroblasts
secrete fibronectin that could interfere with the adhesion assays.
Morphology studies on different densities biofilms were carried using two
different cell lines, the murine C2C12 myoblastic cell line and L929 fibroblastic
cell line. Finally, human bone-marrow derived mesenchymal stem cells were
used to assess the differentiation capabilities of the FNIII7−10 fragment in
long-term cultures. In the bacterial biofilm co-cultures, the 1 % penicillin-
streptomycin antibiotic mix was substituted with 10 µg/mL tetracycline, to
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inhibit the growth of bacteria and prevent the medium acidification due to
lactate production.
Fn−/Fn− murine fibroblasts
Cells were maintained at 37 °C, 5 % CO2 in a humidified atmosphere. The
culture medium was composed of Dulbecco’s modified Eagle medium (DMEM)
supplemented with 4.5 g/L glucose, 100 U/mL penicillin-streptomycin and
10 % calf serum. Cells were passaged twice a week using standard techniques.
NIH3T3
NIH3T3 is a commercial fibroblastic cell line developed from NIH Swiss mouse
embryo cultures. Its growth properties are similar to those of 3T3 and BALB/
3T3. Cells were maintained at 37 °C in a humidified atmosphere with 5 % CO2.
The culture medium contained DMEM with 4.5 g/L glucose, 20 % calf serum
and 1 % (equivalent to 100 U/mL) penicillin-streptomycin. Cells were passaged
twice a week using standard techniques.
C2C12
This is a murine myoblastic cell line with the ability to differentiate to myotubes.
Cells were maintained in the usual conditions, 37 °C, 5 % CO2 humidified
atmosphere. The medium contained DMEM (Dulbecco’s modified eagle me-
dium) with 4.5 g/L, 1 % penicillin-streptomycin and 20 % Foetal Bovine Serum
(FBS). It is not advised to let cultures reach confluence in order to maintain its
differentiation capabilities, as the myoblastic population quickly depletes when
confluence is reached, due to paracrine interactions.
hMSC-BM
Human bone-marrow derived mesenchymal stem cells were kept in DMEM
supplemented with 100 µM pyruvate (Sigma), 1.1 mM L-glutamine (Sigma),
10 % FBS and 1 % penicillin-streptomycin. The culture conditions were the
same as the other cell lines, 37 °C in a humidified atmosphere with 5 % CO2.
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3.5 Immunofluorescence assays
Cell adhesion
Cell adhesion to the biofilm and control substrates was characterized by vin-
culin immunostaining. After culture times, cells were washed with Dulbecco’s
phosphate buffered saline (DPBS, Invitrogen) and fixed in 10 % formalin solu-
tion (Sigma) at 4 °C for 30 min. Formalin was rinsed three times with DPBS,
incubating the samples with permeabilising buffer (0.1 % Triton X-100 in DPBS)
at room temperature for 5 min.
Then, samples were incubated in 1 % bovine serum albumin (Sigma) in
DPBS at room temperature for 30 min, in order to block reactive sites and reduce
the background signal. Samples were then hybridized with a monoclonal anti-
vinculin antibody (Sigma) diluted 1:400 in 1 % BSA / DPBS for 1 hour at
room temperature and washed three times in 0.5 % Tween 20 / DPBS. A
Cy3-conjugated polyclonal rabbit anti-mouse IgG secondary antibody (Jackson
Immunoresearch), diluted 1:200 in 1 % BSA / DPBS, with 1:40 BODIPY FL–
conjugated phallacidin (Invitrogen) was added and incubated for 1 hour at
room temperature in absence of light.
Samples were washed three times with 0.5 % Tween 20 / DPBS and moun-
ted in Vectashield containing DAPI (Vector Laboratories, Peterborough, UK)
mounting medium and imaged using a Nikon Eclipse 80i fluorescence micro-
scope.
Cell differentiation
Myoblastic differentiation of the C2C12 cell line was assessed using sarcomeric
myosin immunostaining. Cultures were fixed at 4 °C with a mixture of 70 %
ethanol, 37 % formaldehyde and glacial acetic acid (mixing ratio of 20:2:1
respectively) for 15 min and blocked with 5 % goat serum in DPBS for 1 h at
RT. Samples were incubated with MF-20 antibody against sarcomeric myosin
(Developmental Studies Hybridoma Bank, University of Iowa, USA) at 1:250
dilution in 5 % goat serum / DPBS, followed by two washes with 0.5 % Tween
20 / DPBS and another blocking step with 5 % goat serum in DPBS for 10 min
at RT.
Samples were washed twice with 0.5 % Tween 20 / DPBS and incubated
with polyclonal rabbit anti-mouse Cy3-conjugated secondary antibody (Jackson
Immunoresearch) diluted 1:200 in 5 % goat serum / DPBS, rinsed three times
with 0.5 % Tween 20 / DPBS and mounted with Vectashield-DAPI (Vector
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Laboratories, Peterborough, UK). Samples were imaged under a Nikon Eclipse
80i epifluorescence microscope.
3.6 Protein quantification by Western blot
Membrane localisation of FNIII7−10
Cells corresponding to 109 cfu were washed and resuspended in 50 µL of lysis
buffer composed of Tris–HCl (50 mM, pH 7.5), sucrose 0.5 M and lysozyme 50
mg/mL, incubated for 2 h at 37 °C and centrifuged at maximum speed.
Supernatant (cytosolic fraction) and pellet (membrane fraction) were sep-
arated and resuspended in Laemmli loading buffer (50 µL), boiled for 5 min
and separated by 10 % SDS-PAGE gels. Proteins were transferred to positively
charged PVDF membranes (GE Healthcare) using the Bio-Rad semidry transfer
cell system. Membranes were blocked using 5 % skimmed milk in DPBS for 1
hour at RT and then incubated with the MAB1937 antibody (Millipore), direc-
ted against the 8th type III human FN domain, diluted 1:1000 in DPBS with
0.1 % Tween 20 and 2 % skimmed milk (Sigma). Incubation was carried out
overnight at 4 °C.
After several washes with 0.1 % Tween 20 / DPBS, the blot was incubated
using anti-mouse antibody conjugated to HRP (GE Healthcare) in a dilution of
1:50,000 in 0.1 % v/v DPBS / Tween 20 and 2 % skimmed milk for 1 h at RT.
Membranes were washed with 0.1 % Tween 20 / DPBS.
Immunoreactive bands were visualized using the ECL Plus Western blot kit
(GE Healthcare) after developing the photographic films.
Expressed FNIII7−10 fragment
Three aliquots of 0.5, 1 and 1.5 mL from a 24 h standing culture of L. lactis-FN
and L. lactis empty strains in GM17-E were lysed using a modified acetone/SDS
protocol [250]. Briefly, cells were harvested by centrifugation at 7,000 g for 5
min, washed twice with DPBS++ (DPBS supplemented with Ca2+ and Mg2+)
and centrifuged again.
The bacterial pellet was treated with 1 mL of acetone at –20 °C for 10 min,
with occasional vigorous vortexing. This extract was centrifuged at 7,000 g for
5 min and carefully dried under a gentle stream of N2 until a porous, dry white
powder was obtained. Proteins were solubilised by incubating the previously
obtained powder in 100 µL of 1 % SDS in ultrapure water for 20 min at RT,
with occasional vortexing. Debris were pelleted by centrifugation at 7,000 g
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for 5 min. 20 µL of the supernatant was mixed with 20 µL of 2× Laemmli
buffer, boiled for 5 min at 95 °C and subjected to 10 % SDS-polyacrylamide gel
electrophoresis (PAGE).
Simultaneously, 750, 500 and 250 ng of purified FNIII7−10 fragment were
loaded in the same gel as controls. Proteins were transferred to a positively
charged PVDF membrane (GE Healthcare) using a semidry transfer cell system
(Bio-Rad).
Membranes were blocked using 5 % skimmed milk in DPBS for 1 hour at RT
and then incubated with the MAB1937 antibody (Millipore), directed against
the 8th type III human FN domain, diluted 1:1000 in DPBS with 0.1 % Tween
20 and 2 % skimmed milk (Sigma). Incubation was carried out overnight at
4 °C.
After several washes with 0.1 % Tween 20 in DPBS, the blot was incubated
using horseradish peroxidase-conjugated anti-mouse antibody (GE Healthcare)
diluted 1:50,000 in DPBS / Tween 20 (0.1 % v/v) and 2 % skimmed milk for 1
h at RT. Membranes were washed several times with 0.1 % Tween 20 in DPBS.
The immunoreactive bands were visualized using the ECL Plus Western blot kit
(GE Healthcare) after developing the photographic films.
FAK phosphorylation
After a 3-hour culture, C2C12 or Fn−/Fn− fibroblasts were lysed with RIPA
buffer (Tris-HCl 50 mM, 1 % Nonidet P-40, 0.25 % sodium deoxycholate,
150 mM NaCl, 1 mM EDTA) supplemented with protease inhibitor cocktail
tablets (Complete, Roche). Proteins were concentrated using Microcon YM-30
Centrifugal Filter devices (Millipore) following manufacturer instructions.
To determine FAK protein expression and its Tyr397 phosphorylated form
(pFAK), concentrated samples were subjected to 7 % SDS-polyacrylamide gel
electrophoresis (PAGE). Proteins were transferred to a positively charged PVDF
membrane (GE Healthcare) using a semidry transfer cell system (Bio-Rad) and
blocked by immersion in 5 % skimmed milk / DPBS for 1 h at room temperature.
The blot was incubated with anti-FAK antibody (Upstate) and anti-pFAK
antibody (Millipore) diluted 1:2,500 in 2 % skimmed milk / 0.1 % Tween 20 /
DPBS. After several washes with 0.1 % Tween 20 / DPBS, the blot was incub-
ated in horseradish peroxidase-conjugated antibody (GE Healthcare) diluted
1:50,000 in 2 % skimmed milk / 0.1 % Tween 20 / DPBS for 1 hour at room
temperature.
After several washes with 0.1 % Tween 20 / DPBS, immunoreactive bands
were visualized using Supersignal West-femto Maximum Sensitivity Substrate
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(Thermo Scientific) after developing the photographic films.
3.7 Enzyme-linked immunosorbent assay (ELISA)
Membrane-bound FNIII7−10
Enzyme-linked immunosorbent assays were used to quantify the biological
activity of the exposed FNIII7−10 fragment displayed on the L. lactis surface.
Three mililitres from a 24 h standing culture of L. lactis-FN and L. lactis-empty
grown in sterile GM17-E, with a bacterial density of 107 cfu/mL, were filtered
through a porous polycarbonate membrane with a mean pore size of 0.8 µm
(Isopore, Millipore).
The membrane was twice washed with DPBS++ to remove non-trapped
bacterial cells. Another set of identical membranes were coated with 20, 10, 5
and 2.5 µg/mL of human plasma fibronectin (Sigma) dissolved in DPBS++ for
1h at RT, and washed twice with PBS++. Uncoated membranes were used to
assess the absence of any background signal in the polycarbonate membranes.
Membranes were then blocked with 1 % bovine serum albumin (Sigma) in
DPBS++ for 1h at RT, and incubated for 1h at 37 °C with mouse monoclonal
HFN7.1 anti-fibronectin antibody. The primary antibody dilution was 1:4,000
from a 32 µg/mL stock.
After that, samples were washed twice with DPBS++ / Tween 20 (0.5 %
v/v) and incubated with alkaline phosphatase-conjugated donkey anti-mouse
secondary antibody (Jackson Immunoresearch) for 1h at RT. Samples were
washed again twice with DPBS++ / Tween 20 (0.5 % v/v). Then, 400 µL of
a 0.6 mM 4-methylumbelliferyl phosphate solution in a pH 10 borax/NaOH
buffer was added.
After an incubation time of 45 min at 37 °C, the supernatant was transferred
to a P96 multiwell plate. Fluorescence was measured at λex = 365 nm and
λem = 460 nm in a Perkin-Elmer Victor3 Multilabel Counter (Perkin Elmer).
ERK1/2 sandwich ELISA
ERK 1/2 phosphorylation was assessed with the DuoSet ERK 1/2 sandwich
ELISA kit (RnD Systems, Minneapolis, USA).
Human bone marrow-derived mesenchymal stem cells, passage 2 (Promo-
cell) were maintained in DMEM supplemented with 1 % P/S, 1.1 mM L-
glutamine, 100 µM pyruvate and 10 % FBS. Then, cells were seeded over
maximum-density L. lactis-empty and L. lactis-FN biofilms produced on PEA
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thin films, FN-coated PEA and bare polystyrene surfaces in the same medium,
but replacing P/S by 10 µg/mL tetracycline, without FBS, at 25,000 cells/cm2.
After 30 minutes, culture medium was removed and cells were lysed with
50 µL of lysis buffer (1 mM EDTA, 0.5 % Triton X-100, 5 mM NaF, 6 M urea,
10 µg/mL leupeptin, 10 µg/mL pepstatin, 100 µM PMSF, 3 µg/mL aprotinin,
2.5 mM sodium pyrophosphate and 1 mM activated sodium orthovanadate in
DPBS, pH 7.2-7.4) for 15 min in ice. Lysate was stored at –80 °C. Assay plates
were coated with capture antibody at 8 µg/mL in DPBS, overnight at room
temperature.
The following day, the plate was washed three times using washing buffer
(0.5 % Tween 20 in DPBS, pH 7.2-7.4) and blocked with blocking buffer (1 %
BSA, 0.05 % NaN3 in DPBS, pH 7.2-7.4) for 1-2 h at room temperature, rinsing
twice with washing buffer. Then, a standard curve covering from 30 ng/mL to
0.23 ng/mL of pERK1/2, with eight two-fold dilutions (in 1 mM EDTA, 0.5 %
Triton X-100, 5 mM NaF, 1 M urea in DPBS, pH 7.2-7.4), was prepared. Samples
were diluted six-fold in the same buffer and incubated for two hours at room
temperature.
Then, wells were washed twice with the washing buffer. Immediately,
the detection antibody, with a final concentration of 400 ng/mL diluted in
1 % BSA in DPBS, was added, allowing a two-hour incubation. Wells were
twice washed again, adding streptavidin-HRP (1/400 in 1 % BSA in DPBS,
pH 7.2-7.4) and incubating for 20 minutes at room temperature. Wells were
twice washed, adding immediately the substrate solution (1:1 mix of H2O2 and
tetramethylbenzydine).
After a 20 min at room temperature, while protecting the plate from the
light, 1/2 volume of stop solution (H2SO4 2N) was added. Absorbance of the
samples was measured at λ = 450 nm. The obtained standard calibration curve
was adjusted to a third-degree polynomial equation, interpolating the sample
concentration values from this curve.
3.8 Image analysis
Image analysis procedures were conducted using the Fiji–ImageJ software [251].
Images were acquired using a Nikon Eclipse 80i epifluorescence microscope,
fitted with a monochromatic Nikon 90i camera with a 12-bit analog-to-digital
converter. 10, 20, 40 and 60× objectives were used in conjunction with binocu-
lar 10× eyepieces. Images were saved in 8-bit per channel RGB BMP format.
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Cell morphology
Cell morphology was determined by capturing images of the vinculin channel
of the immunofluorescence, in our experiments stained with a Cy3-conjugated
secondary antibody.
RGB BMP images were converted to 8-bit grayscale images with Fiji–ImageJ
and binarized with the Otsu algorithm. The resulting binary mask was subjected
to a watershed algorithm to isolate the contiguous, touching cells. Finally,
cell area and roundness was calculated using the Particle Analysis command.





Bacterial and cell viability
Bacterial viability was determined using the BacLight live/dead bacterial viabil-
ity kit (Life Technologies). This kit contains two dyes, SYTO9 and propidium
iodide (PI). SYTO9 is an intercalant, green-fluorescent permeant stain that
stains the DNA of the cells in a given population. Propidium iodide is an in-
tercalant, red-fluorescent and non-permeant stain that only enter cells whose
membrane is structurally compromised. When used together in an appropriate
mixture ratio, 1:1 in this case, PI quenches most of SYTO9 fluorescence. As a
result, viable bacteria show green and non-viable bacteria red fluorescence.
For mammalian cell viability, the mammalian live/dead viability kit (Life
Technologies) was used. This kit comprises two different probes, calcein AM
and ethidium homodimer-2. In viable cells, calcein AM permeates the intact
membrane and, once in the cytoplasm, is hydrolyzed by the ubiquitous cytoplas-
mic esterase activity, giving as a result calcein, a bright green fluorescent dye.
On the other hand, ethidium homodimer-2 is a non-permeant DNA stain that
only enters cells with compromised membrane. After the staining, viable cells
show a bright green cytoplasmic fluorescence while non-viable cells show red
fluorescent nuclei, which are easily distinguishable by fluorescence microscopy.
The same protocol was used to assess bacterial and cell viability. In either
mammalian cells or bacteria, the live/dead kit stains non-viable cells in red and
viable cells in green . Two-channel images from each microscope field were
recorded and saved. Then, each image was processed the same way: green and
red channels were separately converted to 8-bit grayscale images, binarized
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using the Otsu algorithm [252] and the resulting binary mask were subjected to
the particle analysis command of Fiji–ImageJ. Nuclei of non-viable cells showed
red fluorescence while viable cells displayed green fluorescence.
Percentage of viable cells was calculated as the number of cells counted
in the green channel divided by the total number of cells, i.e. the viable cells
plus the non-viable cells. For bacteria, since individual nucleus could not be
resolved, coverage percentage was calculated from the total stained area in the
red and green channels.
Biofilm density
Biofilm density was calculated from either DAPI or live/dead stained biofilms.
For DAPI, single-channel images of the blue channel were converted from
RGB BMP (bitmap format) to 8-bit grayscale images and binarized using the
Otsu [252] algorithm or the Trainable Weka Segmentation machine-learning
algorithm [253] where needed, mainly in images with low contrast or with
uneven background. Total area covered by bacteria was calculated using the
Image Analysis command. The coverage of the bacterial cells with respect to





When live/dead protocol was used to stain bacteria, the red (non-viable)
and green (viable) channels were combined in an RGB BMP image that was
later converted to an 8-bit grayscale image. This image was binarized using the
Otsu thresholding algorithm or the abovementioned Weka machine-learning
algorithm, calculating the total area. Coverage percentage was calculated using
the latter equation.
Western blot quantification
Chemiluminiscence films from the Western blot assays were digitized using
a flatbed scanner with a resolution of 600 dots per inch and 8-bit per pixel
sampling in a single channel grayscale TIFF image.
Images were quantified with Fiji–ImageJ. To do so, individual membrane
images were cropped from the whole image. Vertical lanes of each sample
were selected and processed with the Gel Analysis tool of Fiji–ImageJ. This tool
computes, for each different lane, a pixel intensity profile. A baseline indicating
the background is drawn for each lane, and the software returns a pixel count
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value. This pixel count is considered as the number of pixels contained in each
band. From this value, relative or absolute quantifications can be performed.
In FAK and pFAK, the α-tubulin bands were used as internal controls, norm-
alising the intensity of each band against α-tubulin bands.
Differentiation analysis
For differentiation analysis, two images for each field were taken. One from the
nuclei (DAPI channel), and the other from the myotubes (red channel), stained
with Cy3. Images were acquired at 10× magnification, transformed to an 8-bit
grayscale bitmap and segmented using the Trainable Weka Segmentation plugin
to create a binary mask for both Cy3 and DAPI channels.
Total nuclei per image were counted using the Particle Analysis command.
Then, the binarized DAPI channel was multiplied by the binarized Cy3 channel
image, leaving as a result an image containing only nuclei co-located with the
tubes.
Nuclei in this resulting image were counted using the Particle Analysis com-
mand. The fraction of differentiated cells was calculated dividing differentiated
by total nuclei count.
3.9 Materials preparation
PLLA electrospinning
50 mL of an overnight culture of L. lactis-FN and L. lactis-empty in GM17-E
were pelleted by centrifugation at 3,000 g for 10 min. The pellet was twice
washed with 2 mL of sterile NaCl 0.85 % w/v to remove traces of the growth
medium. Bacteria were harvested by centrifugation at 3,000 g for 10 minutes,
and resuspended in a 10 % w/v sucrose solution, that was immediately frozen
at –80 °C and freeze-dried. Freeze-dried bacteria were resuspended in 750 µL
of hexafluoroisopropanol (HFIP, >99 % pure, Sigma) and filtered through a 75
µm metallic sieve to remove the precipitated sucrose. This solution was mixed
with 750 µL of an 8 % w/v poly-L-lactic acid solution in HFIP and electrospun
using an electric potential of 22 kV, a flow rate of 500 µL/h and a distance
between the extruding needle and the collector of 18 centimeters. The needle
had an internal diameter of 0.15 mm. As a result, a nonwoven mat of PLLA
filaments with trapped bacteria was obtained.
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Ethyl acrylate polymerisation
Poly (ethyl acrylate) (PEA) films were prepared by radical polymerization of
pure liquid ethyl acrylate (Sigma) using 0.35 % w/v benzoin (98 % pure,
Scharlau) as photoinitiator. The polymerization was carried out for 24 hours
in a UV oven. After polymerization, a second post-polymerization step was
performed at 90 °C for 24 hours. Low molecular mass substances were extracted
from the material by in vacuum drying at 60 °C for two days.
PEA spin casting
Poly (ethyl acrylate) sheets were dissolved in toluene to a final 2.5 % w/v
concentration. The solution was stirred for two days until all the polymer
was properly dissolved, obtaining a viscous solution as a result. Spin casting
was performed on 12 or 25 mm glass coverslips at 2,000 rpm for 30 seconds.
Samples were dried in vacuum at 60 °C to remove solvent traces before biofilm
preparation.
PLLA spin casting
A similar protocol was applied to prepare PLLA thin films with trapped bacteria.
L. lactis-FN and L. lactis-empty were cultured overnight on GM17-E in a total
volume of 50 mL. Cells were harvested at 3,000 g for 5 minutes, washed
twice with sterile 0.85 % NaCl and centrifuged again at 3,000 g for 5 minutes.
The pellet was mixed with 1 mL of an 8 % PLLA solution in HFIP. Each 12
mm-coverslip was coated with 100 µL of this solution.
The spin-coater program consisted on a 30-second run at 3,000 rpm, drying
afterwards the coated coverslips in the air, at room temperature, for 1 hour.
Those PLLA thin films with included L. lactis were used for the subsequent cell
cultures.
Chapter 4
Lactococcus lactis cloning and
characterization
4.1 Introduction
Understanding the behaviour of cells on synthetic surfaces is of foremost interest
to engineer microenvironments that mimics and summarise the characteristics
of the extracellular cell matrix. In most cases, direct interaction of cells and syn-
thetic materials, polymers, glass or metals is not possible without the presence
of an intermediate protein layer. [12, 119]
A wide variety of materials have been functionalised with a broad range of
proteins, peptides and growth factors, such as fibronectin, laminin, collagen,
fibrin and others, by using physical or chemical strategies [8–10]. This protein
layer provides biochemical cues where cells can attach, adhere, proliferate and
differentiate. However, the assembly of cells into tissues is a highly orchestrated
set of events that requires time scales ranging from seconds to days or weeks
and dimensions ranging from microns to centimetres, and it is clear that passive
coatings cannot provide this dynamic microenvironment. [9]
The extracellular matrix is a complex network of proteoglycans and gly-
coproteins, including fibronectin, laminin, fibrin, elastin, collagen and others
that provide a well-ordered environment which support cell proliferation, mi-
gration, survival and differentiation. Extracellular enzymes, mainly proteases,
constantly reorder ECM; therefore, the natural niche of these cells is a highly
dynamic environment.
Significant efforts have focused on engineering materials that recapitulate
the characteristics of the ECM, such as the presentation of cell adhesive mo-
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tifs protected by enzymatic cleavable moieties [254], or photoactivable RGD
peptides [14]. In both scenarios, cell behaviour can be controlled to a certain
extent, obtaining as a result a sort of dynamic interface but still far away from
the requirements for a true ECM substitute.
In this chapter, the use of Lactococcus lactis as a living biointerface [216]
is presented. This bacterium has been genetically modified to express the FN-
III7−10 repeats of the human fibronectin, taking advantage of its low exopoly-
saccharide production, to make it accessible to the extracellular environment.
Although with a low polysaccharide production, this strain exhibits the ability to
develop stable biofilms [209] in the proper environment, so a stable monolayer
between the synthetic material and the living cells can be produced.
The expressed fibronectin fragment contains the RGD adhesion and the
PHSRN synergy motifs, both involved in the interaction with integrins, mainly
through the α5β1 integrin [201]. Integrins [11] are transmembrane receptors
linked to cell adhesion, spreading, migration, proliferation and differentiation.
[14]
4.2 Materials and methods
Cloning
A summary of the whole cloning protocol is as follows. First, the FNIII7−10
fragment from the pET-15b-FNIII7−10 plasmid, kindly donated by Dr. Mercedes
Costell from the Universitat de València, was amplified by PCR and subcloned
downstream to GFP in the pGFP-C2 (Clontech) GFP-containing plasmid. The
FNIII7−10-GFP fragment was amplified via PCR and subcloned into the pT1NX
lactococcal plasmid using proper restriction enzymes. Finally, competent L. lactis
cells were prepared and transformed with the pT1NX-FNIII7−10-GFP plasmid.
The protocol is detailed below.
The first step comprised the amplification of the FNIII7−10 from the pET15b-
FNIII7−10 plasmid [255] using PCR.
The following primers were used:
• F1 (with HindIII restriction site, lowercase)
5’-aagcttaCCATTGTCTCCACCAACAAAC
• R1 (with SalI restriction site, lowercase)
5’-gtcgacttaTTCTGTTCGGTAATTAATGGAAA
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The PCR product was subjected to electrophoresis in a 0.7 % agarose gel in
order to isolate the amplified DNA. This band was carefully cut from the gel
under transilluminator UV light, isolating the DNA with the Illustra GFX DNA
and gel band purification kit (GE Healthcare). Once purified, FNIII7−10 ampli-
fied fragment was sequentially digested with HindIII (New England Biolabs)
and SalI (New England Biolabs) in order to generate sticky ends. The same
restriction reaction was carried on the pGFP-C2 plasmid (Clontech). This E. coli
plasmid contains a neomycin/kanamycin resistance gene, the GFP gene and a
MCS downstream to GFP containing HindIII and SalI restriction sites, in frame
with the GFP ORF (Figure 4.1).
Figure 4.1 pGFP-C2 map. FNIII7−10 fragment was subcloned downstream to
GFP using the HindIII and SalI restriction sites.
Once purified, both pGFP–C2 plasmid and FNIII7−10 fragment were ligated
using T4 ligase (New England Biolabs). The reaction mix was further purified
using the Illustra GFX DNA and gel band purification kit (GE Healthcare).
Ligated and purificated product were used to transform E. coli NEB 5α strain
(New England Biolabs) following manufacturer’s protocol. A 50 µL aliquot of
frozen cells kept at –80 °C was thawed on ice for 10 minutes. Then, 5 µL of
the purified ligation product was added to the competent bacteria and gently
shaken while avoiding vortexing.
Competent bacteria were transformed by heat shock method in which the
mix was left 30 minutes on ice followed by a 30-second heat-shock at 42 °C,
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then placed on ice for 5 minutes. 950 µL of super-optimal growth (SOC)
medium (New England Biolabs) was immediately added to the reaction tube
and incubated for 1 hour at 37 °C, while shaking the tube at 250 rpm.
100 µL of the resulting culture was spread in several LB-agar plates sup-
plemented with 50 µg/mL kanamycin and left overnight at 37 °C, to select the
kanamycin-resistant positive clones. Four of the grown colonies were picked
up and cultured at 37 °C for 18 hours in LB medium supplemented with 50
µg/mL kanamycin.
Then, cultures were harvested at 10,000 g for 5 minutes, isolating and
purifying the plasmidic DNA with the GenElute Five-minute miniprep kit from
Sigma. To check the correct insertion of the FNIII7−10 fragment into the pGFP–
C2 plasmid, the obtained DNA was consecutively digested with HindIII and
SalI.
As shown in Figure 4.2, the enzymatic digestion of one of the clones (marked
with the arrow) followed by electrophoretic separation in a 0.7 % agarose gel
showed two bands, one corresponding to the pGFP–C2 plasmid, with a size of
4.7 kb, and the FNIII7−10 fragment with a size of 1.1 kb (Figure 4.2)
Figure 4.2 Electrophoresis of the digested pGFP–C2 plasmid with HindIII and
SalI showing two bands, corresponding to the backbone vector and the insert, in
the fourth lane (white arrow).
The E. coli strain transformed with the positive clone was grown in LB
medium supplemented with 50 µg/mL of kanamycin, overnight, at 37 °C.
Plasmid DNA was then purified using the GenElute Five-minute miniprep kit
(Sigma). This DNA was used to amplify the whole FNIII7−10-GFP fragment by
PCR. To do so, the following primers were used:
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• F1 (with NgomIV restriction site in lowercase)
5’-gccggcATGGGTAAAGGAGAAGAACTTT
• R1 (without restriction sites)
5’-TTCTGTTCGGTAATTAATGGAAA
The resulting PCR product, with a size of 1.7 kb, was subjected to a 0.7 %
agarose gel electrophoresis and purified from the gel (Figure 4.3).
Figure 4.3 Agarose electrophoresis of the amplified PCR product, showing three
different lanes with the same product, with a molecular size of 1.7 kb
This fragment contains the FNIII7−10 gene downstream to GFP, with an
NgoMIV restriction site in 5′. The Lactococcal pT1NX plasid was the chosen
vector to transform L. lactis. This vector contains the constitutive P1 promoter,
the ermM erythromycin resistance gene, the secretion peptide Usp45 and the
Staphylococcus aureus protein A (SpA) spaX gene to covalently bind the fusion
protein into the L. lactis peptidoglycan layer.
A multiple cloning site containing BamHI and NgoMIV, amongst other
restriction sequences, is located between usp45 and spaX, in frame with the
usp45-spaX ORF (see Figure 4.4).
pT1NX was amplified from the bacterial pT1NX-containing strain L. lactis
MG1363-pT1NX. The amplification procedure involved the overnight culture of
this strain in M17 medium supplemented with 10 µg/mL erythromycin and 0.5
% v/v glucose. Plasmidic DNA was isolated using a combination of a manual
protocol and the Five-minute miniprep kit (Sigma).
Cloning of FNIII7−10-GFP into pT1NX was performed by linearizing pT1NX
with BamHI (New England Biolabs), obtaining a linear DNA with two BamHI
sticky ends.
Then, the Klenow fragment of the DNA polymerase I (New England Biolabs)
was used to convert the sticky ends to blunt ends. The resulting pT1NX plasmid
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Figure 4.4 pT1NX plasmid map, showing the NgoMIV and BamHI restriction
sites used in the cloning protocol.
with blunt ends and an NgoMIV restriction site, along the FNIII7−10-GFP frag-
ment (carrying an NgoMIV restriction site in 5′) were digested with NgoMIV, in
separate reactions.
NgoMIV restriction products were purified using the Illustra GFX DNA and
gel band purification kit (GE Healthcare) and mixed in a 5:1 (insert:plasmid)
ratio, joining the DNA chains with T4 ligase (New England Biolabs). Reaction
product of ligation was purified with the kit and used to transform electrocom-
petent L.lactis.
Grown colonies were screened to check the presence of the correct clone.
To do so, 25 colonies were picked up and cultured in 5 mL of M17 medium
supplemented with 0.5 % v/v glucose and 10 µg/mL erythromycin. 1 µL of the
resulting cultures were subjected PCR with the same primers used to amplify the
FNIII7−10-GFP sequence. From these PCR, three positive clones were detected
and sequenced to ensure the correct in-frame insertion of the FNIII7−10-GFP
fragment into the pT1NX plasmid (Figure 4.5)
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Figure 4.5 Agarose gel electrophoresis showing two of the three positive clones
carrying the pT1NX-FNIII7−10-GFP plasmid. After sequencing, clone 14 was found
to carry the inserted fragment in frame. This is the clone used in this work,
hereinafter L. lactis-FN. The L. lactis strain containing the empty pT1NX plasmid
is stated as L. lactis-empty.
ELISA
An enzyme-linked immunosorbent assay (ELISA) was used to quantify the
biological activity of the exposed FNIII7−10 fragment displayed on the L. lactis
surface. 3 mL from a 24 h standing culture of L. lactis-FN and L. lactis-empty
grown in sterile GM17-E, with a bacterial density of 107 cfu/mL, were filtered
through a porous polycarbonate membrane with a mean pore size of 0.8 µm
(Isopore, Millipore).
The membrane was twice washed with DPBS++ to remove the non-trapped
bacterial cells. Another set of membranes was coated with 20, 10, 5 and 2.5
µg/mL of human plasma fibronectin (Sigma) in PBS++, for 1h at RT, and
washed twice with PBS++. Uncoated membranes were used to assess the
absence of any background signal in the polycarbonate membranes.
Membranes were blocked with 1 % bovine serum albumin (Sigma) in PBS++
for 1h at RT to reduce the background signal, and incubated for 1h at 37 °C
with monoclonal mouse HFN7.1 anti-fibronectin antibody at 1:4000 from a 32
µg/mL antibody stock. After that, samples were washed twice with PBS++ /
Tween 20 (0.5 % v/v) and incubated with alkaline phosphatase-conjugated
donkey anti-mouse secondary antibody (Jackson Immunoresearch) for 1h at
RT.
Samples were washed again twice with PBS++ / Tween 20 (0.5 % v/v),
followed by the addition of 400 µL of 4-methylumbelliferyl phosphate (0.6
mM, Sigma) in borax/NaOH pH 10 buffer. After a 45 min incubation at 37 °C,
the supernatant was transferred to a P96 multiwell plate. Fluorescence was
measured at 365/460 nm (excitation/emission wavelengths) with a Perkin-
Elmer Victor3 Multilabel Counter (Perkin Elmer).
The same protocol was used to assess the influence of the antibiotic-containing
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medium used to check whether the biological activity of the expressed FNIII7−10
fragment would be altered. In this case, polycarbonate membranes with trapped
bacteria were transferred to 24 well plates and incubated for 24h, in a humid-
ified atmosphere at 37 °C with 5 % CO2, with the corresponding medium,
namely DMEM, DMEM supplemented with 1 % P/S and DMEM supplemented
with 10 µg/mL tetracycline.
Detection of FNIII7−10 fragment by Western blot
From an overnight culture of L. lactis-FN strain, cells corresponding to 109 cfu
were washed and resuspended in 50 µL of lysis buffer composed of Tris-HCl
50 mM, pH 7.5, with 0.5 M sucrose and 50 mg/mL lysozyme. The bacterial
suspension was incubated 2 h at 37 °C in and centrifuged at 16,000 g for 5
minutes. Supernatant and pellet were separated and resuspended in 50 µL of
Laemmli loading buffer, denatured at 100 °C for 5 minutes and separated by
10 % SDS-polyacrylamide gel electrophoresis (PAGE).
Protein were then transferred to a positively charged PVDF membrane (GE
Healthcare) using a BioRad semidry transfer system cell, followed by immersion
in 5 % skimmed milk in PBS as a blocking buffer. The blocking step lasted 1h
at room temperature.
Membrane was then incubated with mouse mAb1937 antibody (Merck
Millipore), diluted 1:1000 in a 2 % skimmed milk in PBS / Tween 20 0.5 %
solution. This antibody is directed against the 8th type III domain of the human
fibronectin. Incubation lasted 2 hours at room temperature. The primary
antibody was washed several times with PBS / Tween 20 0.5 % and incubated
2 h at room temperature with rabbit anti-mouse horseradish peroxidase-linked
antibody, diluted 1:50,000 in 2 % skimmed milk / PBS / Tween 20 0.5 %.
After several washes with PBS / Tween 20 0.5 %, immunoreactive bands
were visualized with the ECL Plus kit (GE Healthcare) in a photographic film.
Scanning electron microscopy
Freshly prepared biofilms were washed twice with sterile ultrapure water,
to remove traces of the culture medium, and then were fixed with 2.5 %
glutaraldehyde in phosphate buffer (PB) 0.1 M, pH 7.3, for 14 h at 4 °C.
Fixed biofilms were twice washed with PB and dehydrated in ethanol/water
mixtures of 50 %, 70 %, 80 %, 90 % and 100 %, repeating the 100 % step
three times, for 10 minutes each step. Finally, samples were dried using hexa-
methyldisilazane (Sigma) and air-dried for 10 minutes. [256] Prior to imaging,
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samples were sputter coated with a 1 nm layer of platinum and imaged in a
Zeiss Ultra55 Field Emission SEM (Zeiss Microscopy, Germany) with an electron
gun acceleration voltage of 1 kV.
Atomic force microscopy
10 mL of L. lactis-FN and L. lactis-empty stationary-phase cultures were centri-
fuged at 3,000 g for 10 minutes and twice washed with 100 mM sodium acetate
buffer (Sigma) with a pH of 4.8. The resulting pellet was resuspended in the
same volume with the same buffer and filtered through a porous hydrophilic
polycarbonate membrane (Isopore, Merck-Millipore) with an average pore size
of 0.8 µm.
Untrapped bacteria were gently washed with the sodium acetate buffer.
Membranes with trapped bacteria were kept in a P24 multiwell plate while
avoiding dewetting [257]. These samples were imaged in a Multimode AFM
fitted with a NanoScope IIIa controller from Veeco (Manchester, UK) in QNM
PeakForce mode. Silicon nitride cantilevers, with a force constant of 0.7 N/m
were used. Drive amplitude was set to 100 mV and amplitude setpoint to 250
mV.
Confocal laser scanning microscopy
Biofilms from viability assays, after its quantification in a standard fluorescence
microscopy, were mounted with Fluorsave mounting medium and imaged in
a Leica MI8 confocal microscope, using a 63× oil immersion objective. 39
z-planes were scanned and the final image was reconstructed in Fiji – ImageJ
using the 3D viewer plugin.
Bacterial viability
To assess bacterial viability, samples were twice washed with sterile NaCl 0.85 %
solution to remove traces of the growth medium. Then was added a mixture of
SYTO9 (5 µM) and propidium iodide (30 µM) in NaCl 0.85 %, incubating the
biofilms for 15 minutes at room temperature, in absence of light. Afterwards,
biofilms were washed twice with NaCl 0.85 % to remove the incubation medium.
Samples were mounted using Fluorsave medium, kept at 4 °C for 15 minutes
to allow its solidification and imaged in a Nikon Eclipse 80i epifluorescence
microscope.
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Image analysis
Four different fields for each sample were captured using a Nikon Eclipse 80i
fluorescence microscope, at 40× magnification, in the green (FITC) and red
(Cy3) channels. Both channels were treated separately. Images, in a RGB BMP
format, were first converted to 8-bit grayscale format and thresholded using
the Otsu algorithm to create binary masks of the stained bacteria. Total area
was calculated using the Particle Analysis command of ImageJ.
Since it was not possible to resolve individual bacteria, and taking in account
that the only fluorescent pixels present in the images were due to bacterial
fluorescence, viability was calculated as the ratio between areas of the stained
pixels in the green channel (viable bacteria) and areas of the stained pixels in
the merged green and red channels (viable plus non-viable bacteria). Results
were averaged and expressed as mean ± SD.
4.3 Results
Membrane localisation of the FNIII7−10-GFP fragment
Expression and membrane localisation of FNIII7−10 fused to GFP in the L. lac-
tis-FNIII7−10-GFP modified strain (hereinafter L. lactis-FN) was confirmed by
several methods. The first confirmation came from the sequencing of one of
the clones obtained after the electrotransformation. Sequencing confirmed the
in-frame inclusion of a 1.8 kb fragment corresponding to the FNIII7−10-GFP
sequence amplified from the pGFP-C2-FNIII7−10 plasmid.
The combination of Usp45 and Staphylococcus aureus protein A anchor
signals efficiently promoted the localization of FNIII7−10 to the bacterial mem-
brane, as confirmed by fluorescence microscopy. L. lactis-FN cells showed rings
delimiting the bacterial perimeter (Figure 4.6).
Further confirmation of the FNIII7−10-GFP membrane anchoring was ob-
tained with a Western blot analysis. As described in the materials and methods
section, a sample volume of the L. lactis-FN culture was lysed with lysozyme,
analyzing the membrane and cytoplasmic fractions with Western blot. The
fraction corresponding to the membrane showed presence of the fragment,
without detectable FNIII7−10 signal in the cytoplasmic fraction (Figure 4.6).
This result suggests the adequate anchoring mechanism provided by the
Staphylococcus aureus protein A featured in the pT1NX plasmid, and that a
large fusion protein such as FNIII7−10-GFP can be successfully expressed and
promoted to this localization, without affecting L. lactis viability.
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Figure 4.6 Fluorescence image of a stationary-phase L. lactis-FN culture grown
overnight in M17 medium. Scale bar size is 10 µm
Figure 4.7 Western blot analysis of the membrane and intracellular fractions
of L. lactis. FNIII7−10 fragment is only found in the membrane fraction, with no
detectable levels in the intracellular pool.
Biological activity of the FNIII7−10 fragment
The amount of expressed FNIII7−10 fragment was assessed with a Western blot
analysis. Three different volumes of 25, 50 and 75 µL were taken from an L.
lactis-FN culture in stationary phase, lysed and subjected to a 10 % SDS-PAGE
gel electrophoresis (Figure 4.7). 75 µL of L. lactis-empty was used as negative
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control. Three different amounts of a purified FNIII7−10 fragment, 250, 500
and 750 ng were used to make a calibration curve. Figure 4.8 shows that the
amount of FNIII7−10 increases monotonically with the sample volume.
Figure 4.8 Representative membrane used in the quantification of the expressed
amount of FNIII7−10 in the bacterial membrane.
Bands from the cultured bacteria showed higher molecular mass values
due to their structure, since FNIII7−10 is fused to GFP, Usp45 and SpA. The
three bands on the right, used as standards, showed lower molecular weight,
since they proceed from purified FNIII7−10 fragment without GFP or signal or
anchoring motifs. The negative L. lactis-empty control showed undetectable
amounts of FN.
The amount of the FNIII7−10 fragment was quantified using the calibration
curve calculated from the standards by band densitometry analysis, finding a
linear relationship between band density and protein amount.
Based on this, the approximate density of FN fragment per unit volume
of bacteria in a culture in stationary phase was estimated to be around 980
ng/mL, which corresponds to approximately 980 ng/109 cfu, roughly 7 · 104
FNIII7−10-GFP molecules per cell assuming that the fragment has a molecular
weight of 83.1 kDa.
These values depict the total FNIII7−10 mass expressed by the bacteria, but
considering its role in interacting with mammalian cells, is also important to
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Figure 4.9 Linear regression analysis of the control bands used in the quantific-
ation of FNIII7−10 expressed by the L. lactis-FN strain.
assess the FNIII7−10 availability and biological activity after its immobiliza-
tion on a synthetic substrate. This was assessed through an enzyme-linked
immunosorbent assay (ELISA).
A bacterial culture grown until stationary phase was washed to remove
traces of the culture medium and filtered through a porous polycarbonate
membrane with a mean pore size of 0.8 µm, washing the membranes after
filtering to remove unattached bacteria.
Membranes were blocked with BSA to reduce background signal and hy-
bridized with HFN7.1, a monoclonal antibody directed against the flexible
linker between the III9 and III10 repeats of the expressed fragment. ELISA is
a well-established method to probe structural or conformational changes in
adsorbed proteins [258, 259].
Identical polycarbonate membranes were coated with solutions of human
plasma fibronectin at 20, 10, 5 and 2.5µg/mL. Results showed that the FNIII7−10
fragment displayed on the L. lactis-FN has a similar biological activity compared
to the membranes coated with a 20 µg/mL fibronectin solution.
Since tetracycline-containing medium was be used to keep a stable biofilm
over the surface while cultures were performed with mammalian cells, another
ELISA was performed to assess tetracycline influence on the biological activity
of the biofilms. The rationale behind this assay is that tetracycline might inhibit
bacterial protein expression due to its action mechanism.
Three different conditions were tested, a fresh biofilm made in M17 me-
dium, a biofilm incubated for one day in DMEM supplemented with tetracycline
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Figure 4.10 Comparable activity values of the membrane-expressed FNIII7−10
fragment in L. lactis-FN and the membrane coated with FN from a 20 µg/mL
solution. Both L. lactis-empty biofilm and uncoated membranes showed negligible
biological activity. Data shown as mean ± SD, N ≥ 9
Figure 4.11 ELISA of bacterial biofilms (L. lactis-FN) produced from fresh GM17-
E medium and incubated in DMEM supplemented with tetracycline 10 µg/mL for
1 and 4 days respectively. ANOVA showed no statistically significant differences
between samples. Data presented as mean ± SD, N ≥ 9
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at 10 µg/mL, and a biofilm incubated in the same conditions for 4 days. Res-
ults showed a similar biological activity, so we can dismiss any influence of
tetracycline on the FNIII7−10 activity.
This is an expected result, since the FNIII7−10 fragment is constitutively
expressed in the biofilm formation phase and there is no new protein synthesis
after biofilm development.
Biofilm morphology
Figure 4.12 Low-magnification FESEM image of an L. lactis-FN (a and c) and
L.lactis-empty (b and d) biofilm. a) bacterial clusters appear strongly attached
to the surface, creating a scattered non-continuous layer; b) magnified view of a
bacterial cluster. Cells appear joined through a thin exopolysaccharide layer. In
some cells, the glycocalyx, the region where the peptidoglycan layer is synthesized,
is marked by black arrows; c) and d) close-up views of individual diplococcus
showing the glycocalyx and some adhesion fimbriae, proving the presence of
bacterial-secreted extracellular structures that provide an irreversible attachment
to the surface. Images of a 24-hour-old biofilm developed on glass. Scale bar sizes
are 10 µm, 1 µm, 100 nm and 200 nm respectively.
Biofilm morphology was assessed through scanning electron microscopy
(SEM), atomic force microscopy (AFM), fluorescence microscopy and confocal
laser scanning microscopy (CLSM) in order to check whether the presence of
the expressed fragment would affect the shape or the superficial appearance of
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Figure 4.13 AFM images of the polar area of an L. lactis-emtpy (left) and L.
lactis-FN cell (right). These peak-force error images were taken in QNM PeakForce
mode. Both surfaces have a smooth appearance, without defining characteristics,
and almost identical in both strains. Scale bar size is 250 nm (left) and 125 nm
(right)
the bacterial cell wall and the biofilm macrostructure.
SEM images were taken from an L. lactis-FN and a L. lactis-empty biofilm,
showing a non-continuous monolayer of attached bacteria with a morphology
very similar to the one found in the fluorescence images (Figure 4.12).
High-magnification images of the L. lactis-empty strain showed no mor-
phological differences at single-cell level between both strains. In the low-
magnification images, L. lactis-FN strain appears to grow in longer chains
compared to the L. lactis-empty strain, where only diplococcus of at most six or
seven cells appear joined.
AFM images from bacteria trapped in a porous polycarbonate membrane
were also taken. Atomic force microscopy allows higher magnification values
than SEM, so it was possible to image membrane close-ups. No significant
morphological features were detected, in line with the SEM images. Surfaces
showed a smooth appearance with no noticeable differences between strains.
Biofilm viability
Viability and stability of the living interface on the material substrate was also
studied. First step was to check bacterial viability after the biofilm is established,
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using the BacLight (Invitrogen) viability kit. As described in section 3.8, freshly
prepared biofilms were incubated with this kit, which contains two different
stains, a green, permeant one and a red, non-permeant one. These stains are
able to discriminate between viable bacteria, with uncompromised membrane
integrity, and non-viable bacteria, stained in green and red respectively.
Figure 4.14 Bacterial viability in a 24-hour biofilm. a) for L. lactis-FN biofilm,
viability is 98.1 ± 1.1 %; b) for L. lactis-emtpy biofilm, with a viability of 97.1 ±
1.1 %; c) calculated viability by image analysis, from at least five different fields
taken at 40×. Data is shown as mean ± SD, N = 4, scale bar size is 20 µm. ANOVA
showed no statistically significant differences between strains
In the Figure 4.14, viability results of 24-hour biofilms of both strains grown
in GM17-E are shown. Cells were washed and its viability was tested using the
BacLight live/dead kit. No statistically significant differences between strains
were found. This fact suggests that L. lactis is able to synthesize and promote
the FNIII7−10-GFP fragment to its membrane while keeping its viability.
Figure 4.15 shows the 3D reconstruction obtained with a confocal laser
scanning microscope of a maximum-density biofilm developed over glass and
subjected to a viability staining; non-viable cells appear in red and viable cells
in green. Bacterial cells appear as an almost flat biofilm.
Biofilms used in the Figure 4.16 were produced by pouring 1000 µL of an
exponentially growing culture in P24 multiwell plates. Lower density biofilms
were successfully produced using lower volumes, namely 300, 500 and 700 µL,
using the 1000 µL biofilm as the one maximum density. Viability assessment
on these biofilms was also performed, with identical results compared to the
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Figure 4.15 3D reconstruction of a 39-slice stack of a SYTO9 and propidium
iodide-stained biofilm. Bounding box size is 116.4 x 116.4 x 7.8 µm. Since
both strains were able to develop biofilms and taking into account that these
biofilms display remarkably high viability values, an experiment was performed
to determine whether different areal densities could be obtained
maximum density ones, that is to say higher than 97 % for the two assessed
strains. Our hypothesis was confirmed since we obtained different coverage
percentages, and those percentages were directly related to the initial culture
volume.
Biofilm stability
Biofilm stability of the living interface developed on the material surface is
discussed in this section. This strain, once the biofilm has been established, is
able to proliferate as long as there is a sufficient supply of nutrients, mainly
glucose or other suitable carbon source. As a result, there is a production of L-
lactic acid from from homolactic fermentation of glucose that leads to a decrease
in the pH of the culture medium up to pH ≈ 4.5, seriously compromising the
viability of the co-cultured mammalian cells.
Therefore, it is imperative to minimize the metabolic activity of L. lactis
without affecting their viability. We found that tetracycline used at low concen-
trations, 10 µg/mL, is enough to inhibit bacterial replication without impacting
mammalian cell metabolism [260, 261]. Tetracycline is a broad-spectrum bac-
teriostatic antibiotic that binds to the 30S subunit of the bacterial ribosome,
inhibiting the protein synthesis by blocking the attachment of the charged
aminoacyl-tRNA to the ribosomal A site. [262]
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Figure 4.16 Fluorescence image of biofilms obtained from different starting
culture volumes. Images from the L. lactis-FN biofilm, although both strains
showed an almost identical areal density and viability. Viability was nearly identical
to the one calculated in the previous figure in both strains. There is a linear
correlation between both variables, with a maximum of 27 % coverage from an
initial volume of 1000 µL. Data shown as mean ± SD, N = 6. Scale bar size is 20
µm.
Although other antibiotics were considered, mainly penicillin-streptomycin
because it is routinely used in cell biology, tetracycline is preferred due to its
mechanism of action. Instead of inhibiting protein synthesis, which does not
affect the membrane integrity, the action mechanism of penicillin involves the
inhibition of the synthesis of new crosslinks between peptidoglycans inhibiting
the responsible enzyme of this process, DD-transpeptidase.
If we consider that the cell wall is subjected to a constant reorganization
state that involves hydrolysis and transpeptidation, inhibition of this last step
will eventually lead to the breakdown of the peptidoglycan layer, leaving as a
result a cell without the outer cell wall — a protoplast, which lacks the ability
to adhere to any surface as lacks all the components required to develop a
stable biofilm, primarily exopolysaccharides and adhesins. Another harmful
effect is the loss of the FNIII7−10 fragment, which is covalently linked to the
peptidoglycan layer.
Tetracycline seemed to control the bacterial metabolism more effectively
than penicillin-streptomycin. Biofilm stability and viability was assessed in
mammalian cell culture medium (DMEM) supplemented with tetracycline
and penicillin-streptomycin for up to 4 days, the minimum time needed for
myogenic differentiation. Three time points were selected, 1, 2 and 4 days. The
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experiment was conducted by preparing fresh biofilms in GM17 and changing
the medium to high-glucose DMEM (4.5 g/L) without antibiotics, supplemented
with 10 µg/mL tetracycline or 1 % penicillin-streptomycin(100 U/mL), and
incubating the samples at 30 °C and 37 °C in a humidified atmosphere with 5
% CO2.
Viability was tested at the selected time points tested using the Invitrogen
BacLight kit (section 3.8). Overall viability values seems to be independent
of the used antibiotic, at either 30 or 37 °C. The viability value for biofilms
incubated at 30 °C was 78.1 ± 5.2 %, while for 37 °C was 52.4 ± 5.6 %. This
decrease could be attributed to the temperature increase, since there not seems
to be influence of the strain, incubation time or antibiotic, and the optimal
growth temperature of L.lactis is 30 °C.
An unpaired Student’s t test performed over the 30 °C and 37 °C overall mean
values showed statistically significant differences with p= 0.0001. Nevertheless,
since mammalian cells are routinely cultured at 37 °C, biofilm viability seems
good enough for our purposes.
Biofilms treated with penicillin-streptomycin did not showed viability losses
may be attributed to the mechanism of action of streptomycin, identical to
tetracycline. It may explain why viability is almost the same in all the assessed
time points and antibiotics. Streptomycin inhibits bacterial metabolism, so no
ATP is newly synthesized and enzymes like DD-transpeptidase, needed for the
cell wall reorganization process, are effectively inhibited, keeping the cell wall
as-is.
Figure 4.17 Fluorescence microscopy images of DMEM, DMEM + PS and DMEM
+ tetracycline-treated biofilms at t = 4 days. Viable bacteria is shown in green
and non-viable in red. Scale bar size is 25 µm
Metabolic activity of the biofilm was indirectly assessed as a function of the
pH, due to the L-lactic acid production that results from the glucose metabolism.
Temporal evolution of the pH was measured using a pH meter. Fresh biofilms
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Figure 4.18 Viability values after 1, 2 and 4 days on L. lactis-FN and L. lactis-
empty biofilms incubated at 30 and 37 °C with DMEM, DMEM supplemented with
1 % penicillin-streptomycin (P/S) or 10 µg/mL tetracycline (TC). There are no
statistically significant differences between strains, antibiotics or incubation time,
with an overall mean value of 78.1 ± 5.2 % at 30 °C and 52.4 ± 5.6 % at 37 °C,
value shown as a dotted line. An unpaired Student’s t test with the two overall
means showed statistically significant differences with a significance level of p <
0.0001
were incubated at 37 °C in a humidified atmosphere with 5 % CO2, using the
same medium as in the preceding assay.
Attending to the results showed in the Figure 4.19, tetracycline was the
only antibiotic that maintained the pH of the medium above 7, a mandatory
condition to culture mammalian cells over the biofilms without risking its
viability.
The use of antibiotics in the culture medium decreased the density of
bacteria on the material surfaces, as inferred from Figure 4.20. However, even
if it is the case, the bacterial layer that remains in the surface shows a viability
higher than 50 %, enough to support cell adhesion and differentiation, as will be
later discussed. That is to say, even if the biofilm is not perfectly homogeneous,
the bacterial biofilm still shows adequate expression levels of FN for mammalian
cell interactions.
78 CHAPTER 4. LACTOCOCCUS LACTIS CLONING AND . . .
Figure 4.19 Bacterial metabolism inferred from the pH of the medium. Strains
incubated with DMEM supplemented with tetracycline 10 µg/mL (blue lines)
maintained its pH above seven in every moment, while incubation with DMEM
+ P/S led to a slight pH decrease, mainly in the L. lactis-empty strain. With no
antibiotics, pH quickly dropped to a value below 5, as a result of the glucose
conversion into L-(+)-lactic acid.
Figure 4.20 Antibiotic influence on the biofilm areal density. Starting from
maximum density biofilms, P/S seems to have a greater influence than tetracycline,
and L. lactis-emtpy seems also to be more affected than L. lactis-FN. Data shown
as mean ± SD, N = 4
4.4 Conclusions
In this chapter has been described the genetic modification of Lactococcus lactis
subsp. cremoris to express the III7−10 domains of the human fibronectin, which
contains two the adhesive RGD and the synergy PHSRN sequences. Both are
involved in the interaction with integrins, a wide family of transmembrane
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proteins that plays an important role in cell-ECM and cell-cell interactions. [12]
Genetic engineering of this strain has been made with standard techniques.
A fusion protein composed of FNIII7−10 and GFP has been cloned and expressed.
Green fluorescent protein is a widely used expression reporter originally isolated
from the Aequorea victoria jellyfish [90], and displays a bright green fluorescence
when exposed to ultraviolet light.
With the help of a secretion peptide, Usp45, and the membrane-anchoring
peptide LPETG from the SpA protein membrane of Staphylococcus aureus, this
fusion protein efficiently localizes the expressed protein on the peptidoglycan
layer of this strain, becoming exposed to the extracellular medium and thus
available for interaction with mammalian cells through integrins.
Genetically engineered L. lactis strain has been characterised in order to
analyse the expression levels and biological activity of the expressed FNIII7−10
fragment, using two different but complementary techniques, Western blot and
ELISA. By using Western blot has been possible to determine the total amount of
the expressed fragment, and the ELISA technique has been useful to determine
its biological activity, which has been found to be roughly equivalent to a surface
coated with a solution of 20 µg/mL fibronectin, roughly 300 ng/cm2. [263]
L. lactis develops stable biofilms, while keeping high viability values [216].
Bacteria shows high viability levels even with low concentrations of tetracycline,
a bacteriostatic antibiotic.
The use of tetracycline is important when culturing mammalian cells on the
biofilm, in order to avoid an excessive medium acidification due to L-lactic acid
production.
However, as low pH values can compromise the viability of mammalian
cells, it is clear that a metabolic control system is required. L. lactis, regardless
its genetic modification, still showed the ability to develop biofilms.
As shown in the SEM images, L. lactis makes use of some extracellular
proteins, mostly CluA [62, 264], to attach to abiotic surfaces. These biofilms
are strong enough to support the growth of mammalian cells, as will be later
discussed.
Moreover, biofilm density, expressed as number of cells per square centi-
metre or covered area, in percentage, is an easily adjustable parameter. Starting
from different volumes of exponential-phase liquid cultures, thus different
amounts of total biomass, the resulting biofilm shows an increasing coverage
percentage dependent on the initial culture volume.
Summarising, genetically modified Lactococcus lactis to express biologically
active FNIII7−10 fragment on its membrane retains remarkable ability to develop
80 CHAPTER 4. LACTOCOCCUS LACTIS CLONING AND . . .
biofilms much like the strain without membrane-bound heterologous proteins.
These biofilms can be adjusted to different coverage densities, with the exposed





Phenomena occurring at the cell-material interface are of fundamental import-
ance in biotechnological and biomedical strategies to direct cell behaviour on
biomaterials, including cell adhesion, proliferation, migration and differenti-
ation [8, 9]. The interaction of cells with abiotic surfaces such as synthetic
polymers, metals or glass usually takes place via an adsorbed protein layer.
Extracellular matrix proteins such as vitronectin, laminin or collagen have
been used to establish this intermediate layer of proteins at the materials
interface, using physical and chemical methods, in order to mimic to a certain
extent the ECM characteristics. However, a static protein layer is not enough to
provide the dynamic stimuli required to orchestrate cell responses and organise
the formation of a new tissue at the cell-material interface.
Several approaches have been proposed to introduce a dynamic cell/material
interface. Photoactivable RGD adhesive peptides [14] have been engineered,
where RGD is blocked with 3-(4,5-dimethoxy-2-nitrophenyl)-2-butyl (DMNPB),
rendering it unreachable to integrins. When irradiated with light of the proper
wavelength, the capping molecule is cleaved and RGD becomes accessible to
integrins, starting a cellular response. The effect of density and time-point
ligand presentation on cell adhesion, proliferation and differentiation has been
studied.
Other proposed solution has been enzyme-responsive surfaces that presents
RGD sequences on demand [15]. By enzymatic hydrolysis, inactive RGD-
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Figure 5.1 Simplified sketch of the cell-protein-material interaction. Cells inter-
act with the adsorbed protein layer through integrins, transmembrane receptors
involved in multiple cellular processes such as adhesion, migration, differentiation
or proliferation. Integrins also play a role in the organisation of the cytoskeleton
(light green, actin) and interactons with the extracellular matrix (blue, adsorbed
proteins).
containing precursors become active enabling integrin-mediated cell response
on these surfaces. These two approaches rely in chemical modifications of
synthetic peptides, which are previously grafted on the surface. They are present
from the beginning of the assays and activated on demand. This approach goes
one step further from classic passive coatings, but a major issue is that all the
signalling cues should be present since the beginning. Our approach tries to
address this problem by using living organisms with the ability to produce, on
demand, any desired biochemical signal.
This work proposes the use of genetically modified L. lactis, a lactic acid
bacteria with the ability to develop biofilms on most surfaces, enabling the
development of an interfacial layer between synthetic materials and mammalian
cells. L. lactis has been extensively used in genetic engineering, being, as of
today, the most versatile LAB host for protein expression [80]. Its genome has
been fully sequenced [17, 207] and is publicly available with a wide variety
cloning vectors commercially available.
In this chapter, we describe the development of a model system based on L.
lactis cells expressing FN-III7−10 fused to GFP. This protein is efficiently located
in the bacterial cell-wall. Expressed III7−10 fragment contains RGD and PHSRN
sequences which interact α5β1 and other related integrins.
Integrin-mediated adhesion is a complex process that involves the organiza-
tion of focal adhesion (FA) clusters, whose commitment is to link ECM proteins
with the actin cytoskeleton. Focal complexes are mature adhesion sites that
contains structural and signalling proteins, such as focal adhesion kinase (FAK)
and Src. These signalling proteins play the initial step in the organization of
mid- and long-term processes such as differentiation and migration.
The main signalling protein involved in focal adhesion development is the
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Figure 5.2 Conceptual sketch of the membrane localisation of the expressed
III7−10 fragment in L. lactis and the proposed interaction model with the α5β1
integrin, the main fibronectin receptor. Actually, a single integrin molecule is wide
enough to simultaneously interact with the RGD and the PHSRN sequences.
focal adhesion kinase (FAK), a non-receptor tyrosine kinase that activates in
response to cell-ECM adhesion and inactivated by dephosphorylation after
detachment or trypsinization. [131, 132]
FAK triggers a wide variety of signalling pathways involved in cell motility,
invasion, proliferation, cell cycle and development [135–139] and contributes
to integrin activation directed towards the generation and enhancement of cell-
ECM adhesive forces [137]. FAK is also overexpressed in a variety of human
cancers [133], promoting their invasive behaviour. [134, 265]
The activation of FAK via phosphorylation involves FAT and FERM domains
interacting with other integrin-associated proteins [140, 142]. Its activation is
mainly dictated by Tyr-397 autophosphorylation. This phosphorylation creates
a high-affinity site for the SH2 domain of Src, recruiting and activating Src
in the focal adhesion complexes [266]. When Src binds to phosphoTyr-397,
other FAK residues are also phosphorylated [143, 144], including Tyr-576 and
Tyr-577 in the kinase domain activation loop and Tyr-861, involved in the FAK
autophosphorylation process. [145]
Besides triggering adhesion through focal adhesion development, both
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integrins and signalling proteins such as FAK are deeply involved in other
cellular processes. In this chapter, we assess the ability of the bacterially
expressed III7−10 fragment to induce cell differentiation, in particular myogenic
differentiation in the well-established C2C12 in vitro model.
We first examine myogenic differentiation, a complex process that involves
committed myoblastic cells, which undergo polar alignment and fusion, yielding,
first, differentiated multinucleated myotubes and, second, mature muscular
fibres [13]. It is a tightly controlled process orchestrated by several transcription
factors, namely MyoD, myogenin, Myf5 and MRF4 [267]. The initial regulation
of myogenic differentiation involves the p38 mitogen activated protein kinase
(MAPK), a member of the MAPK signalling cascades that can be activated by
multiple stressors including ultraviolet light, cytokines or osmotic stress. Once
activated, p38 MAPK activates other proteins via phosphorylation and initiates
the downstream transcriptional signalling pathway. [268–270]
Myogenic differentiation involves withdrawal from cell cycle through expres-
sion of MyoD and Myf5, which are activated through the p38 MAPK. These two
transcription factors are involved in the change from somites to committed my-
oblasts, fusion-competent cells that undergo cytoplasmic fusion in subsequent
differentiation stages. Under the influence of these two transcription factors,
somites withdraw from cell cycle starting the differentiation process, which
involves morphological changes that eventually leads to formation of competent
myotubes.
The second step in the muscle fibre formation is the activation of other
two transcription factors, myogenin and Myf5. Under their influence, compet-
ent myoblasts acquire the ability to fuse together, developing multinucleated
myotubes. Focal adhesion kinases, which are activated under the influence of
extracellular signals, i.e. interactions of integrins with ECM molecules such as
fibronectin, also play an important role in the myogenic process [271].
Activated FAK interacts with signalling and adaptor proteins, including
p130Cas, Grb2, paxillin, Shc and PI-3k kinase, thereby initiating intracellular
signal transduction cascades [272–274] that, in turn, regulate cellular processes
such as proliferation, migration, survival, and differentiation. FAK inhibition via
siRNA or by expression of dominant negative form results in impaired myoblast
function in both in vitro and in vivo. [275] (Figure 5.3)
In short, myogenic differentiation is a complex process influenced by both
cellular reprogramming via p38 MAPK pathway, which is responsible of MyoD
and Myf5 upregulation. However, FAK activation produced by integrin dimer-
ization also plays an important role in the development of mature myoblasts.
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Figure 5.3 Simplified sketch of the myogenic differentiation process, influenced
by both p38 MAPK signalling pathway and FAK activation, the last one triggered by
the interaction of integrins with the ECM. It has been demonstrated the influence
of fibronectin in the enhancement of myoblast migration, alignment and fusion
into myotubes.
Myotube fusion, migration and alignment is greatly enhanced when cultured
on fibronectin-coated substrates. [13]
Myogenic differentiation is only one amongst the wide variety of cellular
processes directed by the MAPK signalling pathway [276]. MAPK superfamily
includes ERK1/2 amongst hundreds of kinases [277], and is involved in an
amplificatory cascade where an initial trigger, which can be integrin-mediated
signalling, activates a series of kinases which substrates are other kinases. This
signalling cascade can be divided into three tiers; the first tier is comprised of
MAP3K or MAPK kinases kinases, which phosphorylates MAP2K (MAPK kinases,
second tier). Substrates of MAP2K are MAPK or mitogen-activated protein
kinases (third tier), namely ERK1/2/1c, p38α/β/γ/δ and JNK1/2/3. [269,
278]
Activation of the MAPK signalling pathway is used in this thesis to assess the
influence of III7−10 in cell behaviour. Both FAK and ERK1/2 phosphorylation
are assessed using several techniques such as Western blot and ELISA.
Cell proliferation is one of the most important events related to newly
developed tissue, and is tightly controlled by the Ras-Raf-MEK-ERK pathway
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[278]. This pathway can be triggered by integrin dimerization, in response to
extracellular events such as interaction with ECM components (fibronectins, col-
lagen, laminin and others) [11]. Dimerization of integrin subunits leads to Ras
activation, via exchange of GDP by GTP, the active form. Ras-GTP is responsible
for the subsequent activation of the Raf kinase family (Raf-A, B and C), in an
complex multistage process involving homo- and heterodimer formation [279].
Raf activates MEK1/2 (MAP/ERK kinases), whose only substrates are ERK1
and ERK2. MEK1/2 are Tyr-Thr kinases, phosphorylating Thr202/Tyr204 in
ERK1 and Thr185/Tyr187 in ERK2. Active ERK1/2 are promiscuous kinases,
with 175 known substrates [280]. One of these substrates is paxillin, a protein
that plays a prominent role in focal adhesion complexes.
Figure 5.4 Integrin dimerization activates the MAPK pathway signalling cascade,
which results in enhanced focal adhesion formation and maturation via paxillin
phosphorylation. MAPK signalling pathway also activates several genes involved
in cell proliferation and migration.
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ERK1/2 is also responsible for further paxillin activation via phosphoryla-
tion [280, 281]. This activation helps in the formation of mature adhesion
complexes.
Besides FAK and ERK1/2 phosphorylation in response to integrin activation,
human bone marrow-derived mesenchymal stem cells were used to assess the
influence of the bacterially expressed fibronectin on the cell fate. hMSCs are
multipotent cells that reside within the bone marrow and have the ability to
differentiate into cells of the mesodermal lineage such as osteoblasts, chondro-
cytes, myoblasts or adipocytes [282], amongst other lineages such as neurons
[283], cardiomyocites [284] and vascular endothelial cells. [285]
Figure 5.5 Mesenchymal stem cells can undergo osteoblastic, chondrogenic,
myoblastic, adipogenic or fibroblastic differentiation (not shown). Differentiation
was assessed by quantitative real-time PCR.
Experiments on the influence of the FNIII7−10 on mesenchymal stem cell
[286] showed that polymer brushes coated with multimeric units of this frag-
ment induced osteoblastic differentiation, measured through alkaline phos-
phatase activity, of human mesenchymal stem cells cultured in osteogenic
media.
To assess the influence of the III7−10 fragment on hMSC differentiation,
15-day cultures of hMSC on L. lactis-FN and L. lactis-empty biofilms were per-
formed, analysing the gene expression profile to check whether osteoblastic,
chondrogenic, myoblast or adipocyte differentiation took place, without us-
ing differentiation inducers. Gene expression analysis was performed using
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quantitative real-time PCR, a technique that gives quantitative information
about the relative expression of a selected gene over a constitutive expressed
gene, GAPDH in our experiments. The selected genes for each lineage were
osteopontin (OPN) and osteocalcin (OCN) for osteoblasts; SOX9 and Collagen
type II for chondrocytes; GATA4 and MyoD for myoblasts and PPAR-γ and Glut4
for adypocites. CD63 and ALCAM were analysed for self-renewal or stemness
maintenance.
5.2 Material and Methods
Ethyl acrylate polymerisation
Poly (ethyl acrylate) (PEA) sheets were prepared by radical polymerization of
pure liquid ethyl acrylate (Sigma) using 0.35 % benzoin (98 % pure, Scharlau)
as photoinitiator. Polymerization was carried out for 24 hours under UV light.
Then, a second post-polymerization step was performed at 90 °C for 24 hours.
Low molecular mass substances were extracted from the material by in vacuo
drying for 48 hours at 60 °C.
PEA spin casting
PEA sheets were dissolved in toluene to a final concentration of 2.5 % w/v .
The solution was stirred at room temperature until all the polymer was properly
dissolved, obtaining a viscous solution as a result. Spin casting was performed
on 12 or 25 mm glass coverslips at 2000 rpm for 30 seconds. Samples were
dried in vacuo at 60 °C for at least 4 hours in order to remove solvent traces
before biofilm preparation.
Biofilm production
The protocol used to produce biofilms has been described elsewhere [209,
249]. In this work, we use a modified protocol based on the referenced ones.
Lactococcus lactis MG1363 carrying the PT1NX-III7−10-GFP plasmid (L. lactis-
FN) and the empty PT1NX plasmid (L. lactis-empty) were grown from a frozen
glycerinate in GM17E-agar Petri dishes, for 24 h at 30 °C.
Grown colonies were inoculated in fresh GM17-E, using one colony for
each 10 mL of culture, and kept at 30 °C in closed containers. When the
optical density of the culture reached a value of 0.2-0.3, measured at 600
nm, cultures were transferred to 24-well plates containing clean and sterile
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glass coverslips (for short-term cultures) or PEA-coated glass coverslips (for
long-term cultures). Plates were sealed with adhesive plate sealers to guarantee
an anaerobic environment and minimize evaporation, and left at 30 °C.
After 24 h, plates were gently shaken at 150 rpm for 3 minutes. Then, plate
sealer was removed and non-adhered bacteria were twice washed with sterile
ultrapure water, until adhered bacteria were exposed. These washing steps
were controlled with a phase-contrast optical microscope. In the last washing
step, ultrapure water was substituted with a phosphate-buffered saline solution.
Biofilm viability
Biofilm viability was assessed using the same conditions as in cell cultures. Fresh
biofilms were incubated at 37 °C, 5 % CO2 humidified atmosphere with three
different media — DMEM (DMEM), DMEM with 1 % penicillin-streptomycin
(DMEM+PS) and DMEM with 10 µg/mL tetracycline (DMEM+TC). DMEM
contained in all cases 4.5 g/L of glucose. Plates were kept for one, two and
four days and after each time point were subjected to a viability assay. Medium
was removed and the biofilms were washed twice with NaCl 0.85 %.
Samples were imaged in a Nikon Eclipse 80i epifluorescence microscope
and up to 10 fields per sample were used to calculate the viability, defined as
the ratio between viable and total cell number. Image analysis was performed
with Fiji – ImageJ as described in the Bacterial and cell viability section.
Biofilm metabolism
Biofilm metabolism was indirectly inferred from the decrease of the pH of the
medium. As described in the introduction, L. lactis is a homolactic fermentative
strain that metabolises glucose to L-lactic acid.
Fresh biofilms were prepared following the protocol described in the biofilm
production section. Afterwards, to assess the influence of tetracycline and
penicillin-streptomycin, medium was changed to DMEM (DMEM), DMEM with 1
% penicillin-streptomycin (DMEM+PS) and DMEM with 10 µg/mL tetracycline
(DMEM+TC). DMEM contained in all cases 4.5 g/L of glucose. Samples were
then incubated at 37 °C, 5 % CO2 in a humidified atmosphere, and the pH was
monitored as a function of time (0, 0.5, 1, 1.5, 2, 3, 4, 5, 24 and 48 h) with a
pH-meter (Eutech Instruments).
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Production of biofilms with tunable areal density
Single colonies of L. lactis-FN grown overnight in GM17-E agar plates were
inoculated in 10 mL of GM17-E and when optical density measured at 600 nm
reached a value of 0.2-0.3, liquid cultures were transferred to P24 multiwell
plates.
Volumes of 300, 500, 700 and 1000 µL respectively were used for obtaining
increasing areal density. After that, the multiwell plate was sealed and kept
at 30 °C for 24 h. Then, non-adhered bacteria were washed three times with
ultrapure water, with a fourth wash with PBS to avoid autolysis derived from
osmotic shock.
Fn−/Fn− fibroblasts cell culture
Fibronectin-null mutant fibroblasts were maintained in DMEM with 4.5 g/L
glucose, 10 % FBS and 1 % penicillin-streptomycin. After washing and trypsin-
izing, were cultured on the bacteria in DMEM with 4.5 g/L glucose without
FBS, with a seeding density of 7500 cells/cm2, kept at 37 °C in 5 % CO2 in a
humidified atmosphere for 4 hours and then washed twice with PBS++. Then
were fixed with 10 % formalin at 4 °C for 30 minutes.
NIH3T3 cell culture
NIH3T3 cells were maintained in DMEM with 4.5 g/L glucose and supplemented
with 10 % calf serum and 1 % P/S. Afterwards, they were cultured on freshly
prepared biofilms of different densities, in DMEM with 4.5 g/L glucose without
calf serum, and kept at 37 °C in 5 % CO2 in a humidified atmosphere, then
were washed twice with PBS++ and fixed with 10 % formalin, at 4 °C, for 30
minutes.
C2C12 cell culture
C2C12 cells maintained in DMEM with 4.5 g/L glucose, 20% FBS and 1 % P/S
were cultured on different substrates with an initial density of 10,000 cells/cm2
for adhesion assays and 20,000 cells/cm2 for differentiation assays.
For adhesion assays, after three hours of culture in FBS-free medium sup-
plemented with 10 µg/mL tetracycline, cells were fixed in formalin 10 % at 4
°C for 30 minutes. For differentiation cultures, the first three hours of culture
were conducted in FBS-free medium supplemented with 10 µg/mL tetracycline,
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which was removed and substituted with medium containing 1 % insulin-
transferrin-selenium and 10 µg/mL tetracycline. Cultures were kept at 37 °C in
a humidified atmosphere with 5 % CO2, changing the medium every two days.
Cells were then fixed with 70 % ethanol, 37 % formaldehyde and glacial acetic
acid (20:2:1) for 10 minutes at 4 °C.
Human mesenchymal stem cell culture
Bone marrow-derived hMSCs were acquired from PromoCell Inc. Cells were
maintained in DMEM supplemented with 1 % P/S, L-glutamine 1.1 mM, pyr-
uvate 100 µM and 10 % foetal bovine serum. Afterwards, cells were cultured
on freshly prepared biofilms or control solutions in DMEM supplemented with
10 µg/mL tetracycline, 1.1 mM L-glutamine and 100 µM pyruvate and without
FBS. These cultures were used for vinculin immunostaining, ERK1/2 ELISA
assays and quantitative PCR for gene profiling.
Sarcomeric myosin immunostaining
Fixed cells were washed twice with PBS++ and blocked with 5 % goat serum in
PBS++ for 1 h at RT. Samples were then incubated with MF20 anti-sarcomeric
myosin antibody (Developmental Studies Hybridoma Bank, University of Iowa,
USA) at 1:250 dilution in PBS++ with 5 % goat serum, for 1 hour at RT. After
two washes with Tween 20 0.5 % in PBS++, were blocked again with 5 %
goat serum in PBS++ for 10 minutes at RT, then washed twice again with
Tween 20 0.5 % in PBS++. Rabbit anti-mouse conjugated with Cy3 (Jackson
Immunoresearch) was used as secondary antibody, with a dilution of 1:200 in
PBS++ with 5 % goat serum.
After 1 hour at RT in absence of light, samples were washed three times
with Tween 20 0.5 % in PBS++ and mounted with Vectashield-DAPI (Vector
Laboratories).
Vinculin immunostaining
C2C12, Fn−/Fn− fibroblasts and NIH3T3 Cells were fixed with 10 % form-
alin were washed twice with PBS++ and blocked with a solution of 1 % BSA in
PBS++. Monoclonal anti-vinculin antibody produced in mouse (Sigma), diluted
1:400 in BSA 1 % in PBS++ was used as primary antibody. Incubation lasted 1
hour at RT. Then, cells were washed twice with Tween 20 0.5 % in PBS++ and
incubated with rabbit anti-mouse Cy3-conjugated secondary antibody (Jackson
92 CHAPTER 5. CELL-BACTERIA CO-CULTURES AND CELL BEHAVIOUR
Immunoresearch), diluted 1:200 in 1 % BSA / PBS++. The secondary antibody
was incubated for 1 hour at RT in absence of light and with FITC-conjugated
phallacidin 1:100. Cells were then washed three times with Tween 20 0.5 % in
PBS++ and mounted with Vectashield-DAPI (Vector Laboratories)
Human mesenchymal stem cells (hMSC) Cells were fixed in 4 % formalde-
hyde and 2 % w/v glucose in PBS for 15 min at 37 °C. The fixative solution was
removed and cells were permeabilised with 10.3 % w/v sucrose, 0.292 % w/v
NaCl, 0.06 % MgCl2·10H2O, 0.476 % w/v HEPES and 0.5 % v/v Triton X-100
in PBS, pH 7.2, at 4 °C for 5 minutes.
Then, cells were blocked with 1 % BSA in PBS at 37 °C for 30 min, removing
the blocking solution and incubating with mouse anti-vinculin monoclonal
antibody (Sigma) diluted 1:400 in BSA 1 % in PBS++, at 37 °C, for 1h. Cells
were washed three times with Tween 20 0.5 % v/v in PBS++.
Then, the secondary antibody, Cy3-conjugated rabbit anti-mouse (Jackson
Immunoresearch) diluted 1:200 in BSA 1 % in PBS was added and incubated
for 1h at 37 ºC. Afterwards, this solution was removed, adding BODIPY-PL phal-
lacidin diluted 1:40 in BSA 1 % in PBS++ for 30 min at RT. Cells were washed
three times with Tween 20 0.5 % v/v in PBS and mounted with Vectashield-DAPI
(Vector Laboratories).
Image analysis
Differentiation cultures were analyzed from fluorescence images taken in a
Nikon Eclipse 80i epifluorescence microscope. Two different channels were
acquired, red for Cy3 (sarcomeric myosin) and blue for DAPI (nuclei), at
10x magnification, with at least 10 different fields per sample. Images were
transformed to an 8-bit grayscale bitmap (ImageJ – Fiji software) and segmented
with the help of the Trainable Weka Segmentation plugin where needed or the
Otsu thresholding algorithm, to get a binarized mask for both channels.
Total nuclei per image were counted using the Particle Analysis command
of ImageJ on the DAPI images. Then, the binarized DAPI channel image was
multiplied by the Cy3 (sarcomeric myosin) binarized image. After image multi-
plication, only nuclei under myotubes (assigned to differentiated cells) were
displayed and counted. Differentiation percentage was calculated dividing the
differentiated nuclei and the total nuclei count.
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FAK phosphorylation analysis by Western blot
After a 3 hour-culture, cells were washed with PBS++ and lysed with RIPA
buffer (Tris-HCl 50 mM, Nonidet P-40 1 %, Na deoxycholate 0.25 %, NaCl
150 mM, EDTA 1 mM) supplemented with protease inhibitor cocktail tab-
lets (Complete, Roche). Proteins were concentrated using Microcon YM-30
Centrifugal Filter devices (Millipore) as manufacturer described. After two
consecutive centrifugations at 10,000 g for 10 minutes, proteins were re-
covered with a mixture of 7 M urea, 2 M thiourea, 4 % w/v CHAPS (3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate) and 200 mM ditio-
threitol.
To determine FAK protein expression and its Tyr397 phosphorylated form
(pFAK), concentrated samples were subjected to 7 % SDS-PAGE gel electro-
phoresis. Proteins were transferred to a positively charged PVDF membrane
(GE Healthcare) using a semidry transfer cell system (Bio-Rad) and blocked by
immersion in 5 % skimmed milk in PBS for 1 h at room temperature.
The blot was incubated with anti-FAK antibody (Upstate), diluted 1:2500
and anti-pFAK antibody (Millipore), diluted 1:250, in 2 % skimmed milk and
0.1 % Tween 20 in PBS, and left overnight at 4 °C in an airtight container.
After several washes with 0.1 % Tween 20 in PBS, the blot was incubated in
horseradish peroxidase-conjugated antibody (GE Healthcare) diluted 1:50,000
in 2 % skimmed milk, 0.1 % Tween 20 in PBS, for 1 hour at room temperature.
After several washes with 0.1 % Tween 20 in PBS, immunoreactive bands
were developed with the Supersignal West-femto Maximum Sensitivity Substrate
(Thermo Scientific). After a 5-minute incubation, chemiluminiscent bands were
visualized with Amersham high sensitivity chemiluminiscence photographic
film (GE Healthcare).
ERK1/2 phosphorylation by sandwich ELISA
ERK1/2 phosphorylation was assessed with the DuoSet ERK1/2 sandwich ELISA
kit (RnD Systems, Minneapolis, USA), as described in Section 3.7. Cells from a
30-minute culture were lysed using the protocol described in the kit and subjec-
ted to the ELISA protocol. Briefly, the ELISA plate was coated with the capture
antibody overnight, adding the lysate immediately. After hybridisation, the
biotinylated detection antibody was added and then the streptavidin-conjugated
horseradish peroxidase, which was used to catalyse the oxidation of tetramethyl-
benzidine with hydrogen peroxide. The reaction was stopped with sulphuric
acid, measuring the optical density at 450 nm in a multiplate reader.
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Quantitative real-time PCR
hMSC-BM cells were cultured at 20,000 cells/cm2 and cultured for 15 days
on freshly prepared L. lactis-empty and L. lactis-FN maximum density biofilms
produced on PEA-coated, FN-coated PEA and bare glass coverslips. Culture
medium was composed of high-glucose DMEM supplemented with 10 µg/mL
tetracycline, 100 µM sodium pyruvate, 1.1 mM L-glutamine and 1 % FBS. Total
RNA was extracted and purified with a Qiagen RNeasy kit (Qiagen, Venlo, Neth-
erlands), which included a previous DNase treatment to remove genomic DNA.
Total RNA amount and quality was checked with a Nanodrop 1000 (Thermo
Scientific). After extraction, RNA purity was checked using the A260/A280 ra-
tio with values between 1.8 and 2.0, showing that total RNA was succesfully
purified with the kit.
200 ng of total RNA, when possible, were reverse transcribed to cDNA with
the Qiagen QuantiTect Reverse Transcription kit.
Real Time qPCR was carried out in an Applied Biosystems 7500 Real Time
PCR system, normalizing the gene expression to GAPDH and then to two differ-
ent control conditions, L. lactis-emtpy biofilm and FN-coated PEA coverslips.
Reaction was carried out in a final volume of 20 µL.
The following equation was used to quantify the relative expression of the




∆CT1 = CTsample gene −CTGAPDH (sample 1)
∆CT2 = CTsample gene −CTGAPDH (sample 2)
and CT is the threshold cycle, where the exponential amplification phase begins.
Absolute expression values were obtained using the expression absolute expression =
∆CT. Threshold values decreased in a linear fashion with the increase of initial
RNA amounts present in the sample. Reaction efficiencies were tested before
qPCR with values close to 100 % for each primer pair (data not shown).
Statistical analysis
Data is shown as mean ± SD. One-way ANOVA analysis was performed with
the help of GraphPad Prism software, with several p values and a previous
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Gene Pair Sequence
ALCAM Forward 5’-ACG ATG AGG CAG CAG AGA TAA GT-3’
(self-renewal) Reverse 5’-CAG CAA GGA GGA GAC CAA CAA C-3’
CD63 Forward 5’-GCT GTG GGG CTG CTA ACT AC-3’
(self-renewal) Reverse 5’-ATC CCA CAG CCC ACA GTA AC-3’
PPAR-γ Forward 5’-TGT GAA GCC CAT TGA AGA CA-3’
(adipogenic) Reverse 5’-CTG CAG TAG CTG CAC GTG TT-3’
GLUT4 Forward 5’-ATG TTG CGG AGG CTA TGGG-3’
(adipogenic) Reverse 5’-AAA GAG AGG GTG TCC GGT GG-3’
MyoD Forward 5’-CAC TAC AGC GGC GAC TCC-3’
(myogenic) Reverse 5’-TAG GCG CCT TCG TAG CAG-3’
GATA4 Forward 5’-GGA AGC CCA AGA ACC TGA AT-3’
(myogenic) Reverse 5’-GTT GCT GGA GTT GCT GGA A-3’
OPN Forward 5’-AGC TGG ATG ACC AGA GTG CT- 3’
(osteogenic) Reverse 5’-TGA AAT TCA TGG CTG TGG AA -3’
OCN Forward 5’-CAG CGA GGT AGT GAA GAG ACC-3’
(osteogenic) Reverse 5’-TCT GGA GTT TAT TTG GGA GCA G-3’
SOX9 Forward 5’-AGA CAG CCC CCT ATC GAC TT-3’
(chondrogenic) Reverse 5’-CGG CAG GTA CTG GTC AAA CT-3’
Collagen II Forward 5’-GTG AAC CTG GTG TCT CTG GTC-3’
(chondrogenic) Reverse 5’-TTT CCA GGT TTT CCA GCT TC-3’
GAPDH Forward 5’-ACC CAG AAG ACT GTG GAT GG-3’
(house-keeping) Reverse 5’-TTC TAG ACG GCA GGT CAG GT-3’
Table 5.1 Primers used in the qPCR gene expression analysis.
data normality check before analysis of variance. A post-hoc Tukey multiple
comparison test was used to assess differences between samples.
Where data did not to follow a Gaussian distribution, checked with the
D’Agostino–Pearson omnibus normality test, a non-parametric analysis was per-
formed, comparing the mean rank of each column with the post-hoc Dunn test.
Statistically significant differences were indicated with *p < 0.05, **p < 0.01,
***p < 0.001 and ****p < 0.0001
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5.3 Results
Cell adhesion and signalling
Cell adhesion and signalling on L. lactis biofilms Murine fibronectin-null
fibroblasts (Fn−/Fn−) were cultured on L. lactis-FN and L. lactis-empty biofilms,
used as interphase between the material surface and the fibroblasts, in FBS-free
medium, to rule out the presence of any external FN influence on the material
surface other than the FN fragment anchored in the bacterial membrane. After
4 hours, cells cultured on L. lactis-FN displayed well-developed focal adhesion
complexes, showing accumulation of vinculin at focal adhesion sites (figure
5.6).
Glass surfaces coated with a 20 µg/mL fibronectin solution and glass sur-
faces were used as control. Fibroblasts cultured on L. lactis-FN showed a similar
behaviour to that found on fibronectin-coated glass. On the other hand, cells
cultured on L. lactis-empty remained in a rounded shape, without spreading
or focal adhesion plaques development, as on the uncoated glass surface. This
was an expected result since there is no fibronectin at the cell-bacteria-material
interface to trigger cell adhesion.
Focal adhesion kinase (FAK) are part of the focal adhesion complexes and
activate multiple signalling pathways which regulate cell migration, survival,
proliferation and differentiation [287–289]. We examined phosphorylation of
Tyr-397, the autophosphorylation site in FAK and a binding site for Src and PI-3
kinase [266, 290] by Western blotting.
FAK band intensity remained approximately constant, whereas the pFAK
band integrated intensity value was significantly higher for cells cultured on L.
lactis-FN, with levels similar to the ones found in the fibroblasts cultured on
FN-coated glass. Fibroblasts cultured on L. lactis-empty and bare glass exhib-
ited minimal FAK phosphorylation. This result demonstrates that the III7−10
fragment located in the bacterial membrane triggers the adhesion signalling
pathway in contiguous cells.
Cell viability on this living interface was assessed. Fibronectin-null fibro-
blasts were cultured on L. lactis-FN and L. lactis-emtpy monolayers, FN-coated
glass and bare glass, and cultured for 4 hours in serum-free medium. Then, a vi-
ability analysis was performed, using the Invitrogen viability kit for mammalian
cells. This kit provides a two-colour fluorescence assay using two probes that
measure recognized parameters of cell viability: cytoplasmic esterase activity
and cell membrane integrity.
Live cells have ubiquitous intracellular esterase activity, which is required
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Figure 5.6 a) Cells cultured on L. lactis-FN displayed well-developed focal adhe-
sion complexes, while in b) L. lactis-empty remained in a rounded shape. Cells
cultured on fibronectin-coated glass, in c), displayed a similar behaviour to the
ones cultured on L. lactis-FN, remaining unattached and without focal adhe-
sion plaques on bare glass, shown in d). This behaviour suggest the role of the
membrane-displayed fibronectin fragment as an adhesion trigger. Scale bar size is
50 µm
for the conversion of the non-fluorescent, cell permeant dye calcein-AM into
calcein, a polyanionic and intensely fluorescent dye that is well retained within
live cells, producing an intense green fluorescence. On the other hand, ethidium
homodimer-1 is a non-permeant dye that only enters cells with compromised
membrane integrity and binds strongly to nucleic acids, with a 40-fold fluor-
escence enhancement. A fluorescence microscope was used to image the cells
tested with this kit.
Cells showed viability values higher than 93 % for each surface, and up
to 99.5 ± 0.7 % in the cells cultured on the L. lactis-FN monolayer. This
result is consistent with the formation of focal adhesion complexes and FAK
phosphorylation behaviour.
Cell morphology and adhesion are controlled by biofilm density As pre-
viously stated, biofilms of different areal density or bacterial coverage were
obtained from different volumes of bacterial culture. Murine NIH3T3 fibro-
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Figure 5.7 FAK phosphorylation analysis with Western blot. Fibronectin-null
murine fibroblasts cultured on FN-expressing L. lactis showed a pFAK/FAK ratio
higher than fibroblasts cultured on control L. lactis and comparable to cells cultured
on FN-coated glass surface. Phosphorylation ratio was similar in the cells cultured
on glass and on L. lactis-empty. Data was analysed with an ANOVA test, N = 3,
and statistically significant differences between L. lactis-FN, L. lactis-empty, and
glass-FN and glass were found. *p < 0.05
blastic and C2C12 cells were used to assess the influence of this different
bacterial density, and hence different amount of exposed III7−10 fragment.
Four different density biofilms were prepared from four volumes of log-
phase bacterial cultures, namely 300, 500, 700 and 1000 µL, which were
poured on P24 multiwell plates and left for 24 hours at 30 °C. Biofilm densities,
expressed as percentage of area covered by bacteria, were 4.6 ± 1.1 % for 300
µL, 11.4 ± 4.3 % for 500 µL, 19.1 ± 2.8 % for 700 µL and 27.6 ± 8.4 % for
1000 µL.
Cells were seeded at an initial density of 5,000 cells/cm2 in DMEM with 4.5
g/L glucose supplemented with 10 µg/mL tetracycline. After three hours, cells
were immunostained for vinculin and FITCconjugated phallacidin to stain focal
adhesion complexes and actin cytoskeleton respectively. Area and roundness
values were calculated from binary masks segmented from the actin (Cy3, red
channel) as this stain, while much more intense in focal adhesions than in the
cytoplasm and nuclei area, is bright enough to discriminate the whole cell shape
from the non-fluorescent background.
Results obtained from the NIH3T3 cell culture are shown in Figure 5.9.
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Figure 5.8 Viability test of Fn−/Fn− fibroblasts cultured on a) L. lactis-FN , b)
L. lactis-empty , c) FN-coated glass and d) bare glass. Cells were cultured for 4
hours in serum-free medium. The highest viability value corresponded to the cell
population cultured on L. lactis-FN, with a mean value of 99.5 ± 0.7 %, while on
L. lactis-emtpy was 96.7 ± 3.0 %, 96.0 ± 4.7 % for FN-coated glass and 93.5 ± 4.6
% for bare glass. ANOVA analysis of the data showed no statistically significant
differences. N ≥ 6 for all data, represented as mean ± SD
Cell area increased with biofilm density, which is directly related to the
amount of III7−10 available to the cultured cells. ANOVA revealed statistically
significant differences between three groups of samples, L. lactis-emtpy, L. lactis-
FN biofilms, including FN-coated glass and the bare glass surface. Cells cultured
on L. lactis-emtpy and glass presented smaller areas than cells cultured on L.
lactis-FN biofilms and FN-coated glass.
Despite the fact that statistically non-significant differences were found
between areas values of the cells cultured on different density L. lactis-FN
biofilms, data represented in the Figure 5.9 showed an increase in an areal
density-dependent manner, which was expected due to the higher amount of
FN available to develop focal adhesion complexes. The highest value was found
in the cells cultured on FN-coated glass, with very similar values compared to
cells cultured on maximum density L. lactis-FN biofilm.
Data obtained from image analysis allowed the calculation of cell roundness
in the same samples. Cell roundness is defined as the inverse of the aspect ratio
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Figure 5.9 Adhesion behaviour of NIH3T3 cells cultured on a) L. lactis-emtpy
27.6 %; b) L. lactis-FN 4.1 %; c) L. lactis-FN 11.4 %; d) L. lactis-FN 19.1 %; e) L.
lactis-FN 27.6 % coverage biofilm; f) FN-coated glass from a 20 µg/mL fibronectin
solution and g) bare glass. Vinculin is shown in red and nuclei in blue. Cell area
increases as the biofilm density does. ANOVA (*p < 0.05) reveals statistically
significant differences between L. lactis-emtpy, glass and the L. lactis-FN biofilms,
including cells cultured on FN-coated glass. Roundness values were also found to
behave differently on the different surfaces. Data presented as mean ± SD, with
N ≥ 35
Obtained values are shown in Figure 5.9.
Roundness values were found to be inversely related to area values. That
is to say, cells that showed poor spreading and small area values stayed in a
rounder shape than cells cultured on L. lactis-FN biofilms or FN-coated glass.
NIH3T3 is a fibroblastic cell line, so cell spreading involves the development
of an elongated shape, with major/minor semi axis ratio increasing as the cell
spreads. In a similar way to data shown in Figure 5.9, two different categories
were extracted from the ANOVA analysis, one corresponding to cells on L.
lactis-empty biofilm and glass, and the L. lactis-FN biofilms and FN-coated glass.
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Higher area values showed an inverse correlation with roundness values.
The biological meaning is the influence of the III7−10 fragment on the develop-
ment of focal adhesions, and via intracellular signalling, cell behaviour related
to spreading and actin cytoskeletal reorganization, which is ultimately one of
the most important factor that defines the shape of a cell in the initial adhesion
stages. Cells were cultured in serum-free medium to avoid the interference and
to ensure that the only fibronectin available was the fragment displayed on the
bacterial membrane, although these cells are not fibronectin null and in the
mid-term will secrete, create and eventually reorganize a fibronectin network.
To check whether this behaviour was due to the NIH3T3 fibroblastic pheno-
type or if it was only an effect of the different amount of available fibronectin,
the same experiment, under the same conditions, was performed using mur-
ine C2C12 myoblasts. These cells can differentiate and fuse into myotubes,
which eventually leads to a polar alignment and cytoplasmic fusion, but in
short term assays, 3 hours, adhesion behaviour is much like in fibroblasts. Cells
were cultured at the same density on the same L. lactis-empty, L. lactis-biofilms,
FN-coated glass and bare glass, stained with an anti-vinculin antibody and
FITC-conjugated phallacidin, to visualize the actin cytoskeleton, followed by
image analysis and extraction of the morphological features (area, roundness)
from the segmented images.
Figure 5.10 shows the results of the vinculin and phallacidin immunostaining
of a 3-hour culture. Cells cultured on L. lactis-empty biofilm remained in a
round shape, without spreading or focal adhesion development, while in the
L. lactis-FN biofilms there is an increase in the cell area which seems to be
correlated to the areal density of the underlying biofilm. Cell shape is very
similar in L. lactis-empty and bare glass, due to the lack of any adhesion protein.
Cell area and roundness were quantified like in the NIH3T3 culture, that is to
say, fluorescence images of the red channel (vinculin) were segmented and
binarized to obtain the shape of each cell, which where analysed with ImageJ –
Fiji.
A good correlation between cell area and L. lactis-FN biofilm density was
found. Surprisingly, cells cultured on L. lactis-FN biofilm with 27.6 % coverage
showed higher area values than cells cultured on FN. This result agrees with
NIH3T3 results, and is a good support that biofilm density, and thus III7−10
amount available to mammalian cells, is key to direct the early cell response,
specifically cell adhesion and morphology, which is a first step before considering
other long-term processes such as cell differentiation.
However, roundness values in C2C12 were less affected by biofilm density,
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Figure 5.10 Vinculin (red) and actin (green) immunostaining of C2C12 cells
cultured on a) L. lactis-emtpy 27.6 %; b) L. lactis-FN 4.1 %; c) L. lactis-FN 11.4
%; d) L. lactis-FN 19.1 %; e) L. lactis-FN 27.6 % coverage biofilm; f) FN-coated
glass from a 20 µg/mL solution and g) bare glass. DAPI-stained nuclei shown in
blue. An area increase related to L. lactis-FN biofilm areal density was found, with
a maximum corresponding to the L. lactis-FN biofilm with a coverage of 27.6 %.
Cell roundness was calculated using the same images. Results were very similar
as the NIH3T3 cell cultures, with highest roundness values corresponding to L.
lactis-emtpy and glass, due to the lack of spread and focal complexes development,
and lower values corresponding to the L. lactis-FN biofilms and FN-coated glass.
Scale bar size is 100 µm. Data shown as mean ± SD, N ≥ 400
which is likely due to the phenotype of these cells, since they exhibit a star-like
and not an elongated shape like NIH3T3. Best-fit ellipse had closer major– and
minor– semi axis values. Nevertheless, a variance analysis performed on these
data showed statistically significant differences between L. lactis-empty, glass
and the group composed of L. lactis-FN biofilms and FN-coated glass.
Focal adhesion complexes from the same culture were counted and com-
pared to L. lactis-FN biofilm surface coverage. In vinculin immunostaining, focal
adhesions appeared as bright spots, mainly in the cell boundaries. To avoid
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altered area and roundness values that cell overlapping would have produced,
only isolated cells were used.
Figure 5.11 C2C12 cells cultured on a) L. lactis-FN 4.6%; b) L. lactis-FN 11.4 %;
c) L. lactis-FN 19.1 % and d) L. lactis-FN 27.6 % biofilms; e) L. lactis-emtpy biofilm,
f) FN-coated glass and g) bare glass surfaces were used to measure the number
of focal adhesion complexes in at least five different cells. B) Focal adhesion
count of C2C12 cells cultured on L. lactis-FN biofilms and FN-coated glass. We
found statistically significant differences between two groups, L. lactis-FN biofilms
with 4.6 and 11.4 % coverage and L. lactis-FN 27.6 % and FN-coated glass. C)
There is an approximate linear relationship between both variables, suggesting an
increase in focal adhesion count that directly relates to the available amount of
fibronectin displayed to C2C12 cells. ANOVA (*p < 0.05) analysis performed on
N ≥ 5 representative cells, values displayed as mean ± SD
Vinculin-stained cells cultured on different biofilms, shown in Figure 5.11,
were analysed with ImageJ – Fiji to segment and isolate focal adhesions, which
appeared as bright spots in the boundaries of each cell. These values were
compared between each condition, finding that focal adhesion count is also
depends on the amount of displayed III7−10.
Although area values were similar for cells cultured on the lower density L.
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lactis-FN biofilms, focal adhesion analysis revealed that cell area does not need
to be necessarily related to focal adhesion development, as shown in Figure
5.11. The same data is represented in a scatter plot in the same figure.
Figure 5.11 shows a direct relationship between focal adhesion count and
biofilm density, i.e. avilable amount of III7−10 expressed a bacterial membrane
protein. Since cells were cultured in serum-free medium, focal adhesion devel-
opment can be only attributed to this bacterially expressed fibronectin.
Myogenic differentiation and cell signalling
As previously shown, L. lactis modified to express the III7−10 fragment carrying
the RGD adhesion and PHSRN synergy motifs promotes focal adhesion forma-
tion and development as well as FAK signalling at similar levels as native FN in
fibroblasts. It was assessed the ability of this living interface, built on synthetic
surfaces, to support cell differentiation by examining myogenic differentiation.
Integrin-mediated cell adhesion through α5β1 and other integrins triggers
a cascade of intracellular signals such as the p38 mitogen-activated protein
kinase (p38 MAPK) pathway, which is involved in the myoblast differentiation
process, by promoting the activity of several transcription factors and regulating
cell cycle withdrawal. The RGD motif on the 9th type III repeat is responsible
for the early interaction with α5β1.
Lack of this interaction, by either blocking the RGD adhesion motif or by
inhibiting the expression ofα5 subunit in knockout cells, prevents early adhesion
to the substrate. Focal adhesion kinase phosphorylation is an intermediary step
between adhesion and downstream targets, including MAPK pathways. As a
result, Tyr-397 autophosphorylation of FAK plays a central role during myoblast
differentiation in 2D cultures. Although Tyr-397 phosphorylation of FAK is
transiently reduced, contributing to trigger the myogenic genetic program, is
later activated, as it is central to terminal differentiation into myotubes.
Fibronectin also accelerates cell alignment and elongation compared to
other standard substrates like laminin or gelatin [13]. Although C2C12 cells
will eventually grow until confluence and then fuse and differentiate into
myotubes, the presence of the RGD peptide speeds up this process, leading to
myotube formation without the need to reach confluence.
To assess the competence of L. lactis-FN biofilms to induce differentiation,
C2C12 cells were cultured on maximum-density, i.e. 27.6 % coverage L. lactis-
FN biofilms, maximum-density L. lactis-empty biofilms, glass coated with a 20
µg/mL solution of fibronectin, and collagen type I (1 mg/mL) coated glass –
the gold-standard substrate for myogenic differentiation. [291]
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Cells were cultured at 20,000 cells/cm2 in FBS-free medium and allowed
to attach for three hours. Then, medium was then changed to differentiation
medium, containing 1 % insulin-transferrin-selenium without FBS. The culture
was kept four days and a immunostaining for sarcomeric myosin was performed
at the end of the culture. Strikingly, myogenic differentiation values were higher
on the L. lactis-FN biofilms than on native fibronectin and collagen I-coated
substrates. It is important to emphasize that these differences in myogenic
differentiation are not due to cell density differences.
Although a direct correlation between the number of cells on the surface
and the level of myogenic differentiation has been found, the number of cells in
the L. lactis-FN biofilm is slightly lower than in the FN and collagen I controls
(Figure 5.12).
Figure 5.12 A) Myogenic differentiation on L. lactis-emtpy, L. lactis-FN, Collagen
I and fibronectin substrates. Differentiated myotubes were immunostained against
anti-sarcomeric myosin, in green. Nuclei shown in red. B) Higher differentiation
values were found on L. lactis-FN compared to collagen I and FN-coated glass.
C) Cell density on different substrates after 4 days of culture. Dashed line points
out initial seeding density (20,000 cells/cm2). All columns showed statistically
significant differences between each other. Values are presented as mean ± SD,
while the analysis of variance was conducted with N ≥ 10 and *p < 0.05. Data
presented as mean ± SD. Scale bar size is 25 µm
Figure 5.12 shows myotubes developed on the four tested substrates. Dif-
ferentiation levels found in L. lactis-FN biofilm were higher than in collagen I
and FN, whereas in L. lactis-emtpy no myotubes were found.
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Differentiation degree values were calculated by image analysis. At least
10 fields at 10× magnification were taken in two channels, red for nuclei and
green for sarcomeric myosin-stained myotubes.
To calculate the differentiation degree, a total nuclei count was performed
using ImageJ – Fiji, after binarizing the image. Green channel was also binarized
using the Otsu thresholding algorithm and, where needed, a semiautomatic
machine-learning algorithm to obtain properly binarized masks. Both binary
images were multiplied to calculate the number of nuclei below myotubes
(differentiated cells). The ratio between differentiated and total cells can be
seen in Figure 5.12B.
Cells cultured on L. lactis-FN and L. lactis-empty proliferated to a lesser
extent compared to collagen I and FN, but as shown in the Figure 5.12, that
did not have an effect on differentiation values.
Activation of FAK via Tyr-397 autophosphorylation was examined with
Western blot. C2C12 myoblasts were cultured with at 20,000 cells/cm2 in
FBS-free medium, for three hours. Then, cells were lysed and the protein
extract was purified and subjected to a 7 % SDS-PAGE electrophoresis. Bands
corresponding to FAK and pFAK were visualized and quantified by densitometry
with the help of the ImageJ – Fiji software.
Figure 5.13 A) Representative Western blot bands for pFAK and FAK on the
different biointerfaces. α-tubulin was used as housekeeping protein for normaliz-
ation of the analysed values. Quantification of Western blot bands. ANOVA test
showed statistically significant differences between each column, *p < 0.05. Data
presented as mean ± SD
pFAK/FAK ratio was found to be higher in the cells cultured on L. lactis-FN
biofilm and FN-coated glass compared to the ones cultured on L. lactis-emtpy
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and bare glass surfaces. This result supports the previous results, since the
bacterially expressed III7−10 fragment is interacting with the cellular fibronectins
and leading to the activation of the FAK via phosphorylation.
Adhesion and differentation of human mesenchymal stem cells
Behaviour of bone marrow-derived human mesenchymal stem cells (hMSC-BM)
was also studied on L. lactis-empty and L. lactis-FN biofilms. Maximum density
biofilms were produced on PEA-coated glass coverslips, using FN-coated (from
a solution of 20 µg/mL) PEA on glass coverslips as a positive control. After 3h,
cells were immunostained against vinculin, using FITC-conjugated phallacidin
to stain the actin cytoskeleton.
Figure 5.14 Adhesion behaviour of hMSC-BM cells on L. lactis-emtpy and L.
lactis-FN biofilms, FN-coated PEA coverslips and bare glass. hMSC behaviour is
very similar to C2C12, NIH3T3 and Fn−/Fn− fibroblasts.
Much like in the previous adhesion assays, hMSC-BM cells cultured on L.
lactis-emtpy biofilms remained in a rounded shape without any signs of actin
cytoskeleton development. On L. lactis-FN biofilm, a developing cytoskeleton is
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clearly visible, although is less developed than in the FN-coated PEA coverslip.
In glass, as expected, cells showed no adhesion, keeping a rounded shape at
the end of the culture time.
Cell area and roundness were quantified using Fiji–ImageJ software. The
green channel, corresponding to the actin staining, was used to determine cell
area and shape, since in these images the cell silhouette is clearly visible and
easy to segment from the background (Figure 5.14).
Figure 5.15 hMSC-BM cell area (µm2) (A) and roundness (B) after a 3-hour
culture. Highest area values were found on FN-coated PEA coverslips, although
statistical significance between hMSC cells cultured on L. lactis-empty and L. lactis-
FN biofilms were also found. As expected, cells cultured on L. lactis-empty and
glass showed lowest area values. Higher roundness values were present on cells
cultured on L. lactis-empty biofilm and uncoated glass. Statistical significance was
found for cells cultured on L. lactis-empty and PEA-FN. * stands for p < 0.05 and
*** for p < 0.001. Results are presented as mean ± SD. Parametric ANOVA was
performed on N ≥ 15 cells.
Roundness values were found to be very similar across the different tested
conditions, although this can be attributed to the shape of the adhered cells, as
they did not show an elongated, fibroblast-like morphology.
ERK1/2 phosphorylation analysis
Early adhesion behaviour was also assessed via ERK1/2 phosphorylation ana-
lysis. As previously described in the materials and methods section, a 30-minute
culture of hMSC-BM cells on L. lactis-empty, L. lactis-FN biofilms produced on
PEA-coated glass coverslips, FN-coated PEA and bare polystyrene was used to
quantify the amount ERK1/2 phosphorylated on Thr-202/Tyr-204. Results are
shown in Figure 5.16
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Figure 5.16 ERK1/2 phosphorylation on hMSC-BM cells cultured on L. lac-
tis-empty and L. lactis-FN biofilms developed on PEA, FN-coated PEA and bare
polystyrene. Phosphorylation analysis was assessed with sandwich ELISA after a
30-minute culture. Statistically significant differences were found between phos-
phorylation levels of cells cultured on L. lactis-emtpy and L. lactis-FN biofilms (*p
< 0.05), L. lactis-emtpy and FN and polystyrene (****p < 0.0001) and between L.
lactis-FN and FN-coated PEA (**p < 0.01). N ≥ 3, data shown as mean ± SD
As shown in the introduction of this chapter, ERK1/2 are two isoforms of
the extracellular regulated kinase, a kinase pertaining to the MAPK regulatory
pathway, involved in proliferation and migration processes. As expected III7−10
triggers the activation, via dimerization, of the α5β1 integrin, leading to the
activation of this pathway. Cells cultured on the L. lactis-empty biofilm showed
negligible phosphorylation levels, whereas cells cultured on FN-coated PEA and
cell-culture treated polystyrene showed the highest phosphorylation levels.
It is interesting to note that cell area, a variable greatly influenced by the
presence of adhesive cues that allow cells to adhere and spread, and ERK1/2
phosporylation, an event taking place upstream to the formation of focal adhe-
sion complexes and the subsequent activation of the MAPK signalling pathway,
110 CHAPTER 5. CELL-BACTERIA CO-CULTURES AND CELL BEHAVIOUR
are related. In the assays done in this cell line, these two variables seemed
to be related, much like in the results obtained in the other cell lines, notably
C2C12. It looks like biological activity of bacterially expressed III7−10 fragment
is affecting hMSC-BM cells to a lesser extent if compared to the other tested
cell lines. Another explanation could be the fact that this cells require longer
times than the other tested cell lines to fully adhere and develop focal adhesion
complexes.
Differentiation assessment by gene expression analysis
Differentiation analysis was performed in hMSCs cultured at 20,000 cells/cm2
on surfaces covered with L. lactis-empty and L. lactis-FN biofilms (developed
on PEA) FN-coated PEA and bare polystyrene. Cells were maintained in DMEM
supplemented with 10 µg/mL tetracycline.
After 14 days, total RNA was extracted and retrotranscripted to cDNA, which
was used to quantify the relative expression levels of the genes depicted in
Table ?? for each lineage.
Lineage Differentiation markers
Self-renewal ALCAM, CD63




Table 5.2 Summary of the differentiation markers used for qPCR analysis.
∆CT results are shown in Figure 5.17.
Results from the qPCR analysis, with the exception of SOX9 gene, for which
no detectable expression was found in any condition, showed the lowest ∆CT
values for self-renewal markers, ALCAM and CD63. No significant differences
were found across the different assessed conditions.
The other studied genes, related to adipogenic, osteogenic, chondrogenic
and myogenic differentiation showed similar values with, again, statistically
non-significant differences between conditions or genes in the same condition. A
subsequent∆∆CT analysis was done, using two different conditions as controls,
as shown in the Figure 5.18
Relative expression levels, expressed as ∆∆CT, were found not to be statist-
ically significant across conditions, taking two different conditions as controls,
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Figure 5.17 ∆CT values for each studied gene. Lowest values were found in the
self-renewal genes, CD63 and ALCAM, compared to the rest. This result suggest
that hMSCs are maintaining its self-renewal capabilities after 14 days of culture.
Figure 5.18 Relative expression (fold increase) compared to two different con-
trol conditions, that is to say, L. lactis-empty and FN-coated PEA. Again, no stat-
istically significant differences were found between conditions for each studied
gene.
that is to say, cells cultured on L. lactis-empty biofilm and on FN-coated PEA.
As seen throughout this work, cell behaviour on L. lactis-emtpy biofilms
was found to be very similar to the one found on non-functionalised surfaces
such as glass or polystyrene. FN-coated PEA was also used as a kind of positive
control, since FN is known to induce cell adhesion and intracellular signalling
for a multitude of processes.
The conclusion that can be drawn from these results is that, since the
cultures were made in a medium supplemented with 1 % foetal bovine serum,
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the influence of both bacterially expressed III7−10 and adsorbed FN has been
superseded by the protein mixture present in the FBS. Since FBS is vital to ensure
the viability of the hMSCs in long-term cultures, the effect of the bacterially
expressed fibronectin should be assessed by using fibronectin-depleted FBS.
[292]
5.4 Conclusions
Engineering microenvironments to provide cells with dynamic cues, as occurs
in the natural extracellular matrix, is a field of intensive research seeking to
direct the differentiation of stem cells and advance in strategies for tissue repair
and regeneration [293].
Several approaches have been explored, spanning from functionalisation
of material surfaces with cell adhesive motifs to the incorporation of protease-
degradable fragments in polymer hydrogels that allow changes in the material
structure as cells secrete proteases to remodel the ECM [15, 291, 294]. Dynamic
surfaces have also been engineered to present cell adhesive RGD sequences
on-demand. [14, 15, 295]
From a different perspective, dynamic cell microenvironments have been
engineered to present and release growth factors in a sustainable and controlled
way to stimulate and support cell differentiation. [16, 296–301]
As seen in Chapter 4, we have engineered [216] Lactococcus lactis to display
the III7−10 domains of human fibronectin as a membrane-bound protein. III7−10
contains the RGD and PHSRN synergy sequences which promote cell adhe-
sion and differentiation [31, 302]. Several cell lines, namely fibronectin-null
fibroblasts (Fn−/Fn−), NIH3T3 and C2C12 adhere, spread and develop focal
adhesion complexes on the engineered L. lactis biofilm, behaving in a similar
way as when cultured directly on a FN-coated surface. [216]
This strain produces stable biofilms that support cellular growth, adhesion
and differentiation [211] . The formation of the biofilm starts when some
individual cells adhere to the surface, a process governed by weak non-specific
forces — Van der Waals and polar Lewis acid-base interactions [43, 303]. This
initial, reversible attachment becomes irreversible after bacteria make use of
several cell-wall anchored proteins (CWAP) known as adhesins. In L. lactis, the
most prominent ones are the CluA [62, 264] sex factor and the PrtP and NisP
proteinases. [62, 64, 66]
These adhesins modify the bacterial surface properties and ultimately lead
to its irreversible attachment to the surface. After this attachment becomes
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irreversible, the required force to detach additional bacteria increases and
more bacteria are recruited and co-aggregated to the existing ones. Afterwards,
bacteria proliferate and develop the biofilm itself. In this phase, few hours after
the initial irreversible attachment, a co-continuous and stable layer is formed.
L. lactis subsp. cremoris MG1363 is a strain with a low production of exo-
polysaccharides, so biofilms usually show a monolayered morphology, lacking
the horizontal stratified structure found in other strains. [211, 304, 305]
Hence, the formation of L. lactis biofilms seems limited to a monolayer [306]
of strongly attached bacteria, in almost any abiotic surface such as polymers,
glass or metallic surfaces. Usually, the adhesion of the bacterium to the substrate
is mediated by the bacterial fimbriae, also called adhesion pili [307]. These
fimbriae are also involved in the formation of the bacterial aggregates, as shown
in the results section.
Once the biofilm has been successfully established, a need to control its
proliferation arises. We found that the biofilm behaviour can be controlled to
remain in a stationary phase, using low concentrations of tetracycline, up to 15
days. The amount of FNIII7−10 available on the membrane of the bacteria has
been quantified; it promotes cell adhesion, signalling and cell differentiation
[211]. Overall, this living interface based on non-pathogenic bacteria enhances
the myogenic differentiation process. Selecting the proper substrate is also
important due to the nature of the bacterial-surface interactions; it seems that
the use of hydrophobic substrates such as PEA is needed for the establishment
of a stable biofilm that remains stable for at least two weeks.
Further genetic modification of this living interface will be done to engineer
a dynamic system able to provide cells different temporal stimuli beyond cell
adhesion, such as the delivery of growth factors and other molecules upon
external demand. By engineering non-pathogenic bacteria to produce proteins
and growth factors upon external stimuli, we aim at control the interface
between synthetic biomaterials and stem cells to control self-renewal and
differentiation, which can be then applied to several strategies to promote
tissue repair and regeneration [1].

Chapter 6
Bacterial inclusion in polymeric
systems
6.1 Introduction
Cell immobilisation is a simple, cheap and effective way to maintain viable
eukaryotic or prokaryotic cells trapped within a polymer, while retaining its
functional properties. It is a common technique used in applications such as
bioreactors, where whole cells or enzymes are immobilised within a polymeric
substrate and act as live biocatalysts for complex reactions in mild conditions,
or biosensors, where live cells or enzymes are able to sense the external envir-
onment generating a signal in response to these stimulus. [308–310]
Cells can be immobilised in several ways: attachment or adsorption on solid
carrier surfaces; entrapment within a porous matrix; self-aggregation by natural
flocculation or artificially with crosslinking agents; or in cell containment behind
barriers [308]. In previous chapters, a natural immobilisation method, biofilm
formation, has been described. L. lactis cells spontaneously attach to surfaces
as a response to environmental stresses, getting as a result a stable layer of
adhered bacteria. In this chapter, our objective is to further investigate the
possibility of physical entrapment within natural and biodegradable polymers,
to ensure good compatibility between the bacterial cells and the polymeric
matrix.
Amongst the wide variety of commercially available polymers, poly-L-lactic
acid (PLLA) has been selected due to its physical and biocompatibility properties.
Poly-L-lactic acid is a natural polymer obtained from renewable sources such as
corn starch, tapioca roots or sugarcane [311]. High molecular weight PLLA is
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produced through catalytic ring opening polymerization of cyclic lactides, which
are derived from the lactic acid, the final product of lactic homofermentation
of the abovementioned sugar sources [312]. Higher molecular weights can be
achieved through the polycondensation method, where short oligomeric units
react in anhydrous conditions to favour condensation over transesterification.
The PLLA used in this work (Cargill Dow) is a brittle, non-crosslinked and
thermoplastic polymer soluble in tetrahydrofuran (THF), chloroform, benzene,
1,4-dioxane and hexafluoroisopropanol (HFIP) and insoluble in toluene, p-
xylene, water, ethanol and other solvents. [313]
Polylactic acid is widely used as medical biomaterial, due to its good biocom-
patibility properties [314]. PLLA degrades naturally through either chemical
or enzymatic hydrolysis [315], yielding nontoxic degradation products that
are easily reabsorbed by the body. As of today, PLLA is being used in various
biomedical devices including degradable sutures, drug releasing micro and
nanoparticles, and porous scaffolds for cellular applications. [316]
In this work, we have used a whole-cell entrapment approximation to
immobilise L. lactis cells within a PLLA matrix. Two different techniques were
used, electrospinning and spin-casting.
Electrospinning is a technique used to produce polymeric fibres with diamet-
ers comprised between micro- and nanometres. By using an electric potential
in the range of the kilovolts, a charged jet emerges from an extruded molten
polymer or a polymeric solution, leading to the formation of long and very thin
fibres. [317]
Three main components are needed: a direct current high-voltage power
source, a capillary tube from where the solution or molten polymer is extruded
and a conductive, earthed collector [318]. The high-voltage direct current
power source is set-up for a potential difference of several kilovolts with a very
low current intensity, typically in the range of the microamperes. The extruder
is usually a non-bevelled needle directly connected to the power source. A
syringe connected to a syringe pump feeds the extruding needle with a constant
flow of a polymer solution or molten polymer. [319]
An electric field applied on the extruding droplet gives as a result an ac-
cumulation of charges of the same sign in its surface. Repulsive electrostatic
forces accumulate in the air-liquid interface until the accumulated repulsive
forces equal surface tension. As a result, a charged jet emerges from the droplet
creating the Taylor cone. The jet flies to the collector, creating a long and very
thin fibre that collides with the collector. [320, 321]
As the jet leaves the needle, solvent quickly evaporates, resulting in a vis-
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Figure 6.1 Sketch of the electrospinning process and the Taylor cone created at
the end of the needle.
cosity increase of the solution. Polymer chains start to align until a very thin
fibre is formed. This fibre shows a constant and uniform diameter. With the
proper solvent, flying time, polymer concentration and applied voltage, a non-
woven mat of randomly aligned fibres is obtained in the collector. Nevertheless,
the morphology of the collected fibres depends on the geometry of the col-
lector; aligned nanofibres can be easily obtained with a rotating drum with the
adequate linear speed. [318, 322–326]
Other technique used to immobilise bacterial cells in PLLA involves the
production of thin films by using spin casting. A drop of the polymer solution
with the dispersed bacterial wells is deposited onto the centre of the substrate
and spin at high speed. Centripetal acceleration forces the polymer solution to
spread to the edge of the surface. During the high-speed spinning, the solvent
is quickly evaporated leaving a thin polymer film. Film thickness depends on
the nature of the polymer (surface tension, viscosity, drying rate, percent solids,
etc.), the substrate surface and the parameters of the spin process, such as
rotational speed, acceleration and time. [327–329]
Thin PLLA films with trapped L. lactis cells were prepared this way and fur-
ther characterised to assess the viability of the included cells and the availability
of the FN III7−10 fragment expressed in the bacterial cell wall.
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Figure 6.2 Spin casting process. A drop of the polymer solution is quickly spun
and, once the solvent has evaporated, a thin polymer film remains on the surface
of the substrate.
6.2 Materials and methods
Preparation of PLLA nanofibres with trapped L. lactis cells
50 mL of an overnight culture of L. lactis-FN and L. lactis-empty in GM17-E was
pelleted by centrifugation at 3,000 g for 10 min. The pellet was twice washed
with 2 mL of sterile NaCl 0.85 % w/v to remove traces of the growth medium,
harvested again by centrifugation at 3,000 g for 10 minutes and resuspended
in a 10 % w/v solution of sucrose in distilled water. This suspension was
immediately frozen at -80 °C and freeze-dried to remove the water while
keeping cell viability.
Freeze-dried bacteria were resuspended in 750 µL of hexafluoroisopropanol
(HFIP, >99 % pure, Sigma) and filtered through a 75 µm metallic sieve to
remove the precipitated sucrose. The resulting solution was mixed with 750 µL
of an 8 % of poly-L-lactic acid solution in HFIP. This suspension was electrospun
using an electric potential of 22 kV, a flow rate of 500 µL/h and a distance
between the extruding needle and the collector of 18 centimetres. The needle
had an internal diameter of 0.15 mm.
As a result, a nonwoven mat of PLLA filaments with included bacteria was
obtained. This mat was left two hours at room temperature to properly dry the
fibres and immediately used in either viability assays, immunostainings or cell
cultures.
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PLLA spin casting
A similar protocol was applied to prepare PLLA thin films with included bacteria.
L. lactis-FN and L. lactis-empty strains were grown in 50 mL of GM17-E. Cells
were harvested at 3,000 g for 5 minutes and washed twice with sterile 0.85
% NaCl and centrifuged again at 3,000 g for 5 minutes. The pellet was mixed
with 1 mL of an 8 % PLLA solution in HFIP. 100 µL of this solution was used to
prepare each 12 mm glass coverslip.
The spin-coater program consisted on a 30-second run at 3,000 rpm, drying
afterwards the coated coverslips in the air, at room temperature, for 1 hour.
These PLLA thin films with included L. lactis were used for the subsequent
viability assays and cell cultures.
Cell adhesion and immunostaining
Adhesion of NIH3T3 fibroblasts to the PLLA-immobilised L. lactis was assessed
through an anti-vinculin immunostaining. After culture times, cells were washed
with Dulbecco’s phosphate buffered saline (DPBS, Invitrogen) and fixed in
formalin solution 10 % (Sigma) at 4 °C for 30 min. The formalin was washed
three times with DPBS and the samples were incubated with permeabilising
buffer (0.1 % Triton X-100 in DPBS) at room temperature for 5 min.
Then, the samples were incubated in 1 % bovine serum albumin (Sigma) in
DPBS at room temperature for 30 min, in order to reduce the background sig-
nal. The samples were then incubated with monoclonal anti-vinculin antibody
(Sigma) diluted 1:400 in 1 % BSA / DPBS for 1 hour at room temperature.
Samples were washed in 0.5 % Tween 20 / DPBS three times. Cy3-conjugated
polyclonal rabbit anti-mouse secondary antibody (Jackson Immunoresearch),
diluted 1:200 in 1 % BSA/PBS, with 1:40 BODIPY FL-conjugated phallacidin
(Invitrogen) was added to the samples and incubated 1 hour at room temperat-
ure.
Samples were washed three times with 0.5 % Tween 20 / PBS and mounted
with Vectashield-DAPI mounting medium (Vector Laboratories, Peterborough,
UK). Samples were imaged using a Nikon Eclipse 80i epifluorescence micro-
scope.
Bacterial viability
Bacterial viability was assessed using the protocol depicted in the Bacterial and
cell viability section.
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Scanning electron microscopy
Samples were imaged using a Jeol JSM 6300 system (Jeol Ltd., Tokyo, Japan)
operating at 20 kV. Previously to imaging, samples were sputtered with gold
and visualized. Images were acquired using the TIFF raster format with 512
lines of horizontal resolution.
6.3 Results
Immobilisation in poly-L-lactic acid nanofibres
Nonwoven random mats made of poly-L-lactic acid (PLLA) nanofibres were
electrospun according to the protocol described in the materials and methods
section. Cell pellets from L. lactis-FN and L. lactis-emtpy overnight cultures
were washed and resuspended in hexafluoroisopropanol (HFIP) and mixed
with equal volumes of either 8 % or 4 % PLLA solution in HFIP. The resulting
bacterial dispersion, in 4 % or 2 % PLLA in HFIP, was electrospun to produce
random nonwoven mats, with a mean fibre diameter of 0.49 ± 0.07 µm.
Figure 6.3 Proposed model of L. lactis cells (brown) trapped within PLLA fibres
(gray)
Bacterial cells appear as bulges with a mean diameter of 0.96 ± 0.06 µm,
trapped within the individual fibres.
Fibres with immobilised L. lactis cells, along with control PLLA and FN-
coated PLLA, were immunostained with the HFN7.1 antibody to assess the
availability and biological activity of the FNIII7−10 fragment. This antibody is
directed against the flexible linker between the III9 and III10 fragments.
As expected, fibronectin immunostaining showed almost no signal in the
fibres with included L. lactis-empty strain cells. Fibres with L. lactis-FN cells
showed fluorescence to a certain extent, while in the FN-coated membrane,
individual fibres were clearly distinguishable. The negative control, raw PLLA,
showed no fluorescence at all.
According to this result, it seems to be a lower FNIII7−10 exposure in the
fibres with trapped L. lactis-FN membrane than in the fibronectin-coated PLLA
nanofibres. This result suggests that immobilised bacterial cells are not correctly
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Figure 6.4 Scanning electron microscopy images of the trapped L. lactis cells
in the electrospun poly-L-lactic acid fibres. Cells appear as bulges trapped in the
fibres.
Figure 6.5 Fibronectin immunostaining in the electrospun membranes. A), ES-
PLLA membrane with L. lactis-empty bacteria included; B) with L. lactis-FN strain;
C) ES-PLLA membrane coated with fibronectin from a 20 µg/mL solution, and D)
uncoated ES-PLLA membrane.
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exposing the FNIII7−10 fragment, probably due to the thin PLLA layer that covers
the whole cell, while in the FN-coated fibres the fibronectin domains are located
in the surface of the PLLA, being more accessible to the cultured cells.
To assess the influence of the FNIII7−10 fragment in the cellular behaviour,
NIH3T3 fibroblasts were cultured in serum-free medium for a total culture time
of three hours, and then immunostained for vinculin (red) and actin (green).
Nuclei were counter-stained with DAPI (blue).
Figure 6.6 Vinculin (red) and actin (green) immunocytochemistry on NIH3T3
cells seeded on the electrospun membranes containing A) L. lactis-empty cells, B)
L. lactis-FN cells, C) fibronectin-coated fibres and D) bare PLLA fibres.
This adhesion assay is coherent with the previous anti-FN immunostaining.
Cells seeded on L. lactis-empty and L. lactis-FN trapped cells and on bare PLLA
fibres showed almost no actin cytoskeleton or focal adhesion development, with
an overall smaller size than the ones seeded on FN-coated PLLA electrospun
fibres.
It can be concluded that the lower accessibility of the fibronectin fragment
had a negative effect on the initial adhesion and cytoskeleton development
behaviour, thus this approach seems to be less effective than immobilisation
with biofilm presented in the previous chapters.
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Immobilisation in poly-L-lactic acid thin films
Starting from cell pellets from stationary phase cultures, thin PLLA films were
produced using spin casting, a widely used technique for producing thin and
uniform polymer films. The polymer solution containing bacteria was deposited
in the centre of the substrate and spun at high speed, forcing the solution to
spread on the substrate by means of the centripetal force. As a result, a thin
film was obtained, while the solvent evaporated during the spinning process.
Figure 6.7 Proposed model of a PLLA thin film prepared on glass with trapped
L. lactis cells.
Unfortunately, although great effort was put in the maintenance of a homo-
geneous suspension, bacterial cells eventually clumped leading to the formation
of minuscule droplets, a kind of phase separation due to the aqueous nature of
the cells, in contrast to the non-polar nature of the chloroform.
Although some phase-separation was observed, a very thin and transparent
with included bacteria PLLA film was produced. A viability test was performed
on the trapped bacterial cells, as seen in Figure 6.8.
In both strains, bacterial cells clumped, creating small droplets, while the
rest of the PLLA remained virtually bacteria-free. The yellowish tint of the
images, a composite of the green and red channel, could be due to the fact that
both channels showed similar fluorescent intensity under the microscope. No
definitive conclusion can be obtained from these images, as the viability results
are not clear and cells appear clumped.
Both cell trapping in electrospun PLLA fibres and spin-coated PLLA does
not seem to be suitable techniques for cell immobilisation, due to unresolved
issues such as the low biological availability of the FNIII7−10 fragment and
inconclusive results from the viability assay. In fact, the use of organic solvents
like chloroform or hexafluoroisopropanol are very likely to affect cell integrity
and viability.
Further approaches based in polymer-immobilised cells will need to consider
the high sensitivity of these bacterial cells to organic solvents and the need to
ensure the availability of the expressed FNIII7−10 fragment to the mammalian
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Figure 6.8 Fluorescence images of the bacterial viability test. L. lactis cells were
trapped in a thin film of PLLA produced using the spin casting technique. In A)
and B), L. lactis-empty cells; in C) and D), L. lactis-FN cells.
cells that will be in direct contact with bacteria.
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6.4 Conclusions
Although bacteria-based dynamic biointerfaces based on bacterial immobilisa-
tion through spontaneous biofilm formation hold great promises, immobilisation
in polymeric supports opens a wide range of applications for this bacteria-based
biointerfaces.
For example, immobilisation in water-based, porous polymers such as algin-
ate, chitosan, gelatin, agar or agarose could enhance the bacterial stability and
lifespan of these supports, provided proper environmental culture conditions.
This is a competitive advantage over biofilms, which are subjected to a finite
and well established life cycle, while cells immobilised within a polymer can
be maintained in an almost-stationary state, much like in the bioreactors used
for industrial production of products such as bacteriocins, lactic acid and other
products.
Nevertheless, immobilisation within a polymeric matrix also entails disad-
vantages. The most obvious one is the fact that membrane surface-exposed
biochemical signals, such as the FNIII7−10 fragment assessed throughout in this
work, become less accessible to mammalian cells.
The biggest disadvantage faced in this work has been the need to use
non-polar solvents when working with water-insoluble polymers such as PLLA,
and is clear that is preferable the use of water-soluble polymers for bacterial
cells immobilisation; the use of stringent environmental conditions should be
avoided in order to maintain bacterial viability and structural integrity of the
expressed proteins.
Anyway, the use of membrane-bound biochemical cues is only one amongst
the range of potential uses of genetically engineered bacteria for tissue en-
gineering. The development of a new tissue is driven by static and dynamic
biochemical signals, being fibronectin only one in the wide variety of signals
needed for the development of a mature tissue.
Depending on the chosen tissue, soluble factors and small molecules play an
important role, and in this point is where immobilised cells within hydrophylic
polymers can play an important role, since a direct, physical contact between
bacteria and mammalian cells is not strictly needed and the inclusion within
a porous polymer can be enough to allow passive diffusion within the culture
medium.
This newly developed biointerface can be used not only for expressing
static cues (proteins, small molecules or growth factors), in resemblance to the
passive protein coatings used until today, but to express on-demand cues in




In this work, a new model for surface functionalisation based on live organisms
has been established, specifically the lactic bacteria Lactococcus lactis. This strain
has been engineered to express the III7−10 fragment of the human fibronectin,
which carries the RGD adhesion and the PHSRN synergy motifs, both involved
in the integrin-ECM interaction.
The extracellular matrix is a complex and dynamic system that cannot
be mimicked using a simple, passive coating. Although this work presents
a functional living interface, it does not show any functional characteristics
beyond the presentation of a constitutively expressed recombinant protein to
the aboveground cell layer. Is at this point where this system can show its full
potential, and can be modified to act as a truly dynamic interface with the ability
to display almost any desired biochemical cue in response to user-selectable
triggers.
Lactococcus lactis is one of the most studied gram-positive microorganisms;
is the model organism for the lactic acid bacteria clade with many genetic
tools available. Lactococcus lactis has already been used as a vehicle for recom-
binant protein expression with uses such as oral vaccine delivery and other
heterologous proteins.
There is a wide variety of available constitutive and inducible expression
systems, for example NICE, a nisin-induced promoter; the acid-inducible P170
promoter; Pgad, a chloride-inducible system or Zirex, a zinc-regulated expres-
sion system, amongst others. These inducers can be of the on-off type or
regulated, such as the NICE system. With these tools readily available to the
researcher, the logical next step is the development of biointerfaces with a)
single constitutive or inducible expression systems that will allow a tightly con-
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trolled spatio-temporal control of protein expression, and b) the combination
of two or more of these expression systems in a single bacterial population,
enabling protein expression control and allowing the expression of more than
one protein in a single biointerface.
In the context of tissue engineering, there are several proteins and growth
factors of special interest, due to its role in the development and growth of
specific tissue types. Bone morphogenetic protein-2 (BMP2) is a growth factor
pertaining to the TGF-beta superfamily involved in the development of bone
tissue. Bone is the tissue with the highest regeneration potential, and, given an
appropriate microenvironment and the proper cell line, the presence of BMPs
is essential for the biological reaction chain that leads to the development of
mature bone tissue. Nowadays, the most used source of BMPs for research and
clinical purposes is the expression of recombinant versions of this proteins; the
use of an inducible, in-situ BMP2 source will enable the possibility to trigger
the signalling induced by this protein family in a more controlled fashion.
Not only bone regeneration could be favoured by this new type of dynamic
interface. Vascular endothelial growth factor-2 (VEGF2) is another example
of recombinant protein that is being currently used in research. VEGF2 is a
diffusible mitogen with vasculogenic and angiogenic properties that plays an
important role in the de novo development of blood vessels and in hypoxic
conditions. Since wound healing often require the presence of angiogenic
factors, VEGF2 can be used for the development of new blood vessels in growing
tissues.
Although cell immobilisation through the formation of biofilms seems to be
suitable for most purposes, inclusion in polymeric systems should be further ex-
plored. Several hydrophylic polymers, mostly polysaccharides such as agarose,
pullulans and alginate have been used in bioreactors and other applications.
The disadvantage of using polymers only soluble in organic solvents (polycapro-
lactone, poly-L-lactic acid and others) is the foreseeable loss of bacterial viability,
so using water-based polymers is a must.
Nevertheless, since it can be difficult to obtain bacterial inclusion without
blocking the extracellular exposure of membrane-expressed proteins, hybrid
systems could be a suitable solution. In these hybrid systems, a bacterial strain
whose only objective is to express soluble factors such as growth factors or
small molecules could be immobilised within a water-based polymer and the
same strain, with membrane-anchored expression, could be immobilised as a
biofilm in the surface of the polymer.
This is a system that would be easy to develop and test in the short-term
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and would help in issues such as the need to control the bacterial proliferation
and lactic acid production.
Summarising, functional living bionterfaces presented in this thesis could
be developed, with a minimum effort, to include several strains in the same
system and express many, either on-demand or constitutively, proteins, soluble
factors, small molecules and almost any needed biochemical cue to assist in




1. The lactic bacteria strain Lactococcus lactis subsp. cremoris has been genet-
ically engineered to display the III7−10 fragment of the human fibronectin
in its cell wall. This fragment contains two important sequences, RGD
and PHSRN, involved in the cell-ECM interaction via integrins.
2. This genetic modification has been done using standard techniques, that
is to say, PCR and restriction site cloning. Fibronectin fragment has been
cloned as a fusion protein with GFP as reporter protein, using the Usp45
signal peptide as secretion signal and S. aureus protein A to covalently
anchor the fragment to the peptidoglycan layer of L. lactis.
3. The modified strain, stated as L. lactis-FN throughout the work, has been
characterized to ensure that the fragment is correctly expressed in the
bacterial cell wall by using different techniques: western blot for assessing
the cell wall localization of the protein and fluorescence microscopy to
detect the green fluorescent protein. Both techniques have given the
expected results, since the FNIII7−10 fragment is covalently linked to the
bacterial peptidoglycan layer.
4. L. lactis, much like the vast majority of the bacterial species, has the
ability to develop biofilms, communities of sessile bacteria attached to
a surface in order to increase its survival rate. Development of biofilms,
although detrimental to most applications, can be exploited in our favour
to produce a physical, monolayer of bacterial cells strongly attached to a
surface, which play the role of the interfacial layer between the synthetic
substrate and the mammalian cell population that can grow and develop
on this biofilm.
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5. Biofilm areal density, or number of bacterial cells per area unit, can be
finely tuned by using different volumes of a bacterial culture in the log
phase. Since total bacterial biomass depends on the initial volume, larger
volumes will lead to denser biofilms.
6. Biological activity of the expressed fibronectin fragment was assessed
with several techniques. ELISA was used to quantify the exposure of the
fragment and its availability to mammalian cells. Biological activity was
found to be practically identical to a fibronectin-coated surface with an
approximate density of 300 ng/cm2.
7. To further confirm the biological availability and activity of the expressed
fibronectin fragment, several mammalian cell lines were cultured on the
L. lactis-FN biofilm. Adhesion behaviour and integrin-mediated signalling
through focal adhesion kinase (FAK) phosphorylation was confirmed on
NIH3T3 fibroblasts, Fn−/Fn− fibroblasts and C2C12 myoblasts. Myogenic
differentiation was also found to be higher on the cells cultured on the L.
lactis-FN biofilm than in the L. lactis-emtpy biofilm, with differentiation
degrees similar to the ones found in the standard differentiation substrate,
Collagen I and fibronectin.
8. Human mesenchymal stem cell response to the L. lactis-FN biofilm was
also assessed. hMSCs showed focal adhesion development and ERK1/2
phosphorylation. ERK is an enzyme involved in the MAPK pathway, re-
sponsible for a wide variety of cellular processes such as differentiation,
adhesion, migration and proliferation. MAPK activity is induced by integ-
rin dimerization amongst other factors, so we can infer that the FNIII7−10
fragment is responsible for activating several intracellular signalling path-
ways.
9. Differentiation analysis of hMSCs by qPCR showed that no differentiation
was taking place on these cells after a two-week culture. mRNA expression
levels of the two studied self-renewal genes ALCAM and CD63 were
significantly higher than other differentiation markers, but this result has
to be further verified since the fibronectin present in the serum used in
the culture could be outgrowing the influence of the bacterially expressed
fragment.
10. Finally, bacterial inclusion into polymeric systems such as PLLA was as-
sessed, although no improvement over the biofilm model was found.
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Trapping bacterial cells within PLLA requires the use of organic solvents
which are detrimental to bacterial viability; moreover, polymer surround-
ing bacterial cells hides the fibronectin fragment from mammalian cells.
Cultures done on L. lactis-FN trapped within electrospun nanofibres and
spin-coated PLLA thin films showed no difference between a bare polymer
surface and the same surface with included bacteria. Nevertheless, bac-





After cloning, plasmid pT1NX-FNIII7−10–GFP was sequenced to ensure the in-
frame insertion of the FNIII7−10-GFP fragment. Plasmid map and annotated
sequence is as follows.
Figure 8.1 Map of the pT1NX-FNIII7−10-GFP plasmid developed in this thesis
LOCUS Exported 7513 bp ds-DNA
DEFINITION synthetic circular DNA
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KEYWORDS pT1NX-FNIII7-10-GFP
SOURCE synthetic DNA construct
ORGANISM synthetic DNA construct
REFERENCE 1 (bases 1 to 7513)

























































1 gaattcgatt aagtcatctt acctctttta ttagtttttt cttataatct aatgataaca
61 tttttataat taatctataa accatatccc tctttggaat caaaatttat tatctactcc
121 tttgtagata tgttataata caagtatcag atctgggaga ccacaacggt ttcccactag
181 aaataatttt gtttaacttt agaaaggaga tatacgcatg aaaaaaaaga ttatctcagc
241 tattttaatg tctacagtga tactttctgc tgcagccccg ttgtcaggtg tttacgccgg
301 catgggtaaa ggagaagaac ttttcactgg agttgtccca attcttgttg aattagatgg
361 tgatgttaat gggcacaaat tttctgtcag tggagagggt gaaggtgatg caacatacgg
421 aaaacttacc cttaaattta tttgcactac tggaaaacta cctgttccat ggccaacact
481 tgtcactact ttctcttatg gtgttcaatg cttttcaaga tacccagatc atatgaaacg
541 gcatgacttt ttcaagagtg ccatgcccga aggttatgta caggaaagaa ctatattttt
601 caaagatgac gggaactaca agacacgtgc tgaagtcaag tttgaaggtg atacccttgt
661 taatagaatc gagttaaaag gtattgattt taaagaagat ggaaacattc ttggacacaa
721 attggaatac aactataact cacacaatgt atacatcatg gcagacaaac aaaagaatgg
781 aatcaaagtt aacttcaaaa ttagaccatt gtctccacca acaaacttgc atctggaggc
841 aaaccctgac actggagtgc tcacagtctc ctgggagagg agcaccaccc cagacattac
901 tggttataga attaccacaa cccctacaaa cggccagcag ggaaattctt tggaagaagt
961 ggtccatgct gatcagagct cctgcacttt tgataacctg agtcccggcc tggagtacaa
1021 tgtcagtgtt tacactgtca aggatgacaa ggaaagtgtc cctatctctg ataccatcat
1081 cccagctgtt cctcctccca ctgacctgcg attcaccaac attggtccag acaccatgcg
1141 tgtcacctgg gctccacccc catccattga tttaaccaac ttcctggtgc gttactcacc
1201 tgtgaaaaat gaggaagatg ttgcagagtt gtcaatttct ccttcagaca atgcagtggt
1261 cttaacaaat ctcctgcctg gtacagaata tgtagtgagt gtctccagtg tctacgaaca
1321 acatgagagc acacctctta gaggaagaca gaaaacaggt cttgattccc caactggcat
1381 tgacttttct gatattactg ccaactcttt tactgtgcac tggattgctc ctcgagccac
1441 catcactggc tacaggatcc gccatcatcc cgagcacttc agtgggagac ctcgagaaga
1501 tcgggtgccc cactctcgga attccatcac cctcaccaac ctcactccag gcacagagta
1561 tgtggtcagc atcgttgctc ttaatggcag agaggaaagt cccttattga ttggccaaca
1621 atcaacagtt tctgatgttc cgagggacct ggaagttgtt gctgcgaccc ccaccagcct
1681 actgatcagc tgggatgctc ctgctgtcac agtgagatat tacaggatca cttacggaga
1741 aacaggagga aatagccctg tccaggagtt cactgtgcct gggagcaagt ctacagctac
1801 catcagcggc cttaaacctg gagttgatta taccatcact gtgtatgctg tcactggccg
1861 tggagacagc cccgcaagca gcaagccaat ttccattaat taccgaacag aagatccaaa
1921 agaggaagac aataacaagc ctggcaaaga agacaataac aagcctggca aagaagacaa
1981 taacaagcct ggcaaagaag acaacaacaa gcctggcaaa gaagacaaca acaagcctgg
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2041 taaagaagac aacaacaagc ctggcaaaga agacggcaac aagcctggta aagaagacaa
2101 caaaaaacct ggtaaagaag atggcaacaa gcctggtaaa gaagacaaca aaaaacctgg
2161 taaagaagac ggcaacaagc ctggcaaaga agatggcaac aaacctggta aagaagatgg
2221 taacggagta catgtcgtta aacctggtga tacagtaaat gacattgcaa aagcaaacgg
2281 cactactgct gacaaaattg ctgcagataa caaattagct gataaaaaca tgatcaaacc
2341 tggtcaagaa cttgttgttg ataagaagca accagcaaac catgcagatg ctaacaaagc
2401 tcaagcatta ccagaaactg gcgaagaaaa tccattcatc ggtacaactg tatttggtgg
2461 attatcatta gccttaggtg cagcgttatt agctggacgt cgtcgcgaac tataactagt
2521 agatccggct gctaacaaag cccgaaagga agctgagttg gctgctgcca ccgctgagca
2581 ataactagca taaccccttg gggcctctaa acgggtcttg aggggttttt tgctgaaagg
2641 aggaactata tccggatgac ctgcaggcaa gctctagaat cgatacgatt ttgaagtggc
2701 aacagataaa aaaaagcagt ttaaaattgt tgctgaactt ttaaaacaag caaatacaat
2761 cattgtcgca acagatagcg acagagaagg cgaaaacatt gcctggtcga tcattcataa
2821 agcaaatgcc ttttctaaag ataaaacgta taaaagacta tggatcaata gtttagaaaa
2881 agatgtgatc cgtagcggtt ttcaaaattt gcaaccagga atgaattact atccctttta
2941 tcaagaagcg caaaagaaaa acgaaatgat acaccaatca gtgcaaaaaa agatataatg
3001 ggagataaga cggttcgtgt tcgtgctgac ttgcaccata tcataaaaat cgaaacagca
3061 aagaatggcg gaaacgtaaa agaagttatg gaaataagac ttagaagcaa acttaagagt
3121 gtgttgatag tgcagtatct taaaattttg tataatagga attgaagtta aattagatgc
3181 taaaaatttg taattaagaa ggagtgatta catgaacaaa aatataaaat attctcaaaa
3241 ctttttaacg agtgaaaaag tactcaacca aataataaaa caattgaatt taaaagaaac
3301 cgataccgtt tacgaaattg gaacaggtaa agggcattta acgacgaaac tggctaaaat
3361 aagtaaacag gtaacgtcta ttgaattaga cagtcatcta ttcaacttat cgtcagaaaa
3421 attaaaactg aatactcgtg tcactttaat tcaccaagat attctacagt ttcaattccc
3481 taacaaacag aggtataaaa ttgttgggag tattccttac catttaagca cacaaattat
3541 taaaaaagtg gtttttgaaa gccatgcgtc tgacatctat ctgattgttg aagaaggatt
3601 ctacaagcgt accttggata ttcaccgaac actagggttg ctcttgcaca ctcaagtctc
3661 gattcagcaa ttgcttaagc tgccagcgga atgctttcat cctaaaccaa aagtaaacag
3721 tgtcttaata aaacttaccc gccataccac agatgttcca gataaatatt ggaagctata
3781 tacgtacttt gtttcaaaat gggtcaatcg agaatatcgt caactgttta ctaaaaatca
3841 gtttcatcaa gcaatgaaac acgccaaagt aaacaattta agtaccgtta cttatgagca
3901 agtattgtct atttttaata gttatctatt atttaacggg aggaaataat tctatgagtc
3961 gcttttgtaa atttggaaag ttacacgtta ctaaagggaa tgtagataaa ttattaggta
4021 tactactgac agcttccaag gagctaaaga ggtccctagc gctcttatca tggggaagct
4081 cggatcatat gcaagacaaa ataaactcgc aacagcactt ggagaaatgg gacgaatcga
4141 gaaaaccctc tttacgctgg attacatatc taataaagcc gtaaggagac gggttcaaaa
4201 aggtttaaat aaaggagaag caatcaatgc attagctaga actatatttt ttggacaacg
4261 tggagaattt agagaacgtg ctctccaaga ccagttacaa agagctagtg cactaaacat
4321 aattattaac gctataagtg tgtggaacac tgtatatatg gaaaaagccg tagaagaatt
4381 aaaagcaaga ggagaattta gagaagattt aatgccatat gcgtggccgt taggatggga
4441 acatatcaat tttcttggag aatacaaatt tgaaggatta catgacactg ggcaaatgaa
4501 tttacgtcct ttacgtataa aagagccgtt ttattcttaa tataacggct ctttttatag
4561 aaaaaatcct tagcgtggtt tttttccgaa atgctggcgg taccccaaga attagaaatg
4621 agtagatcaa attattcacg aatagaatca ggaaaatcag atccaaccat aaaaacacta
4681 gaacaaattg caaagttaac taactcaacg ctagtagtgg atttaatccc aaatgagcca
4741 acagaaccag agccagaaac agaatcagaa caagtaacat tggatttaga aatggaagaa
4801 gaaaaaagca atgacttcgt gtgaataatg cacgaaatcg ttgcttattt ttttttaaaa
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4861 gcggtatact agatataacg aaacaacgaa ctgaatagaa acgaaaaaag agccatgaca
4921 catttataaa atgtttgacg acattttata aatgcatagc ccgataagat tgccaaacca
4981 acgcttatca gttagtcaga tgaactcttc cctcgtaaga agttatttaa ttaactttgt
5041 ttgaagacgg tatataaccg tactatcatt atatagggaa atcagagagt tttcaagtat
5101 ctaagctact gaatttaaga attgttaagc aatcaatcgg aaatcgtttg attgcttttt
5161 ttgtattcat ttatagaagg tggagtttgt atgaatcatg atgaatgtaa aacttatata
5221 aaaaatagtt tattggagat aagaaaatta gcaaatatct atacactaga aacgtttaag
5281 aaagagttag aaaagagaaa tatctactta gaaacaaaat cagataagta tttttcttcg
5341 gagggggaag attatatata taagttaata gaaaataaca aaataattta ttcgattagt
5401 ggaaaaaaat tgacttataa aggaaaaaaa tctttttcaa aacatgcaat attgaaacag
5461 ttgaatgaaa aagcaaacca agttaattaa acaacctatt ttataggatt tataggaaag
5521 gagaacagct gaatgaatat cccttttgtt gtagaaactg tgcttcatga cggcttgtta
5581 aagtacaaat ttaaaaatag taaaattcgc tcaatcacta ccaagccagg taaaagcaaa
5641 ggggctattt ttgcgtatcg ctcaaaatca agcatgattg gcggtcgtgg tgttgttctg
5701 acttccgagg aagcgattca agaaaatcaa gatacattta cacattggac acccaacgtt
5761 tatcgttatg gaacgtatgc agacgaaaac cgttcataca cgaaaggaca ttctgaaaac
5821 aatttaagac aaatcaatac cttctttatt gattttgata ttcacacggc aaaagaaact
5881 atttcagcaa gcgatatttt aacaaccgct attgatttag gttttatgcc tactatgatt
5941 atcaaatctg ataaaggtta tcaagcatat tttgttttag aaacgccagt ctatgtgact
6001 tcaaaatcag aatttaaatc tgtcaaagca gccaaaataa tttcgcaaaa tatccgagaa
6061 tattttggaa agtctttgcc agttgatcta acgtgtaatc attttggtat tgctcgcata
6121 ccaagaacgg acaatgtaga attttttgat cctaattacc gttattcttt caaagaatgg
6181 caagattggt ctttcaaaca aacagataat aagggcttta ctcgttcaag tctaacggtt
6241 ttaagcggta cagaaggcaa aaaacaagta gatgaaccct ggtttaatct cttattgcac
6301 gaaacgaaat tttcaggaga aaagggttta atagggcgta ataacgtcat gtttaccctc
6361 tctttagcct actttagttc aggctattca atcgaaacgt gcgaatataa tatgtttgag
6421 tttaataatc gattagatca acccttagaa gaaaaagaag taatcaaaat tgttagaagt
6481 gcctattcag aaaactatca aggggctaat agggaataca ttaccattct ttgcaaagct
6541 tgggtatcaa gtgatttaac cagtaaagat ttatttgtcc gtcaagggtg gtttaaattc
6601 aagaaaaaaa gaagcgaacg tcaacgtgtt catttgtcag aatggaaaga agatttaatg
6661 gcttatatta gcgaaaaaag cgatgtatac aagccttatt tagtgacgac caaaaaagag
6721 attagagaag tgctaggcat tcctgaacgg acattagata aattgctgaa ggtactgaag
6781 gcgaatcagg aaattttctt taagattaaa ccaggaagaa atggtggcat tcaacttgct
6841 agtgttaaat cattgttgct atcgatcatt aaagtaaaaa aagaagaaaa agaaagctat
6901 ataaaggcgc tgacaaattc ttttgactta gagcatacat tcattcaaga gactttaaac
6961 aagctagcag aacgccctaa aacggacaca caactcgatt tgtttagcta tgatacaggc
7021 tgaaaataaa acccgcacta tgccattaca tttatatcta tgatacgtgt ttgttttttc
7081 tttgctgttt agcgaatgat tagcagaaat atacagagta agattttaat taattattag
7141 ggggagaagg agagagtagc ccgaaaactt ttagttggct tggactgaac gaagtgaggg
7201 aaaggctact aaaacgtcga ggggcagtga gagcgaagcg aacacttgat tttttaattt
7261 tctatctttt ataggtcatt agagtatact tatttgtcct ataaactatt tagcagcata
7321 atagatttat tgaataggtc atttaagttg agcatattag aggaggaaaa tcttggagaa
7381 atatttgaag aacccgatta catggattgg attagttctt gtggttacgt ggtttttaac
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 Functional Living Biointerphases 
 Phenomena occurring at the biological/non-biological inter-
face are of fundamental importance in biotechnological and 
biomedical strategies to direct cell behavior on biomaterials, 
including cell adhesion, proliferation and differentiation. [ 1–2 ] 
The interaction of cells with synthetic materials takes place via 
a layer of proteins, such as fi bronectin (FN), either adsorbed or 
grafted on the material surface. [ 1–3 ] Synthetic biomaterials have 
been functionalized with a broad range of proteins and growth 
factors seeking to provide (static) cues to direct cell behavior. 
However, the interactions of cells with their surroundings are 
exquisitely dynamic processes which comprise different spatio-
temporal stimuli at different stages. Therefore the simple func-
tionalization of material surfaces can by no means provide the 
required dynamic environment for these processes to occur 
in a biomimetic way. Here we show that genetically modifi ed, 
non-pathogenic bacteria can be engineered to play the role 
of functional living biointerphases between synthetic mate-
rials and living cells. As a proof of concept, we have modifi ed 
 Lactococcus lactis to express a fi bronectin fragment that incorpo-
rates both the PHSRN synergy sequence and the RGD binding 
motifs (FNIII 7-10 ) and display this ligand as a membrane 
protein. We found that  Lactococcus lactis expressing FNIII 7-10 
is able to enhance cell adhesion and signaling, leading to the 
development of focal adhesion plaques and phosphorylation 
of focal adhesion kinase (FAK). Our results demonstrate that 
modifi ed bacteria can colonize the surface of an implant and 
provide the adequate stimuli to direct the behavior of mamma-
lian cells. This functional interphase between synthetic bioma-
terials and cells consist of living organisms could be further 
modifi ed to express any desired protein upon external request, 
which constitutes a new paradigm to direct cell behavior in 
regenerative medicine and several biotechnological and bio-
medical problems. 
 The cell-material interaction is a complex bi-directional and 
dynamic process that mimics to a certain extent the natural 
interactions of cells with the extracellular matrix (ECM). The 
interaction of cells with synthetic materials is not a direct one 
but occurs via a layer of proteins such as fi bronectin (FN), vit-
ronectin, and fi brinogen, which are immobilized on the mate-
rial surface. [ 3 ] Cells primarily interact with these proteins via 
integrins, a family of transmembrane cell adhesion receptors. [ 4 ] 
Integrin-mediated adhesion is a complex process that involves 
integrin association with the actin cytoskeleton and clustering 
into focal adhesions: supramolecular complexes that contain 
structural proteins (vinculin, talin, tensin, etc.) and signaling 
molecules (focal adhesion kinase–FAK, etc.). [ 5 ] FAK is a non-
receptor tyrosine kinase that becomes activated in response to 
cell-matrix adhesion and is a key signaling protein involved in 
regulating cell motility, invasion, survival, and proliferation. [ 6 ] 
 Signifi cant efforts have focused on engineering materials 
that recapitulate characteristics of ECM, such as the presenta-
tion of cell adhesive motifs or protease degradable cross-links, 
in order to direct cellular responses. [ 7,8 ] Similarly, various 
approaches have been made in order to provide cells with 
dynamic-like environments able to provide proteins and factors 
using controlled delivery strategies. Direct loading, electrostatic 
interaction, covalent binding, and the use of carriers are the 
main strategies used, including the incorporation of protease-
degradable sites, adhesive ligands to direct protein and growth 
factors release. [ 9–15 ] However, the development of a cell-material 
interphase able to provide biological stimuli upon demand, a 
functional dynamic interphase between living cells and syn-
thetic materials, has not been established yet. We hypothesized 
that non-pathogenic bacteria can provide such a role, since they 
can colonize the surface of a broad range of synthetic materials 
and be genetically modifi ed to express or secrete the desired 
adhesive proteins and factors to a living cell population. 
 Among the broad range of non-pathogenic bacteria, we have 
selected food-grade  Lactococcus lactis , a gram-positive bacterium 
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with very low production of lipopolysaccharides (LPS), a man-
datory condition to preserve the accessibility of cells to the 
expressed proteins in the bacteria membrane. Moreover, 
 Lactococcus lactis has been widely used for recombinant thera-
peutic proteins production, therapeutic drug delivery and vac-
cine production. [ 16–20 ] 
 L. lactis was grown overnight at 30 ºC in M17 medium 
supplemented with 0.5% glucose in static conditions. After 
adding the grown culture over the material surface at 30  ° C, 
we observed that  L. lactis adhered, colonized and formed a co-
continuous, stable bacteria multilayer on different material sur-
faces (polymers, glass, etc.) after 3 h. To assess the interaction 
of seeded cells with the layer of bacteria in direct contact with 
the synthetic biomaterial, the material surface was coated with 
gelatin (0.1%) and the excess of bacteria was washed with PBS 
(phosphate buffered saline) before cell seeding. 
 Figure 1 shows a diagram of the living interphase developed 
in this work as a functional linker between synthetic materials 
and cells. We genetically modifi ed  L. lactis (MG1363) to express 
FNIII 7-10 in their membrane. After cloning FNIII 7-10 fused to 
GFP in pGFP-C2, then GFP-FNIII 7-10 fragment was subcloned 
(NgomIV/Klenow BamHI) in pT1NX vector [ 21 ] which con-
tains P1 lactococcal promoter, [ 22 ] usp45 lactococcal secretion 
signal sequence, and spax  Staphylococcus aureus anchor signal 
( Figure  2 a). GFP-FNIII 7-10 was cloned in frame with both sig-
nals and the resultant construct was electroporated in  L. lactis 
MG1363. The secretion and anchor signals effi ciently promoted 
the localization of GFP-FNIII 7-10 on bacteria wall. Figure  2 b 
shows bacteria aggregates displaying green fl uorescence rings, 
which show cell-surface display of the fi bronectin fragment. 
Further, to provide more evidence for the membrane expression 
of FNIII 7-10 , fractionation and western blot analysis for bacterial 
membrane proteins were performed (Figure  2 c). FNIII 7-10 was 
detected only on the part of the bacteria lysate ascribed to mem-
brane proteins (Figure  2 c, lane 1) but without any trace of the 
fragment in the intracellular fraction (Figure  2 c, lane 2). 
 L. lactis expressing FNIII 7-10 in their membrane colonize the 
surface of the synthetic material forming a homogeneous and 
viable layer of bacteria (Figure  2 d, left). Afterwards, fi broblasts 
were seeded on this layer of bacteria in serum free medium. 
In order to avoid adhesion mediated by proteins secreted by 
the mammalian cells, we used FN-null fi broblasts (FN -/-) to 
rule out the presence of any external FN on the material sur-
face other than the FN fragment anchored in the bacteria 
membrane. FN -/- fi broblasts were seeded over a layer of GFP-
FNIII 7-10 bacteria and control bacteria (empty pT1NX vector) 
as an interphase between the material surface and fi broblasts. 
Cells were allowed to attach and spread for 4 hours, and remain 
viable during the experiment without signifi cant differences 
between  L. lactis expressing FNIII 7-10 and surfaces covered with 
plasma FN ( Figure  3 ). Subsequently, cells werefi xed and stained 
for the focal adhesion protein vinculin (Figure  3 a). 
 Strikingly, cells seeded on bacteria expressing FNIII 7-10 dis-
played well-developed focal adhesions plaques, showing accu-
mulation of vinculin at focal adhesion sites (Figure  3 a, image 
1). This result indicates that FNIII 7-10 anchored in the mem-
brane of  L. lactis is able to provide the adequate functionalities 
to direct cell adhesion and spreading. This behavior is similar 
to that found when fi broblasts are seeded on a layer of adsorbed 
FN on the same material surface, as it is shown in Figure  3 a, 
 Figure  1 .  Functional living biointerphases. Non-pathogenic bacteria have been modifi ed to express a fi bronectin fragment FNIII 7-10 in their membrane 
(including GFP for identifi cation), and grown to colonize the material surface. Mammalian cells are then cultured on this living biointerphase which 
triggers cell adhesion and signaling. 
















image 3. [ 23 ] In contrast, when fi broblasts are seeded on a layer 
of the control bacteria (empty pT1NX vector) only rounded cells 
are found, without any spreading or focal adhesion plaques. 
This result was expected since there is no adhesion protein at 
the cell-material interface to trigger cell behavior (Figure  3 a, 
image 2). That is to say, cells behave on the control bacteria 
as if they were seeded directly on the bare material surface 
(Figure  3 a, image 4). 
 Focal adhesion kinase (FAK) localizes to focal adhesions to 
activate multiple signaling pathways that regulate cell migra-
tion, survival, proliferation, and differentiation. [ 24–26 ] We exam-
ined the phosphorylation of tyrosine-397, the autophosphoryla-
tion site in FAK and a binding site for src and PI-3 kinase [ 27,28 ] 
by Western blot ( Figure  4 ). Although the band for FAK remains 
approximately constant, the level of phosphorylation (pFAK) is 
signifi cantly higher for cells cultured on FNIII 7-10 -expressing 
 L. lactis whereas fi broblasts cultured on con-
trol bacteria exhibited minimal FAK phos-
phorylation (Figure  4 ). This result demon-
strates that the FNIII 7-10 displayed on the 
bacterial membrane can trigger adhesion sig-
nalling pathway in contiguous cells. Impor-
tantly, FAK phosphorylation levels were 
equivalent between FNIII 7-10 -expressing bac-
teria and synthetic surfaces coated with FN, 
indicating that the protein displayed on the 
bacterial surface retains high bioactivity. 
 In conclusion, we have developed a func-
tional interphase between synthetic materials 
and cells based on modifi ed bacteria that 
express a fi bronectin fragment (FNIII 7-10 ) 
and display it as a membrane protein. This 
living interphase supports cell adhesion 
(focal adhesion formation) and cell signal-
ling (FAK phosphorylation). Moreover, as 
this interphase is based on a living system, it 
can be further designed and exploited to pro-
vide the spatio-temporal requested proteins 
and factors to direct cell proliferation and dif-
ferentiation at the material interface. Taken 
together, this approach establishes a new 
paradigm in biomaterial surface functionali-
zation for biomedical applications. 
 Experimental Section 
 Plasmids, primers and cell line : pGFP-C2 
plasmid (Clontech) was used to construct a vector 
containing FNIII 7-10 downstream to GFP. FNIII 7-10 
was amplifi ed the plasmid pET15b-FNIII 7-10 . [29] 
The forward and reverse primers used for FNIII 7-10 
amplifi cation were: F1 (with HindIII restriction 
site).  aagctta CCATTGTCTCCACCAACAAAC and 
R1 (with SalI restriction site and stop codon) 
 gtcgac ttaTTCTGTTCGGTAATTAATGGAAA. pT1NX 
vector was used to clone GFP-FNIII 7-10 using the 
following primers F2; (with NgomIV restriction 
site): GCCGGCATGGGTAAAGGAGAAGAACTTT R2; 
TTCTGTTCGGTAATTAATGGAAA. Fibronectin-null 
FN-/- mouse fi broblasts were kindly provided by 
Prof. Mercedes Costell (University of Valencia, Spain). 
 Bacterial strains and plasmid extraction :  Lactococcus lactis subsp. 
 cremoris MG1363 [ 30 ] and pT1NX containing MG1363 were grown 
as standing cultures at 30  ° C in M17 medium (Oxoid, Basingstoke, 
UK) supplemented with glucose (0.5% v/v) and when necessary, 
erythromycin (10  μ g mL  − 1 ). For plasmid extraction from MG1363, a 
combination of manual protocol [ 22 ] and  Five Minute Miniprep  Kit (Sigma) 
was applied. After adding ice-cold sodium acetate (3  M , pH 4.8) and 
15 min centrifugation at maximum speed, the lysate was transferred to 
miniprep column and extracted following the manufacturer’s protocol. 
 Preparation of competent cells and electroporation : Competent cells 
of strain MG1363 was prepared by growing the cells in rich medium 
containing glycine (1% v/v). [ 31 ] Cells were harvested at an OD 600 of 
0.6-0.8, resuspended in sucrose (0.5  M ) and glycerol (10% v/v) and then 
frozen at −80 ºC. Electroporation was performed at 2.5 kV using BTX 
(Harvard Apparatus). In these conditions with desalted DNA, the typical 
time constant was 4.5. Electroporated cells were transferred directly to 
5 mL medium (M17, 0.5  M sucrose, 20 m M MgCl 2 , 2 m M CaCl 2 ) and 
 Figure  2 .  FNIII 7-10 expression in  L. lactis. a) Plasmid map for  L. lactis expression of GFP-
FNIII 7-10 . b) Fluorescence microscopy image of GFP-FNIII 7-10 expression in  L. lactis . A character-
istic ring is observed which supports the membrane anchorage of the FN fragment. c) Western 
blot analysis of membrane and intracellular fractions of  L. lactis . FNIII 7-10 is only found in the 
membrane fraction, with no detectable levels in the intracellular pool. d) bacterial viability assay. 
After 3 hours of culture (1-  L. lactis FNIII  7-10 and  2-L. lactis ) samples were stained with the Life 
Technologies LIVE/DEAD kit for bacteria (SYTO9 permeant green stain and propidium iodide 
non-permeant red stain). e) Quantifi cation by image analysis: both strains showed viability 
higher than 97%. 

















incubated (2 h at 30 ° C). Subsequently the culture was centrifuged, 
resuspended in 0.5 mL of the later medium and extended on M17-agar 
plates supplemented with erythromycin (10  μ g mL  − 1 ). 
 Western blots : Cells corresponding to 10 9 cfu were washed and 
resuspended in 50  μ l of washing buffer (Tris/HCl (50 m M pH 7.5) 
containing sucrose (0.5  M ) and lysozyme (50 mg mL  − 1 )). The suspension 
was incubated (2 h at 37 ° C) then centrifuged at maximum speed. 
Supernatant and pellet were separated and resuspended in Laemmli 
loading buffer (50  μ L) and boiled for 5 min and separated by 10% 
SDS-PAGE gels. FNIII 7-10 was detected by mouse anti-human fi bronectin 
cell binding domain antibody (MAB1937-Millipore). 
 Immunofl uorescence : Bacteria were seeded (10 9 cfu/mL) over glass 
coverslip coated with gelatin 0.1%. After 3 hours, the coverslip was 
washed with PBS several times to obtain a monolayer. FN-/- fi broblasts 
 Figure  3 .  a) FNIII 7-10 -expressing bacteria support cell viability, cell adhesion and focal adhesion assembly. FN -/- fi broblasts were seeded on different 
interphases and stained for vinculin after 4h. a1) Cells on modifi ed  L. lactis to express FNIII 7-10 in the membrane. a2) Cells on control  L. lactis (empty 
vector). a3) Cells on a material surface coated with fi bronectin. a4) Cells on the bare material surface (without any adhesion protein). b) Fibroblast 
viability assay. Cells were seeded on different surfaces: b1)  L. lactis FNIII 7-10 monolayer; b2)  L. lactis monolayer; b3) FN coated glass and b4) bare mate-
rial surface. c) After 4 hours cells were stained with calcein AM (green cells, viable) and ethidium homodimer (red cells, non-viable). The viability was 
higher than 93% for every surface, and higher than 99.5  ± 0.7% on  L. lactis FNIII 7-10 . 
















were seeded on the bacteria in DMEM (Dulbecco’s modifi ed eagle 
medium) without FBS (fetal bovine serum) for 4 hours (1.5  · 10 4 cells/
well). Cells were fi xed and stained with mouse anti-vinculin antibody. A 
confocal microscopy (Leica TCS SP2 AOBS) was used. 
 FAK phosphorylation : After 3 hours of culture, cells were lysed with 
RIPA buffer (Tris-HCl 50 m M , 1% Nonidet P-40, 0.25% Na deoxycholate, 
NaCl 150 m M , EDTA 1m M ) supplemented with protease inhibitor 
cocktail tablets (Complete, Roche). Proteins were concentrated using 
Microcon YM-30 Centrifugal Filter devices (Millipore) as manufacturer 
described. To   determine FAK protein expression and its phosphorylated 
form (pFAK), concentrated samples were subjected to 7% SDS-PAGE gel 
electrophoresis. Proteins were transferred to a positively charged PVDF 
membrane (GE Healthcare) using a semidry transfer cell system 
(BioRad) and blocked by immersion in skimmed milk (5% w/v) in PBS 
for 30 min at room temperature. The blot was incubated with anti-FAK 
antibody (Upstate) and anti-pFAK antibody (Millipore) diluted 1:2500 in 
PBS containing Tween 20 (0.1%) and skimmed milk (2%). After several 
washes with PBS with Tween 20 (0.1% v/v), the blot was incubated in 
horseradish peroxidase-conjugated antibody (GE Healthcare) diluted 
1:50000 in PBS containing Tween 20 (0.1% v/v) and milk (2% w/v) for 
1 hour at room temperature. After several washes with PBS containing 
Tween (0.1% v/v) and milk (2% w/v), immunoreactive bands were 
visualized using Supersignal West-femto Maximum Sensitivity Substrate 
(Thermo Scientifi c). 
 Cell viability : After 4 hours of culture, medium was removed and the 
coverslip were washed three times with PBS, then incubated 45 minutes at 
room temperature with the LIVE/DEAD mammalian cell viability kit (Life 
Technologies), using calcein AM (2  µ m ) and ethidium homodimer (2  µ m ) 
in PBS. This kit stains live cells in green and dead cells in red. Cells were 
observed in epifl uorescence microscope and manually counted using at 
least seven microscope fi elds at 20x magnifi cation for every surface. 
 Bacterial viability : Bacteria were seeded (10 9 cfu/mL) over glass 
coverslip coated with gelatin 0.1%. Coverslips were washed twice with 
NaCl 0.85% w/v. Then, the bacterial monolayer was incubated for 
30 min using a SYTO9 (5  µ m ) and propidium iodide (30  µ m ) in NaCl 
0.85% w/v solution. Afterwards, coverslips were washed once and 
mounted. Bacteria were counted using ImageJ software, using at least 
four microscope fi elds at 40x magnifi cation for every strain. 
 Figure  4 .  FAK phosphorylation for cells adhering to functional biointerphase. FN -/- fi broblasts were seeded on: modifi ed  L. lactis to express FNIII 7-10 
in the membrane; control  L. lactis (empty vector); a material surface coated with fi bronectin; bare material surface (without any adhesion protein). 
a) Representative Western blot for phosphorylated and total tyrosine-397 residue on FAK (pFAK and FAK, respectively). b) Quantifi cation of the fraction 
of phosphorylated FAK by image analysis of the Western blot bands. Error bars represent the standard deviation of three independent experiments. 
∗ stands for p < 0.05 
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Genetically modified Lactococcus lactis, non-pathogenic bacteria expressing the FNIII7-10 fibronectin
fragment as a protein membrane have been used to create a living biointerface between synthetic materials
and mammalian cells. This FNIII7-10 fragment comprises the RGD and PHSRN sequences of fibronectin to
bind a5b1 integrins and triggers signalling for cell adhesion, spreading and differentiation. We used L. lactis
strain to colonize material surfaces and produce stable biofilms presenting the FNIII7-10 fragment readily
available to cells. Biofilm density is easily tunable and remains stable for several days. Murine C2C12
myoblasts seeded over mature biofilms undergo bipolar alignment and form differentiated myotubes, a
process triggered by the FNIII7-10 fragment. This biointerface based on living bacteria can be further
modified to express any desired biochemical signal, establishing a new paradigm in biomaterial surface
functionalisation for biomedical applications.
U
nderstanding the behaviour of cells on synthetic surfaces is of foremost interest to engineer microenvir-
onments that direct cell adhesion, proliferation and differentiation. To favour the interaction with cells,
surfaces of synthetic biomaterials have been functionalized with a broad range of proteins, fragments,
peptides and growth factors including fibronectin (FN), laminin, vitronectin and others, by using physical and
chemical strategies1–3. However, these passive coatings can by no means provide the dynamic stimuli required to
orchestrate cell responses and organise the formation of a new tissue at the material interface. Significant efforts
have focused on engineering materials that recapitulate characteristics of the ECM, such as the presentation of cell
adhesive motifs or protease degradable cross-links, in order to direct cellular responses4,5. Photoactivable RGD
adhesive peptides were used to investigate the effect of the density and time point of ligand presentation on cell
adhesion, proliferation and differentiation6. Similarly, enzyme-responsive surfaces that present cell adhesive
RGD sequences on-demand, that is, by enzymatic hydrolysis of inactive RGD containing precursors that carry
cleavable steric blocking groups, have been used to spatiotemporal controlled attachment of cells7. However, the
development of a cell/material interface able to provide biological stimuli upon demand, a functional dynamic
interface between stem cells and synthetic materials, has not been established yet. We hypothesised that non-
pathogenic bacteria can colonise the surface of a broad range of synthetic materials and can be genetically
modified to constitutively express or secrete the desired adhesive proteins and factors to a living cell population
upon external demand. This work shows that non-pathogenic bacteria that constitutively express a fibronectin
fragment enhance cell differentiation. However, our long-term goal is to transform this living interface into a
dynamic system able to secrete other proteins and growth factors upon demand.
We have recently shown that genetically modified, non-pathogenic bacteria, can play the role of a (living)
biointerface between mammalian cells and synthetic biomaterials and we chose Lactococcus lactis subsp. cremoris
as host for membrane expression of the fibronectin FNIII7-10 fragment8. This fragment contains the RGD
adhesion motif (10th repeat of the type III fragment) and the PHSRN synergy site (9th repeat of type III fragment),
both of them necessary to promote a5b1 integrin mediated adhesion9. Lactococcus lactis is a gram-positive, non-
pathogenic bacterium, with GRAS (Generally Regarded as Safe) status and with low production of exopolysac-
charides, a mandatory condition to ensure the accessibility of the displayed FNIII7-10 fragments on the bacteria
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biofilms: these bacteria firmly attach to synthetic surfaces and estab-
lish communities10,11. This results in a stable layer of bacteria on the
material surface which present FNIII7-10 fragments8.
Mammalian cells interact with FN via integrins, a family of
transmembrane receptor proteins that anchor them to the ECM.
Integrin-mediated adhesion is a complex process that involves the
organization of focal adhesion clusters that link the ECM to the
cytoskeleton. Focal complexes are mature adhesion sites that con-
tains structural proteins (vinculin, paxilin, talin, tensin) and signal-
ling molecules (FAK, focal adhesion kinase, Src)3,12,13. We have
previously shown that FN null fibroblasts (FN -/-) adhered on this
living biointerface based on L. lactis expressing FNIII7-10, develop
focal adhesions and promote FAK-based signalling8.
This work investigates the potential of this living interface based
on L. lactis expressing a FN fragment as a membrane protein to direct
cell differentiation by evaluating myogenic differentiation14. As prev-
iously reported8, a modified L.lactis (MG1363) was engineered to
express FNIII7-10 as a membrane protein. The used construct features
the Usp45 secretion peptide, GFP and the FNIII7-10 fragment con-
taining the RGD adhesion (module III10) and PHSRN synergy site
(module III9). The construct is anchored into the bacterial peptido-
glycan layer by the protein A anchor (spaX) from Staphylococcus
aureus. This anchor protein is covalently linked to the tetrapeptides
of the peptidoglycan layer. L. lactis hardly produces any exopolysac-
charide, which granted the availability of the FN fragment to interact
with mammalian cells seeded on the bacterial layer (Fig. 1).
Results
We have first characterised the formation of the L. lactis biofilm on
glass, including the amount of FN that is available for cell interaction.
Then we have addressed the stability of the biofilm after different
days, that results in using a strategy to diminish bacterial metabolism
and prevent uncontrolled proliferation. Afterwards, we have
explored C2C12 interactions on this living interface, first in the
short-term (cell adhesion, cell morphology) and then in the long-
term (differentiation and related signalling).
Characterization of the bacterial-expressed fibronectin. The
Usp45 secretion and spaX (S. aureus protein A) anchor signals
Figure 1 | Schematic of living biointerfaces. C2C12 murine myoblasts were seeded on top of L. lactis biofilms that express a FNIII7-10 fragment as a
membrane protein. The construct features the Usp45 secretion peptide, GFP and the fibronectin fragment FNIII7-10 that contains both RGD (FNIII10)
and PHSRN synergy sites (FNIII9). The construct is inserted into the bacterial peptidoglycan layer by the protein A anchor (spaX). This anchor protein is
covalently linked to the tetrapeptides of the peptidoglycan layer. L. lactis strain forms stable biofilms with very low exopolysaccharide production, which
granted exposure of FN fragments to mammalian cells. C2C12 differentiated into myoblasts triggered by the FNIII7-10 fragment displayed on the bacterial
membrane.
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efficiently promote the localization of FNIII7-10 in the bacterial
membrane. We have confirmed the presence of FNIII7-10 by the
tagged GFP, which shows fluorescent rings defining the perimeter
of each bacterium (Supp Fig. S1)8. Fig 2a shows bacterial morphology
at high magnification by SEM. Additional SEM and AFM images are
included in Supp Fig. S1. We have quantified the amount of FNIII7-10
Figure 2 | Visualisation and quantification of FNIII7-10 in the bacterial membrane. (a) Low voltage SEM image of L. lactis-FN adhered to a glass
surface showing the glycocalyx and the adhesion fimbriae. Scale bar size is 200 nm. (b) – (d) Western blot analysis of membrane fractions of L. lactis using
protein extracts from 75, 50 and 25 mL of a stationary phase culture and 750, 500 and 250 ng of a purified FNIII7-10 fragment as standards (quantification
curve shown in d). Proteins isolated from bacteria have higher molecular weight due to GFP, the Usp45 and the spaX fragments (e) Quantification of
FNIII7-10 on the bacteria membrane using ELISA with HFN7.1 antibody. Biofilm activity is roughly equivalent to a surface coated with a solution of 20 mg/
mL of plasma fibronectin (300 ng/cm2). L. lactis-empty shows negligible fibronectin activity (1000 mL of bacterial culture was used both for L. lactis-
empty and L. lactis-FN, that correspond to a surface area coverage of 27.6 6 8.5%). (f) ELISA of bacterial biofilms (L. lactis-FN) from fresh GM17-E
medium and incubated in DMEM with tetracycline 10 mg/mL for 1 and 4 days respectively. ANOVA shows no statistically significant differences between
samples. All data presented as mean 6 SD.
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available on L. lactis membranes using two techniques that provide
complementary information. First, we performed fractionation and
Western blot analysis for bacterial membrane proteins and
subsequent quantification using a recombinant FNIII7-10 fragment
as the part of the bacteria lysate ascribed to membrane proteins
(Fig. 2b). Image analysis of the Western blot bands reveal that the
total amount of FNIII7-10 increases as the volume of the sample
(number of colonies) does. Based on this, the approximate density
of FN fragment per unit volume of bacteria is 0.98 mg/mL, which
corresponds approximately to 9.8 mg/108 CFU (Fig. 2 c,d). However,
considering the role of this living interface in interacting with
mammalian cells, is also important to calculate the availability of
FNIII7-10 after bacteria have been immobilised on a synthetic
material. To do so, we have performed an enzyme-linked
immunosorbent assay (ELISA) with a monoclonal antibody on
high density biofilms, prepared from 1000 mL of culture (Fig. 2e).
This is a well-established method to probe for structural or
conformational changes in adsorbed proteins15,16. We used the
monoclonal HFN7.1 antibody to probe the availability of the
flexible linker between the 9th and 10th type III repeats of FN17.
Figure 2e shows the amount of this integrin-binding domain on
the surface of the living interface is similar to adsorbing FN from a
solution of concentration 20 mg/mL on glass, a surface density of FN
ca. 300 ng/cm2,18,19. As we will use tetracycline containing medium
(TC) to maintain a stable biofilm on the material surface during
experiments with mammalian cells, and since TC might inhibit
bacterial protein expression, we have assessed that there is no
influence of TC on FNIII7-10 expression as a membrane protein
(Fig 2f).
In summary, the engineered living interface presents a high den-
sity of FNIII7-10 available on the cell surface, seeking to promote focal
adhesion organisation and trigger cell fate.
Biofilm formation and stability. We next examined the stability of
the living interface on the material surface. This strain, once the
biofilm has been established, is able to continue proliferating as
long as there is a sufficient supply of nutrients.
L. lactis is a homofermentative strain that metabolises any carbon
source found in the medium, glucose in our experiments, to L-(1)-
lactic acid, in an anaerobic fashion20. This production of lactic acid
leads to a decrease in the pH of the culture medium up to ,4,
seriously compromising the viability of the aboveground cells.
Here arises the need to control the pH of the medium, by inhibiting
the bacterial metabolism. We have found that tetracycline used at low
concentrations, 10 mg/mL, is enough to inhibit the bacterial replica-
tion without impacting mammalian cell metabolism21,22 (Fig 3 and
Figure 3 | Biofilm metabolism and viability. To assess the metabolism of the bacterial community inside the biofilm in conditions compatible with the
culture of C2C12 cells, biofilms of L. lactis-FN and L. lactis-empty were produced. Then, GM17-E medium was changed to either DMEM, DMEM
with 1% penicillin/streptomycin (P/S) or DMEM with 10 mg/mL tetracycline (TC). After 1, 2 and 4 days of culture in DMEM, DMEM1P/S and
DMEM1TC, viability was tested using the LIVE/DEAD BacLight bacterial viability kit, where viable bacteria are stained in green and non-viable in red.
(a) Representative images after 4 days. Scale bar size is 25 mm. (b) Image quantification shows that viability is not affected by either the use of antibiotics or
the culture time. No statistically significant differences among conditions were found. Data is presented as mean 6 SD. (c) Simultaneously, bacterial
metabolism was inferred by measuring the pH of the medium as a function of time, to assess the production of lactic acid. Addition of tetracycline
maintained the pH stable and above 7.5. The use of P/S was enough to maintain the pH above 6.5. In antibiotic-free DMEM, the pH dropped to a
minimum of 4 due to the transformation of glucose in the medium into lactic acid.
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results on cell differentiation later in this work). Tetracycline is a
broad-spectrum antibiotic that binds to the 30S subunit of the micro-
bial ribosomes, inhibiting the protein synthesis by blocking the
attachment of the charged aminoacyl-tRNA to the ribosomal A site23.
Conversely, penicillin acts inhibiting the peptidoglycan cell-wall
remodelling, ultimately leading to cell breakdown. As we only intend
to maintain the cell population under control, it is counterproductive
to promote cell lysis, and, as side effect, the modification of the
biofilm morphology. Moreover, tetracycline is more effective con-
trolling the pH at low concentrations and is nontoxic to mammalian
cells21,22 (see also our results on cell behaviour afterwards).
Biofilms of different densities were formed on glass and remained
stable after several days on the material surface. We have effectively
shown that we can control the surface density of bacteria on the
material surface by controlling the seeding volume (Supp Fig. S2).
We selected high-density bacterial cultures to have the highest pos-
sible L. lactis density on the material surface readily available for cell
differentiation experiments. We have assessed the stability of the
layer of bacteria at different time points up to 4 days. This is the time
needed for myogenic differentiation experiment afterwards. Fig. 3
shows live/dead staining for L. lactis grown on glass using different
media (DMEM, DMEM 1 tetracycline (TC), DMEM 1 penicillin
and streptomycin, stated as P/S). After 4 days of culture bacteria
viability (measured by the ration of live to total cells) is unaffected
by the presence of small amounts of antibiotics in the culture med-
ium and it is maintained at ca. 60% (Fig. 3b).
The temporal evolution of the pH in the different media used is
shown in Fig. 3c. Only when the culture medium is supplemented
with TC, acidification does not occur and the pH remains stable for
four days (Fig 3c). We suggest that this acidification of the culture
medium is a consequence of the L. lactis metabolism. As said before,
L. lactis is a homofermentative strain that metabolises any suitable
carbon source found in the medium - glucose in our experiments - to
L-(1)-lactic acid. Then, the production of L-(1)-acid lactic, with a
pKa of 3.8624 must be responsible for the acidification of the culture
medium. Addition of TC maintains a stable pH, which suggests that
no L-lactic acid is produced and that, consequently, bacterial meta-
bolism is inhibited.
The use of antibiotics in the culture medium diminished the den-
sity of bacteria on the material surfaces, as it can be inferred from
Fig. 3a and we have quantified in Supp Fig. S3. However, even if this is
the case, the layer of bacteria that remains on the surface is viable and
sufficient to support cell adhesion and cell differentiation, as it is
shown afterwards. That is to say, even if the layer of bacteria attained
on the material surface is not homogeneous (see e.g. Supp Fig S2), the
attained bacterial surface involves the adequate expression of FN for
mammalian cell interactions.
Cell morphology, adhesion and differentiation on L. lactis. The
density of the biofilm directs area and roundness of mammalian cells.
We first studied cell morphology on established biofilms of different
densities on glass (Supp Fig. S2). Both cell area and roundness are
directly related to the biofilm density, as shown in fig. 4. C2C12 cells
seeded on biofilms of different densities showed increased area
(Fig. 4b), with minimal changes in cell roundness (Fig. 4c). In
addition, focal adhesions were formed on cells seeded on L. lactis-
FN biofilms. The number of focal adhesion plaques increased with
the density of bacteria on the surface (Supp Fig. S4). These results
suggest that L.lactis–FN directs cell adhesion and cell morphology in
the short-term, which is necessary before considering other long-
term processes such as cell differentiation.
We previously showed that L. lactis modified to express FNIII7-10
as a membrane protein promotes focal adhesion formation and FAK
signalling at similar levels as native FN in fibroblasts8. Now, we
assessed the ability of this living interface to support cell differenti-
ation by examining myogenic differentiation25. Sarcomeric myosin
expression and cell bipolar alignment and fusion into myotubes,
markers of myogenesis, were significantly higher on L. lactis modi-
fied with FNIII7-10 (Fig. 5a) as compared to L. lactis-empty (control
bacteria that do not contain FNIII7-10). Surprisingly, myogenic dif-
ferentiation was higher on the modified L. lactis than on native
fibronectin and collagen type I, which represents the gold-standard
substrate for myogenic differentiation (Fig. 5b)14. It is important to
emphasise that these differences in myogenic differentiation are not
due to differences in the number of cells on the substrates. It is known
that a direct correlation between the number of cells on the surface
and the level of myogenic differentiation has been found, however
the number of cells on the modified bacteria is slightly lower than on
the FN and Col I controls (Fig 5c).
Integrin-mediated cell adhesion triggers a cascade of intracellular
signals such as the p38 mitogen-activated protein kinase (p38
MAPK) pathway, which is involved in the myoblast differentiation
process, by promoting the activity of several transcription factors and
regulating cell cycle withdrawal26,27. An intermediary step between
adhesion and downstream targets, including MAPK pathways, is the
phosphorylation of FAK28; as a result, FAK phosphorylation at
Tyr397 plays a central role during myoblast differentiation in 2D
cultures29,30. Initially, FAK phosphorylation at Tyr397 is transiently
reduced —contributing to trigger the myogenic genetic program—
but it is later activated, as it is central to terminal differentiation into
myotubes30. In order to study the activation of FAK on the L. lactis
expressing FNIII7-10 we examined the phosphorylation of Tyr397 by
Western blot. FAK phosphorylation was similar on modified L. lactis
and FN-coated glass (Fig 5d e), in good correlation with the high
levels of cell differentiation found in this work (Fig 5b).
These results suggest that enhanced cell differentiation can be
triggered by FNIII7-10 expressed on the membrane of L. lactis. The
fact that the same experiments have been done with L. lactis-empty
strain without significant levels of cell differentiation absolutely con-
firm FNIII7-10 expressed on the bacteria membrane as the trigger of
differentiation.
Discussion
Engineering microenvironments to provide cells with dynamic cues,
as occurs in the natural extracellular matrix, is a field of intensive
research seeking to direct the differentiation of stem cells and ad-
vance in strategies for tissue repair and regeneration31. Several
approaches have been explored spanning from the simple functio-
nalisation of material surfaces with cell adhesive motifs to the incorp-
oration of protease-degradable fragments in polymer hydrogels that
allow changes in the material structure as cells secrete proteases to
remodel the ECM7,14,32. Dynamic surfaces have been engineered to
present cell adhesive RGD sequences on-demand6,7,33.
From a different perspective, dynamic cell microenvironments
have been engineered to present and release growth factors in a
sustainable and controlled way to stimulate and support cell differ-
entiation34–40. We have recently shown that non-pathogenic bacteria
can be genetically modified to establish a functional interface
between cells and synthetic materials, and we anticipate that this
living interface could be further modified to instruct cells to perform
different functions in a highly regulated manner8. As an initial step
and proof of concept towards this long-term goal, we engineered8
food-grade Lactococcus lactis, a gram-positive bacterium with very
low production of lipopolysaccharides (LPS) - previously used for
recombinant therapeutic proteins production, therapeutic drug
delivery and vaccine production41 - to present a fibronectin fragment
(FNIII7-10) as a membrane protein. FNIII7-10 contains RGD and the
PHSRN synergy sequences and promote cell adhesion and differ-
entiation42,43. We have previously shown that fibronectin null fibro-
blasts (FN -/-) adhere, spread and develop focal adhesions on this
engineered L. lactis expressing FNIII7-10, in a similar way as when
seeded directly on a FN coating8.
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Here, we show that this living interface that constitutively express
a FN fragment is able to produce stable biofilms that support cell
growth, cell adhesion and cell differentiation. The formation of the
biofilm starts when some individual cells adhere to the surface, a
process governed by weak non-specific forces - Van der Waals and
polar Lewis acid-base interactions44,45. This initial, reversible attach-
ment becomes irreversible after bacteria make use of several cell-wall
anchored proteins (CWAP) known as adhesins. In L. lactis, the most
prominent ones are the CluA sex factor and the PrtP and NisP
proteinases10,46,47. These adhesins act modifying the bacterial surface
properties and ultimately lead to an irreversible attachment of the
bacteria to the surface. After bacteria attachment becomes irrevers-
ible, the force required to detach additional bacteria increases and
more bacteria are recruited and co-aggregated to the existing ones.
Afterwards, these bacteria proliferate and develop the biofilm itself.
In this phase, a few hours after the initial irreversible attachment, a
stable layer is formed. As L. lactis MG1363 is a strain with a low
production of exopolysaccharides, biofilms are usually monolayered,
lacking the horizontal stratified structure found in other species48,49.
Hence, the formation of L. lactis biofilms seems limited to a thin
layer, usually a monolayer50, of strongly attached bacteria to almost
any abiotic surface, such as polymers, glass or metallic surfaces.
Usually, the adhesion of the bacterium to the substrate is mediated
by the bacterial fimbriae, also called adhesion pili51. These fimbriae
are also involved in the formation of the bacterial aggregates, as
shown in Supp Fig. S1.
Once the biofilm has been successfully established, a need to con-
trol its proliferation arises, and we found that the monolayer can be
controlled to remain in a stationary phase (using low amount of
tetracycline) on the material surface during the time needed to com-
plete the myogenic differentiation process (up to 4 days). We have
quantified the amount of FNIII7-10 that is available on the surface of
the bacterial and verified that it promotes cell adhesion, signalling
and cell differentiation. Overall, this living interface based on non-
Figure 4 | Morphological features of C2C12 myoblasts related to biofilm density. A 3 h culture of C2C12 cells seeded on top of biofilms of different
surface density. Briefly, 10,000 cells/cm2 were seeded on top of L. lactis-FN biofilms of increasing density (covered surface area 4.6%, 11.4%, 19.1% and
27.6%), and L. lactis-empty biofilm produced with an surface density of 27.6%. Afterwards, cells were stained with a monoclonal anti-vinculin antibody
(shown in red), whereas the actin cytoskeleton was stained with phallacidin (in green). Both nuclei of C2C12 cells and bacterial cells are shown in blue. (a)
C2C12 cells seeded over L. lactis-empty biofilm showed no adhesion and remained in their original rounded shape. Cells seeded on L. lactis-FN biofilms
showed good adhesion and well-developed focal adhesion plaques and actin cytoskeleton. Scale bar is 100 mm. (b) Quantification of cell area on the
different biointerfaces suggests a correlation between cell area and the surface density of the biofilm. Area and roundness of at least 450 cells were
quantified using the ImageJ software. (c), Quantification of cell roundness, defined as roundness 5 (4?Area)/(p?(major axis)2). ANOVA test (N $ 400)
shows statistically significant differences between cells seeded on L.lactis-empty, FN-coated surfaces and glass.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 4 : 5849 | DOI: 10.1038/srep05849 6
153
pathogenic bacteria supports myogenic differentiation. Further gen-
etic modification of this living interface is being currently done to
engineer a dynamic system able to provide cells different temporal
stimuli beyond cell adhesion, such as the delivery of growth factors
and other molecules upon external demand. By engineering non-
pathogenic bacteria to synthesise proteins and growth factors upon
external stimuli, we aim at control the interface between synthetic
biomaterials and stem cells to control self-renewal and differenti-
ation, which can be then applied to several strategies to promote
tissue repair and regeneration.
Methods
Genetic modification of L. lactis. The GFP-containing plasmid pGFP-C2 (Clontech)
was used to construct a vector contain ing FNIII7-10 downstream to GFP. FNIII7-10
fragment was amplified from the plasmid pET15b- FNIII7-1052. The forward and
reverse primers used for the FNIII7-10 amplification were F1, with HindIII restriction
site:
aagcttaCCATTGTCTCCACCAACAAAC, and R1, with SalI restriction site:
gtcgacttaTTCTGTTCGGTAATTAATGGAAA. The lactococcal plasmid PT1NX
was used to clone the GFP- FNIII7-10 fragment using the following primers: F2, with
NgomIV restriction site gccggcATGGGTAAAGGAGAAGAACTTT; and R2:
TTCTGTTCGGTAATTAATGGAAA. Lactococcus lactis MG136353 containing
the PT1NX plasmid was grown as standing culture, in anaerobic conditions, at 30uC
in M17 medium (Oxoid, Basingstoke, UK) supplemented with glucose (0.5% v/v,
Sigma) and erythromycin (10 mg/mL, Sigma-Aldrich) (hereinafter GM17-E). The
plasmid extraction was carried using a protocol described elsewhere8. Competent L.
lactis MG1363 cells were prepared growing the cells in rich medium supplemented
with glycine (1% v/v). Cells were harvested when the culture reached an optical
density of 0.6–0.8 measured at 600 nm, resuspended in glucose (0.5 M) with glycerol
(10% v/v) and frozen at 280uC. Electroporation was performed at 2.5 kV using a
BTX electroporator (Harvard Apparatus). In these conditions, with desalted DNA,
the typical time constant was 4.5. Electroporated cells were transferred directly to
5 mL medium composed of M17, glucose (0.5 M), MgCl2 (20 mM) and CaCl2
Figure 5 | Myogenic differentiation and cell signalling on living biointerfaces. (a) Fluorescence staining after 4 days of culture showing sarcomeric
myosin-positive cells (green) and cell nuclei (red) on L. lactis-FN, L. lactis-empty, collagen I (1 mg/mL) coated glass, and FN (20 mg/mL) coated glass.
Scale bar is 25 mm. (b) Myogenic differentiation as determined by the percentage of sarcomeric myosin-positive cells on the different interfaces. Higher
degree of differentiation was found on L. lactis-FN compared to collagen I and FN coated glass. (c) C2C12 cell density on biofilms and control substrates
(d) Representative western blot bands for pFAK and FAK on the different biointerfaces. (e) Quantification of western blot bands. ANOVA test shows
statistically significant differences between each column. Data is presented as mean 6 SD.
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(2 mM) and incubated for 2 h at 30uC. The resultant culture was centrifuged,
resuspended in 50 mL of the later medium and extended on GM17-E agar plates.
Biofilm formation. The protocol to establish a biofilm on the material surface has
been published elsewhere54,55. Briefly, Lactococcus lactis MG1363 containing the
PT1NX- FNIII7-10 -GFP plasmid8 (hereinafter L. lactis-FN) and L. lactis containing
the PT1NX empty vector (L. lactis-empty) were grown as standing cultures in GM17-
E broth at 30uC. Then, 1 mL of each culture was used to streak fresh GM17-E agar
plates (1% w/v agar). The plates were kept at 30uC for 24 h. A single colony from a
GM17-E agar plate was inoculated into sterile GM17-E broth (Oxoid). The culture
was grown until OD660 , 0.3, and then transferred to a P24 multiwell plate containing
sterile glass coverslips in each well, using 300 mL and 1000 mL respectively in order to
produce low and high areal density biofilms. The multiwell plate was sealed with
Parafilm and left at 30uC in anaerobic conditions for 48 h. After that, the planktonic
(non-adhered) bacteria were removed by shaking the multiwell plate at 150 rpm for
3 min followed with three washing steps with sterile ultrapure water. In the last wash,
the ultrapure water was substituted with PBS supplemented with CaCl2 and MgCl2
(PBS11). The same protocol was used for empty and FN-expressing strains.
Biofilm viability and metabolism. For bacterial viability studies, after 1, 2 or 4 days,
biofilms were gently washed twice with sterile NaCl 0.85% w/v solution and incubated
for 30 min using the BacLight LIVE/DEAD kit (Life Technologies), containing
SYTO9 (5 mM) and propidium iodide (30 mM) in NaCl 0.85% w/v. Afterwards,
samples were washed and mounted using BacLight Oil mounting medium (Life
Technologies). Bacteria were counted using Fiji – ImageJ software56, using at least four
microscope fields at 403 magnification for every sample. The viability was
determined as the ratio between the viable and total number of bacteria.
For metabolism analysis, biofilms were prepared following the biofilm formation
protocol. Afterwards, the medium was changed to either DMEM or DMEM con-
taining tetracycline (TC, 10 mg/mL)) or DMEM containing 1% penicillin-strep-
tomycin (P/S). Biofilms were kept at 37uC in a humidified atmosphere under 5% CO2,
and the pH was monitored as a function of time (0, 0.5, 1, 1.5, 2, 3, 4, 5, 24 and 48 h)
using a pH-meter (Eutech Instruments).
AFM and SEM imaging of the biofilms. For SEM imaging, bacterial biofilms were
produced as described in the biofilm formation section. Freshly washed biofilms were
fixed in 2.5% glutaraldehyde in phosphate buffer (PB, 0.1 M, pH 7.3) for 14 hours at
4uC. Then, biofilms were washed twice with PB and dehydrated in an ethanol/water
mixture of 50%, 70%, 80%, 90%, 95% and 100% for 10 minutes each. The 100%
ethanol step was repeated three times. Afterwards, samples were immersed twice in
hexamethyldisilazane (Sigma) and air-dried for 10 minutes57. Samples were stored in
vacuum until imaging in the microscope. Prior to imaging, samples were sputter-
coated with a 1 nm layer of platinum and observed in a Zeiss Ultra 55 Field Emission
SEM (Zeiss Microscopy, Germany) with 1 kV of gun acceleration voltage.
For AFM, a culture in stationary phase was washed twice with sodium acetate
(100 mM, pH 4.8) and three millilitres of the resulting bacterial suspension with the
same bacterial density as the original culture were filtered through a porous poly-
carbonate membrane with a mean pore size of 0.8 mm (Millipore). The membrane
was gently washed with the same sodium acetate solution to remove the non-trapped
bacteria, while avoiding dewetting58. The wet sample was imaged in a Multimode
AFM equipped with a NanoScope IIIa controller from Veeco (Manchester, UK) in
QNM mode. Si cantilevers from Veeco were used, with a force constant of 0.7 N/m.
Drive amplitude was 100 mV and amplitude setpoint was 250 mV.
Surface density of FN - ELISA. 3 mL from a 24 h standing culture of L. lactis-FN and
L. lactis-empty grown in sterile GM17-E, with a bacterial density of 107 cfu/mL, were
filtered through a porous polycarbonate membrane with a mean pore size of 0.8 mm
(Isopore, Millipore). The membrane was washed twice with PBS11 to remove the
non-trapped bacterial cells. Another set of membranes was coated with 20, 10, 5 and
2.5 mg/mL of human plasma fibronectin (Sigma) in PBS11 for 1 h at RT, and
washed twice with PBS11. Uncoated membranes were used to assess the absence of
any background signal in the polycarbonate membranes. Membranes were then
blocked with 1% bovine serum albumin (Sigma) in PBS11 for 1 h at RT, and
incubated for 1 h at 37uC with monoclonal mouse HFN7.1 anti-fibronectin antibody.
The primary antibody dilution was 154000 from a 32 mg/mL antibody stock. After
that, samples were washed twice with PBS11/Tween 20 (0.5% v/v) and incubated
with ALP-conjugated donkey anti-mouse secondary antibody (Jackson
Immunoresearch) for 1 h at RT. Samples were washed again twice with PBS11/
Tween 20 (0.5% v/v), and 400 mL of 4-methylumbelliferyl phosphate (0.6 mM,
Sigma) in borax/NaOH pH 10 buffer was added. After 45 min at 37uC, the
supernatant was transferred to a P96 multiwell plate. Fluorescence was measured at
365/460 nm (excitation/emission wavelengths) with a Perkin-Elmer Victor3
Multilabel Counter (Perkin Elmer).
Surface density of FN - Western blot. Three aliquots of 1.5, 1 and 0.5 mL from a 24 h
standing culture of both L. lactis-FN and L. lactis-empty strains in GM17-E were lysed
using a modified acetone/SDS protocol59. Briefly, cells were harvested by
centrifugation at 7000 g for 5 min, washed twice with PBS without Mg21 and Ca21
and centrifuged again. The pellet was treated with 1 mL of acetone at -20uC for
10 min, with occasional vigorous vortexing. The extract was centrifuged at 7000 g for
5 min and carefully dried under a gentle stream of N2 until a porous, dry white
powder was obtained. Proteins were solubilised by incubating the previously obtained
powder with 100 mL of SDS (1% w/v) for 20 min at RT, with occasional vortexing.
Debris were pelleted by centrifugation at 7000 g for 5 min. 20 mL of the supernatant
was mixed with 20 mL of 2x Laemmli buffer and boiled for 5 min at 95uC, and
samples were loaded on 10% SDS-PAGE gels. Simultaneously, 750, 500 and 250 ng of
a purified fragment of FNIII7-10 were loaded in the same gel as controls. Proteins were
transferred to a positively charged PVDF membrane (GE Healthcare) using a semi-
dry transfer cell system (Bio-Rad). Membranes were blocked using 5% skimmed milk
in PBS for 1 hour at RT and then incubated with the MAB1937 antibody (Millipore)
directed against the 8th type III repeat in human FN diluted 151000 in PBS
containing Tween 20 (0.1% v/v) and skimmed milk (2% w/v), overnight, at 4uC. After
several washes with PBS/Tween 20 (0.1% v/v), the blot was incubated using
horseradish peroxidase-conjugated anti-mouse antibody (GE Healthcare) diluted
1550,000 in PBS/Tween 20 (0.1% v/v)/skimmed milk (2% w/v) for 1 h at RT.
Membranes were washed several times with Tween 20 (0.5% v/v) in PBS. The
immunoreactive bands were visualized using the ECL Plus Western blot kit (GE
Healthcare).
C2C12-biofilm co-culture. C2C12 cells (American Type Culture Collection) were
maintained in DMEM medium with 20% Foetal Bovine Serum (FBS) and 1%
penicillin-streptomycin. Then, they were seeded over freshly washed biofilms at
20.000 cells per cm2. The culture was maintained 3 h at 37uC in a humidified
atmosphere under 5% CO2 to ensure initial adhesion to the biofilm. After 3 h, the
medium was changed to DMEM with 1% ITS (insulin-transferrin-selenium, Life
Technologies) and tetracycline (10 mg/mL, Sigma-Aldrich) to maintain the
proliferation of the bacteria under control and prevent the acidification of the culture
medium by lactic acid production. The culture was kept for 4 days at 37uC and 5%
CO2 in a humidified atmosphere.
Immunofluorescence. Cultures were fixed at 4uC with 70% ethanol, 37%
formaldehyde and glacial acetic acid (205251) for 15 min and then blocked with 5%
goat serum in PBS11 for 1 h at RT. The samples were incubated with MF-20
antibody against sarcomeric myosin (Developmental Studies Hybridoma Bank,
University of Iowa, USA) at 15250 dilution in PBS11 and 5% goat serum, followed
by two washes with PBS11/Tween 20 (0.5% v/v) and another blocking step with 5%
goat serum in PBS11 for 10 min at RT. Then were washed twice with PBS11/
Tween 20 (0.5% v/v) and incubated with rabbit anti-mouse Cy3-conjugated
secondary antibody (Jackson Immunoresearch) at 15200 dilution in PBS11 with 5%
goat serum. Samples were then washed three times with PBS11/Tween 20 (0.5% v/
v), mounted with Vectashield-DAPI, and observed under an epifluorescence
microscope (Nikon Eclipse 80i).
Images from the fluorescence microscope (DAPI channel - nuclei, and Cy3 channel
- sarcomeric myosin) of the C2C12 culture were acquired at 103 magnification,
transformed to an 8-bit grayscale bitmap (Fiji - ImageJ software) and segmented
using the Trainable Weka Segmentation plugin to create a binary mask, for both
DAPI and Cy3 channels. Total nuclei per image were counted using the particle
analysis command. Then, the segmented DAPI channel image was subtracted from
the Cy3 channel segmented image, and the remaining nuclei were counted and
assigned to non-differentiated cells. The fraction of differentiated cells was calculated
subtracting the non-differentiated nuclei from the total nuclei count.
For vinculin and actin visualisation, a slightly different protocol was used. Cell
fixation was performed using formalin for 30 min at 4uC. Then cells were blocked
with 1% BSA in PBS11. A monoclonal anti-vinculin antibody (Sigma), diluted
15400 in BSA 1%/PBS11 was used as primary antibody. The incubation lasted
1 hour at RT. Then, cells were washed twice with PBS11/Tween 20 (0.5% v/v), and
incubated with rabbit anti-mouse Cy3 conjugated (Jackson Immunoresearch), 15200
dilution, with FITC-conjugated phallacidin (Life Technologies) diluted 15100 in 1%
BSA/PBS11/Tween 20 (0.5% v/v). The secondary antibody was incubated 1 hour at
RT in absence of light. Cells were washed three times with PBS/Tween 20 (0.5% v/v)
and mounted with Vectashield-DAPI (Vector Laboratories).
FAK phosphorylation. After 3 hours of culture, cells were lysed with RIPA buffer
(Tris-HCl 50 mM, 1% Nonidet P-40, 0.25% Na deoxycholate, 150 mM NaCl, 1 mM
EDTA) supplemented with protease inhibitor cocktail tablets (Complete, Roche).
Proteins were concentrated using Microcon YM-30 Centrifugal Filter devices
(Millipore) as manufacturer described. To determine FAK protein expression and its
Tyr397 phosphorylated form (pFAK), concentrated samples were subjected to 7%
SDS-PAGE gel electrophoresis. Proteins were transferred to a positively charged
PVDF membrane (GE Healthcare) using a semidry transfer cell system (Bio-Rad) and
blocked by immersion in skimmed milk (5% w/v) in PBS for 1 h at room temperature.
The blot was incubated with anti-FAK antibody (Upstate) and anti-pFAK antibody
(Millipore) diluted 152500 in PBS containing Tween 20 (0.1%) and skimmed milk
(2%). After several washes with PBS/Tween 20 (0.1% v/v), the blot was incubated in
horseradish peroxidase-conjugated antibody (GE Healthcare) diluted 1550000 in
PBS/Tween 20 (0.1% v/v) and milk (2% w/v) for 1 hour at room temperature. After
several washes with PBS containing Tween (0.1% v/v) and milk (2% w/v),
immunoreactive bands were visualized using Supersignal West-femto Maximum
Sensitivity Substrate (Thermo Scientific).
Statistical analysis. All data presented in this paper are shown as mean 6 SD.
Figure 4b and 4c (cell area and cell roundness): A D’Agostino & Pearson omnibus
normality test was performed, finding that the data do not follow a Gaussian
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distribution. Then, a non-parametric ANOVA followed by a Kruskal-Wallis (Dunn)
multiple comparison test was performed, with p 5 0.05.
Figure 5b and 5e, corresponding to the C2C12 differentiation assay and cell
density respectively: A D’Agostino & Pearson omnibus normality test was done,
finding that the data follows a Gaussian distribution. Then, a one-way ANOVA
with p 5 0.05 followed by a Tukey multiple column comparison test was per-
formed.
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